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ABSTRACT  
   
[FeFe]-hydrogenases are enzymes for the reduction of protons to hydrogen. They 
rely on only the earth abundant first-row transition metal iron at their active site 
(H-cluster). In recent years, a multitude of diiron mimics of hydrogenases have been 
synthesized, but none of them catalyzes hydrogen production with the same exquisite 
combination of high turnover frequency and low activation energy as the enzymes. 
Generally, model complexes fail to include one or both of two features essential to the 
natural enzyme: an intricate array of outer coordination sphere contacts that constrain the 
coordination geometry to attain a catalytically optimal conformation, and the redox non-
innocence of accessory [FeS] clusters found at or near the hydrogen-activating site. The 
work presented herein describes the synthesis and electrocatalytic characterization of 
iron-dithiolate models designed to incorporate these features. First, synthetic strategies 
are developed for constructing peptides with artificial metal-binding motifs, such as 1,3-
dithiolate and phosphines, which are utilized to append diiron-polycarbonyl clusters onto 
a peptide. The phosphine-functionalized peptides are shown to be better electrocatalysts 
for proton reduction in water/acetonitrile mixtures than in neat acetonitrile. Second, we 
report the impact of redox non-innocent ligands on the electrocatalytic properties of two 
types of [FeFe]-hydrogenase models: dinuclear and mononuclear iron complexes. The 
bidentate, redox non-innocent α-diimine ligands (N-N), 2,2'-bipyridine and 
2,2'-bipyrimidine, are used to create complexes with the general formula 
(μ-SRS)Fe2(CO)4(N-N), new members of the well known family of asymmetric diiron 
carbonyls. While the 2,2'-bipyridine derivatives can act as electrocatalysts for proton 
reduction, surprisingly, the 2,2'-bipyrimidine analogues are found to be inactive towards 
ii 
catalysis. Electrochemical investigation of two related Fe(II) complexes, (bdt)Fe(CO)P2 
for bdt = benzene-1,2-dithiolate and P2 = 1,1'-diphenylphosphinoferrocene or methyl-2-
{bis(diphenylphosphinomethylamino}acetate, related to the distal iron in [FeFe]-
hydrogenase show that these complexes catalyze the reduction of protons under mild 
conditions. However, their reactivities toward the external ligand CO are distinguished by 
gross geometrical differences. 
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Chapter 1 
Introduction: An overview of hydrogenases, active site analogues of [FeFe]-
hydrogenases, and the summary and scope of this dissertation 
 
Introduction 
The utilization of hydrogen by micro-organisms as a fuel or usage of protons as terminal 
electron acceptors (producing hydrogen gas) is catalyzed by a class of metalloenzymes 
named hydrogenases.
1, 2
 Hydrogenases harbor earth-abundant transition metal clusters 
that have the ability to activate or produce hydrogen. The relevance of this reaction 
towards building a future hydrogen economy has spurred widespread interest in these 
enzymes.
3, 4
 Hydrogen is a carbon neutral, environmentally friendly fuel that is poised to 
become a major energy carrier in the future by virtue of its clean combustion to water in 
fuel cells,
5
 and direct production of hydrogen from water using solar energy is 
appealing.
6
 However, owing to the intrinsic stability of the hydrogen molecule, both 
production and oxidation of hydrogen at ambient temperatures require efficient 
electrocatalysts, and the current industry standards are mostly based on expensive noble 
metals such as platinum or palladium, the sustainability of which on a global scale is 
doubtful.
7, 8
 Hydrogenases offer a possible alternative to precious metal catalysts because 
they can operate with very high turnover frequencies at low electrochemical 
overpotential, and their catalytic activity relies on active sites composed of first row 
transition metals such as nickel and iron.
9, 10
 Therefore, understanding the mechanism of 
2 
these enzymes and expanding that chemistry by constructing biomimetic molecular 
catalysts or artificial metalloenzymes has become a significant research goal. 
Overview of Hydrogenases 
Hydrogenases can be classified into three types depending on the metal content of the 
active site: [NiFe]- and [FeFe]-hydrogenases, which produce or oxidize hydrogen, and a 
third type, referred to as [Fe]-hydrogenases, which can activate hydrogen in the presence 
of an organic cosubstrate but do not mediate redox reactions of protons or hydrogen.
11
 
Although phylogenetically unrelated, [NiFe]- and [FeFe]-hydrogenases share several 
common features. In both enzymes, the hydrogen producing (or oxidizing) bimetallic 
active site is buried deeply in a naturally engineered cavity of the protein and connected 
to the surface via a series of iron-sulfur clusters that serve as a conduit for fast electron 
transfer.
12, 13
 As shown in Figure 1-1A, the active site of [FeFe]-hydrogenases, commonly 
referred to as the H-cluster, is composed of two sub-sites connected via a bridging 
cysteinyl thiolate: a redox active [4Fe4S] cubane which operates as a redox-buffer by 
delocalizing and transferring electrons, and a biologically unusual [2Fe2S] unit where the 
catalytic reaction takes place.
14-17
 The [2Fe2S] subunit consists of two iron centers that 
are bound by a combination of five diatomic CN
-
 and CO ligands and connected by a 
unique non-proteinaceous bridging dithiolate, SCH2XCH2S, where the bridgehead atom, 
X, is likely a nitrogen (NH).
18-21
 The iron adjacent to the cubane is thought to be a six 
coordinate, low spin Fe(II) center, and the iron distal to the cubane is a five coordinate Fe 
center with an open coordination site at which the substrate turnover is believed to take 
place. The [NiFe] active site features a heterobimetallic assembly with remarkable 
similarity to the [2Fe2S] cluster of [FeFe]-hydrogenases (Figure 1-1B). It also contains a 
3 
low spin Fe(II) center bound to CO and CN
-
 ligands that is bridged to a nickel center 
through two cysteinyl thiolates.
22-24
 The nickel first coordination sphere is completed by 
two terminal cysteine thiolates. Theoretical and experimental studies indicate that the 
Fe(II) center remains redox-silent throughout the enzymatic cycle, and the oxidation state 
of the nickel center varies between Ni(II) and Ni(III).
25, 26
 The third type, 
[Fe]-hydrogenases, is structurally distinct from the other two types since it contains a 
mononuclear iron complex as active site and no iron-sulfur clusters.
27
 Nonetheless, the 
active site of [Fe]-hydrogenases bears some resemblance to those of the bimetallic 
enzymes in that it also possesses a low spin Fe(0) or Fe(II) center coordinated to two CO 
ligands, one thiolate and one N/O ligand (Figure 1-1C).
28-30
 The similarity in the ligand 
sets present in the organometallic active sites of all three types of hydrogenases implies 
that these ligands play a critical mechanistic role that facilitates proton reduction and 
hydrogen activation at the iron or nickel center under ambient conditions. 
Active site models of [FeFe]-hydrogenases 
Although natural hydrogenase enzymes are excellent catalysts for proton reduction (or 
hydrogen activation), their utility in bio-fuel cell application has been limited by a 
number of factors. First, isolation of these enzymes in large quantities from natural 
sources is difficult. Second, utilization of enzymes as electrocatalysts in bio-fuel cells 
requires high loadings on electrodes which may prove impossible to achieve. Third, the 
extreme sensitivity of these enzymes toward small molecules such as oxygen and carbon 
monoxide makes them unsuitable for long term use in any device. These limitations have 
prompted the development of model organometallic complexes that are inspired by the 
biomechanistic insights obtained by studying the enzymes and built from inexpensive 
4 
first-row transition metals. The elucidation of atomic level crystal structures of the 
hydrogenases and the surprising chemical similarities of the active sites of these 
evolutionarily unrelated enzymes to each other and to well known classes of 
organometallic compounds have led to the synthesis of a multitude of model complexes. 
In this dissertation, we will focus specifically on organo-iron models of [FeFe]-
hydrogenases and discuss the major features thought to be essential in functional mimics 
of this enzyme. 
The [2Fe2S] subsite of the H-cluster in [FeFe]-hydrogenases is reminiscent of 
rudimentary 'CO mobilized' iron-sulfur complexes of the form (μ-SRS){Fe(CO)3}2  
where  R denotes organic groups. Derivatives of this class of diiron compounds, 
synthesized by modification of the bridging dithiolate and substitution of one or more 
carbonyls with donor abiological ligands, have provided a library of structural and 
functional models of the [2Fe2S] subunit.
31-33
 However, it is worth noting that although 
several of these diiron models display moderate electrocatalytic activity towards proton 
reduction, they require significantly higher overpotential, exhibit slower catalytic rates 
and are rarely bidirectional compared to the native enzymes.
34
 Several structural and 
functional differences are responsible for the poor catalytic performances of these 
complexes. First, in contrast to the enzymatic catalysis in which the cluster operates in 
the Fe
I
Fe
I
 redox state (Hred),
12, 26, 35
 the model diiron complexes invariably rely on the 
Fe
I
Fe
0
 redox state for proton reduction.
32
 As a result, synthetic diiron analogues require 
substantially higher overpotential to carry out electrocatalytic proton reduction. Second, 
the outer coordination sphere interactions inside the protein cavity of the natural enzyme 
modulate the geometry of the [2Fe2S] subsite to attain a 'rotated' conformation in which 
5 
the two iron centers are each in square pyramidal first coordination spheres but with one 
center inverted relative to the other. On the other hand, the catalytically active diiron 
model complexes generally feature the two iron centers in an eclipsed conformation.
36
 
While the 'rotated' geometry creates a free coordination site on the distal iron (Fed) of H-
cluster to facilitate substrate binding, the reactive binding site of the models is between 
the two iron centers. Third, the natural catalytic cycle involves terminal hydride 
intermediates that are formed at the open coordination site on Fed.
13, 26
 Since the synthetic 
analogues lack a free coordination site on one iron center, they often employ relatively 
inert, bridging hydride intermediates.
31, 32
 Fourth, while the [2Fe2S] cluster in the natural 
system can bind exogenous ligands such as CO and H2, 
15, 17, 37
 such reactivity is rarely 
observed in synthetic analogues because of the lack of the free coordination site.
33, 38, 39
 
The enzyme can be oxidized to Fe
II
Fe
I
 state, capable of binding H2, but the diiron (Fe
I
Fe
I
) 
model complexes have limited stability under oxidative conditions.
40, 41
 Fifth, according 
to theoretical studies, the [4Fe4S] cubane fulfills crucial redox functions that are central 
to the enzymatic catalytic cycle,
42, 43
 but examples of diiron model complexes featuring 
redox-active cofactors are relatively scarce.
33, 44-46
 Designing bio-inspired electrocatalysts 
with improved activity by incorporating some or all of these critical factors represents an 
important and challenging target for synthetic chemists. 
Summary and scope of the dissertation 
The central hypothesis of this thesis is that two essential features of the natural enzyme, 
the protein environment and the redox active [FeS] cofactors, are crucial for facile 
catalysis and therefore, model complexes should be designed to incorporate these 
features. In this dissertation we will describe the synthesis and electrocatalytic properties 
6 
of a number of distinct diiron models of [FeFe]-hydrogenases. The specific goals of the 
research presented herein were to: (1) develop synthetic methodologies for appending 
diiron cluster onto peptide scaffolds, (2) investigate the influence of non-innocent ligands 
on the electrochemical properties of the complexes, and (3) study the effect of varying 
the coordination geometry around iron centers. 
First, we present two different synthetic strategies for incorporating two metal-
binding functional groups not usually found in proteins, 1,3-dithiol and phosphines, into 
small peptides. These ligands have been subsequently used to anchor diiron-polycarbonyl 
clusters (Chapter 2, 3). With the improved solubility of the complex provided by the 
peptide, we are able to study the electrocatalytic activities of the metallopeptide 
complexes in mixed aqueous solvents. The activities display an interesting trend of 
improved catalysis with an increasing amount of water. Second, we describe the impact 
of a bidentate, chelating, redox non-innocent ligand, 2,2'-bipyridyl (bpy), on the 
electrocatalytic properties of the diiron model {μ-S(CH2)3S}Fe2(CO)4(bpy), a new 
member of the well-known family of diiron carbonyls (Chapter 4). It is basic compared 
to related disubstituted complexes and is reduced at unexpectedly mild potentials. Third, 
we expand the bpy research to explore the impact of the identity of the bridging dithiolate 
and the bidentate, chelating N-donor ligand on the electrocatalytic properties of diiron 
analogues (Chapter 5). Two different dithiolate ligands, 1,3-propanedithiolate and 1,2-
benzenedithiolate, and two N-donor ligand, 2,2'-bipyridine and 2,2'-bipyrimidine, are 
used for the electrochemical studies. Finally, we describe the electrocatalytic activity of 
pentacoordinate Fe(II) complexes related to the distal iron in [FeFe]-hydrogenase 
(Chapter 6). These complexes catalyze electrochemical proton reduction at exceptionally 
7 
mild overpotentials albeit with modest turn-over frequencies. In summary, the 
hydrogenase related model systems presented herein lay the foundation for developing 
more sophisticated systems with tailored secondary coordination sphere interactions and 
widen our  knowledge of the utility of non-innocent ligands in building efficient 
molecular electrocatalysts. 
 
Figure 1-1. Structures of hydrogenases. X-ray crystal structures of (A) the [FeFe]-
hydrogenase from Clostridium pasteurianum (PDB code: 3C8Y),
47
 (B) the [NiFe]-
hydrogenase from Desulfovibrio vulgaris Miyazaki F (PDB code:  1H2R),
48
 and (C) the 
[Fe]-hydrogenase from Methanocaldococcus jannaschii (PDB code: 3F47).
49
 The top 
row shows the structures of the holoenzymes and the bottom row shows the enzyme 
active sites. The protein structures were drawn using PyMOL. The atoms are represented 
as carbon (grey), nitrogen (blue), oxygen (red), sulfur (yellow), nickel (green), and iron 
(orange). 
8 
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Abstract 
A general method for immobilization of synthetic analogues of the [FeFe]-hydrogenase 
in designed peptides via on resin modification of an amino acid sidechain with a dithiol 
functional group is described. Utilizing a unique amine side chain as anchor, the dithiol 
unit is coupled to the peptide via formation of an amide. This dithiol unit precisely 
positions the two required sulfurs for formation of a (μ-SRS)[Fe(CO)3]2 cluster on 
reaction with Fe3(CO)12. UV-vis and FTIR spectroscopy demonstrate formation of the 
desired complex. 
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Introduction 
Hydrogen is an energy currency in both biological and industrial settings, and 
hydrogenases are the biological catalysts for the interconversion of protons and hydrogen.  
This reaction is at the heart of hydrogen's usage as a fuel.
[1]
 Unlike industrial catalysts 
that rely on precious metals to catalyze hydrogen activation, biology takes advantage of 
the earth-abundant metals nickel and iron. FTIR and X-ray crystallographic studies have 
shown that both [NiFe]- and [FeFe]-hydrogenases contain unusual, organometallic active 
sites utilizing biologically unprecedented CO and CN as intrinsic ligands.
[2-9]
  
The structure of the active site of [FeFe]-hydrogenases (Scheme 2-1) consists of 
an unusual [Fe2S2] subunit bridged to an ordinary [4Fe4S] cubane via a single cysteinyl 
sulfur atom. The diiron subsite contains two features that are remarkable from a 
biological perspective: (1) the aforementioned diatomic ligands and (2) a dithiol organic 
bridging molecule that has been alternatively proposed to contain carbon, nitrogen or 
oxygen at its central position.
[10-13]
 From a synthetic chemistry perspective, the active site 
of [FeFe]-hydrogenases has remarkable structural similarities to many known iron 
carbonyl compounds, and considerable progress in understanding the mechanism of this 
enzyme has been achieved via synthesis of relevant model compounds.
[14-20]
 
Despite the wealth of biomimetic chemistry that has been reported, there still exist 
several important functional differences between synthetic model compounds and [FeFe]-
hydrogenases. Model compounds cycle through the more reduced Fe(I)-Fe(0) redox state 
during electrocatalytic reduction of protons whereas [FeFe]-hydrogenases are believed to 
utilize the Fe(II)Fe(I) state.
[14]
 Similarly, model compounds require substantial 
overpotentials to catalyze the reduction of protons at slower rates than can be achieved by 
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the enzymes. Finally, none of the [FeFe]-hydrogenase models are able to oxidize 
hydrogen while the enzymes are known to perform reversible catalysis.  
Increasingly, attention is being focused on generation of functional [FeFe]-
hydrogenase model complexes that can perform electrocatalysis or photocatalysis. In 
these investigations, a number of synthetic strategies have been developed for coupling 
relevant diiron models to electrode surfaces, redox cofactors, or photoactive centers.
[21-25]
 
In parallel, strategies for investigating the impact of second coordination sphere 
interactions and burial of the active site in superstructures isolated from bulk solvent are 
starting to emerge. 
[22, 26-32]
 On the other hand, relatively little attention has been paid to 
developing strategies for attachment of diiron models to amino acids
[28, 33-35]
 or peptidic 
scaffolds
[36, 37]
 - this, despite the fact, that evidence continues to build indicating that the 
enzyme tertiary structure plays a crucial role in tuning the properties of the active site to 
achieve near diffusion limited, bidirectional catalysis.   
De novo designed proteins have proven an invaluable tool in the study of complex 
oxidoreductases and have been designed to bind a number of both naturally occurring and 
artificial metallocofactors.
[38-43]
 The construction of miniaturized, peptidic systems 
coordinating hydrogenase-related metallocenters presents unique synthetic challenges. 
One approach has been utilization of the naturally occurring amino acid cysteine as an 
anchor for construction of a (μ-SRS)[Fe(CO)3]2 cluster.
[36]
 This strategy has the 
disadvantage of relying on the correct placement of two distinct cysteines to form the 
desired complex. A second synthetic route involves modification of an amino acid to 
create an artificial amino acid ligand for the desired metal complex. In this report, we 
present a method to modify a peptide still attached to its resin support in order to create 
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an artificial derivative of a lysine bearing a propanedithiol unit. The appended sulfur 
sidechain posesses two sulfurs poised to anchor a covalently attached Fe2(SRS)(CO)6 
unit. This approach can serve as a general method for modification of a wide range of 
designer synthetic peptides to probe interactions between amino acids and [FeFe]-
hydrogenase small models. 
Results and Discussion 
Scheme 2-2 shows the general strategy for synthesis of an Fe2(SRS)(CO)6 unit 
appended to a dithiol modified lysine residue. First, the desired peptide is constructed 
via standard Fmoc/ t-Bu solid phase peptide synthesis. During synthesis, an 
orthogonally protected amino acid residue, in this case lysine, is introduced that 
serves as the site for dithiol incorporation. The dithiol unit is provided by 3-
(acetylthio)-2(acetylthiomethyl)propanoic acid.
[44]
 This propanoic acid derivative can 
be coupled to a primary amine to form a stable amide. After modification of the 
lysine, the rest of the peptide can be simultaneously deprotected and cleaved from the 
resin via standard trifluoroacetic acid methods and purified before incorporation of 
the diiron unit via reaction with Fe3(CO)12. 
Reactions with peptides can present unique challenges relative to reactions 
with small, organic ligands. First, peptides are not usually soluble in the organic 
solvents traditionally utilized for organometallic synthesis. Second, the number and 
diverse composition of functional groups present in a peptide require carefully 
orchestrated protection/ deprotection to avoid side products. To demonstrate the 
efficacy of this synthetic approach, a simple variant of the N-terminal sequence of the 
Nickel-superoxide dismutase (SODA) from Streptomyces coelicolor was utilized. The 
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SODA peptide, ACDLPCG, binds nickel, is soluble and monomeric in aqueous 
solution, is spectroscopically well characterized, and retains some of the catalytic 
activity of the complete enzyme.
[45]
 Three variations in this sequence were 
introduced. First, the two cysteine residues were exchanged for serines to eliminate 
competition from these thiols for interaction with iron while maintaining the 
approximate length and polarity of the sidechain. Second, the aspartic acid was 
exchanged for a lysine as an attachment point for the iron cluster. Finally, a 
tryptophan residue was introduced at the N-terminus to facilitate quantification of the 
peptide, yielding the final sequnce, WASKLPSG. 
Figure 2-1 shows the analytical HPLC and Figure 2-2 the NMR spectra from 
(A) deprotected, unmodified peptide, (B) peptide modified with the dithiol acid, and 
(C) peptide modified with the diiron cluster. The HPLC traces demonstrate that with 
each additional modification the peptide became more hydrophobic, eluting at a 
higher percentage of acetonitrile. These changes in hydrophobicity facilitated 
efficient purification to yield high quality products as shown in the NMR spectra. The 
peaks of peptide modified with the dithiol acid can clearly be observed after coupling 
to the lysine at 1.10 (t, 2H), 2.4-2.55 (1H) and 3.0-3.15 (4H). These peaks are then 
shifted after incorporation of the diiron unit to overlap with the resonances of the -H 
of the lysine residue. Meanwhile, the peaks for all other protons in the peptide can be 
accounted for and are virtually unaffected by the modifications of the peptide 
(complete assignment can be found in Table 2-1). ESI-Mass spectrometry has also 
been utilized to demonstrate that the products have the expected composition and the 
iron cluster is coordinated via a single peptide monomer. 
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The UV-vis and FTIR spectra of Fe2(CO)6-modified peptide are shown in 
Figure 2-3. The UV-vis spectrum consists of three notable features: an absorption at 
334 and a shoulder at 465 nm both associated with the Fe-S core, and the 
characteristic absorbance of the tryptophan residue at 280 nm. The ratio of the 
extinction coefficients of these features is similar to that observed previously for 
incorporation of cluster into peptide via cysteine, providing additional evidence for 
nearly stoichiometric incorporation of cluster in the purified product.
[36]
 The FTIR 
spectrum of the Fe2(CO)6-modified peptide has three bands at 2075, 2035 and 1999 
cm
-1
 arising from the coupled CO vibrational modes of the complex.  These  confirm 
the presence of the carbonyls on each iron. Furthermore, the close agreement between 
these values and those observed for (-S(CH2)3S)[Fe(CO)3]2 suggests that, as 
expected, the iron complex is completely exposed to solution when attached to the 
peptide. Finally, ESI-MS data of Fe2(CO)6-modified peptide also implies the presence 
of the CO ligands since ions formed by loss of CO ligands [complex-CO, complex-
(CO)3 and complex-(CO)6] could clearly be identified (Figure 2-4). 
The complex (μ-S(CH2)3S)Fe2(CO)6 is an unremarkable catalyst, but it can 
undergo substitution of the carbonyls by a number of different types of ligands such 
as cyanide or phosphines to form more active species.
[14]
 Similarly, 
Fe2(CO)6-modified peptide is also able to undergo substitution reactions. As shown in 
Figure 2-3, addition of excess PMe3 to an acetonitrile solution of the peptide, results 
in a uniform shifting of the frequencies of the ν(CO) bands to approximately 100  cm-1 
lower wavenumbers (1974, 1939, and 1894). The compound (μ-S(CH2)3S)-
[Fe(CO)2(PMe3)]2 is reported to have ν(CO) bands at 1979, 1942, and 1898 cm
-1
.
[46]
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Thus, the observed data is consistent with formation of a disubstituted phosphine 
derivative and indicates that the cluster is accessible for ligand exchange.  
Conclusions 
We have demonstrated the ability to incorporate a (μ-SRS)Fe2(CO)6 model of [FeFe]-
hydrogenases into a peptide via on resin construction of a modified amino acid. This 
synthetic scheme is general and allows covalent connection of the diiron unit to any 
unique primary amine. Importantly, the synthesis can be performed in water/methanol 
mixtures yielding a water-soluble product in high yield.  
This approach provides a convenient method for constructing peptide-based 
models of [FeFe]-hydrogenases. Through variation of the peptide scaffold, it will be 
possible to construct complexes in carefully tailored cavities designed to incorporate 
selected aspects of the enzyme active site.  The 3-(acetylthio)-2-(acetylthiomethyl)- 
propanoic acid unit may also be utilized as a handle to construct other sulfur-ligated 
metallocenters. 
Experimental Section 
General. All reactions were performed under an atmosphere of nitrogen. Unless 
otherwise specified, all chemicals were of the highest purity available from Sigma-
Aldrich. Fmoc protected amino acids and peptide coupling reagents were obtained 
from Protein Technologies (Tucson, AZ, USA). Solvents including DMF, acetonitrile, 
methanol, ethyl acetate, hexanes, ether CDCl3 and D2O were obtained from Sigma 
Aldrich. 
Instrumentation. MALDI-MS (matrix assisted laser desorption/ionization mass 
spectrometer) characterization of peptides was performed on a Voyager DE STR in 
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the Proteomics and Protein Chemistry Laboratory at Arizona State University. 
ESI-MS (electrospray ionization mass spectrometry) was performed using a Thermo 
Quantum Discovery Max triple-quadrupole mass spectrometer in the Environmental 
Biogeochemistry Laboratory at Arizona State University. Measurements were 
conducted in positive (+) and negative (–) ionization modes using a methanol:water 
(50:50 by volume) mobile phase at a flow rate of 10 mL min
-1
 and the following 
ionization conditions: spray voltage, 4000 (+, –); capillary temperature, 270 °C; 
sheath gas pressures, 25(+) and 15(–); auxiliary gas pressure, 2 (+, –). NMR spectra 
were recorded at 400 or 500 MHz (
1
H) on Varian Liquid-State NMR instruments in 
CDCl3 solutions containing 0.1% TMS (tetramethylsilane) unless otherwise 
mentioned. UV-vis measurements were performed on a Hewlett-Packard 8453 
spectrophotometer using quartz cuvettes with a 1 cm pathlength. Peptide 
concentrations were determined via absorbance of the tryptophan residue 
(280 = 5600 M
-1
cm
-1
). FTIR spectra were recorded on a Thermo Nicolet Avatar-360 
spectrometer as a dry film on a CaF2 window. Each spectrum is an average of 1024 
scans collected under nitrogen at 1 cm
-1 
resolution. The clean CaF2 window was used 
as a reference. 
2-Bromomethylpropenoic acid. Diethyl bis(hydroxymethyl)malonate (13 g, 0.058 
mmol) was dissolved in HBr (25 mL of 48% aqueous solution, ~0.2 mol) and was 
heated at 120-125
o
C in an oil bath for 45 min. On cooling the solution to -80 
o
C, 
white crystals appeared. The crystals were removed by filtration and the filtrate was 
heated again to 120-125
o
C for 45 min. This solution was again cooled to -80 
o
C and 
additional crystals were filtered off. This process was repeated a third time. All the 
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white crystals were collected and dissolved in 30 mL dichloromethane, washed with 
2x10 mL 1N HCl, dried over anhydrous MgSO4 and concentrated under reduced 
pressure to yield a white crystalline solid (2.8 g, 29.4%). 
1
H NMR (400 MHz):  6.48 
(1H, s), 6.09 (1H, s), 4.17 (2H, s). 
3-(acetylthio)-2-(acetylthiomethyl)propanoic acid. To a stirred suspension of 2-
bromomethylpropenoic acid (2.8 g, 0.017 mol) in 50 mL water at 0 ºC was added an 
aqueous solution of sodium carbonate (3.1 g, 0.029 mol in 15 mL) in small portions. 
To the resulting mixture, thiolacetic acid (1.25 mL, 0.017 mol) was added dropwise, 
and the solution was stirred at 0 ºC for 2 hours. The solution was acidified with  6M 
HCl, and the white precipitate was extracted with ethyl acetate (3x25 mL). The 
EtOAc layer was dried over anhydrous MgSO4 and concentrated under reduced 
pressure to yield a colorless oil. With this colorless oil, the reaction was repeated (as 
1
H NMR of the oil indicated the presence of ~33% unreacted starting material, 2-
bromomethylpropenoic acid) to produce pure 2-(acetylthiomethyl)acrylic acid as a 
colorless oil (3 g); 
1H NMR (400 MHz): δ 6.38 (1H, s), 6.02 (1H, s), 3.75 (2H, s), 
2.32 (3H, s). To this 2-(acetylthiomethyl)acrylic acid was added thiolacetic acid (2 
mL, 0.027 mol) and stirred at room temperature. After 36 hours, 
1
H NMR spectra of 
the reaction mixture showed no olefinic peaks. The unreacted thiolacetic acid was 
removed from the reaction mixture under reduced pressure and the yellow oil like 
residue was purified by column chromatography on silica gel with  hexane/ethyl 
acetate (3:1) as eluent followed by hexane/ethyl acetate (2:1) giving 3-(acetylthio)-2-
(acetylthiomethyl)propanoic acid as a white solid (2.8 g, 70%). Rf = 0.2 (3:1 
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hexane/ethyl acetate); 
1H NMR (400 MHz): δ 3.19 (4H, m), 2.91 (1H, p), 
2.35 (6H, s). 
Peptide synthesis. The eight amino acid containing peptide (WASKLPSG) was 
synthesized on a Protein Technologies PS3 automated peptide synthesizer using the 
standard Fmoc/ t-Bu (Fmoc, 9-fluorenylmethoxycarbonyl) protection strategy and 
HBTU (o-Benzotriazole-N,N,N',N'-tetramethyluronium hexaflurophosphate) as 
coupling reagent on Fmoc-Gly wang resin (Aapptec 0.54 mmole/g, 100-200 mesh) at 
0.1 mmole scale.
(25)
 Lysine with orthogonally protected side chain, Fmoc-Lys(ivDde)-
OH [ivDde, 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl], was used 
for solid-phase peptide synthesis so that the side chain amine group of lysine can be 
selectively deprotected and modified. Following synthesis, the peptide was acetylated 
at the N-terminus [1:1 (v/v) acetic anhydride: N-methylmorpholine for 20 min, two 
times]. 
Coupling of 3-(acetylthio)-2-(acetylthiomethyl)propanoic acid to peptide and 
purification. Resin bound peptide (64 mg, 0.033 mmole) was treated with 2% 
hydrazine in DMF (10 mL) for 45 min at room temperature under nitrogen to remove 
the protecting group from lysine. Following deprotection, 3-(acetylthio)-2-
(acetylthiomethyl)propanoic acid (35 mg, 0.15 mmole), HATU [2-(1H-7-
Azabenzotriazol-1-yl)-1,1,3,3,-tetramethyluronium hexafluorophosphate 
methanaminium] (55 mg, 0.14 mmole) and DIEA [N,N-diisopropylethylamine] (30 
L, 0.16 mmole) dissolved in 5 mL DMF were added to the resin under nitrogen and 
stirred at room temperature for 30 min. This coupling reaction was repeated. The 
resin was then washed with DMF (5x2 mL). The thioacetal groups were reduced to 
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thiol by treatment with 2-3% hydrazine in DMF (10 mL) under nitrogen for 40 min. 
Then the peptide was simultaneously deprotected and cleaved from the resin using 
95:2.5:2.5 trifluoroacetic acid (TFA): water: triisopropylsilane (TIPS) for two hours 
and fifteen minutes. The crude cleavage solution was filtered and the residual resin 
was washed with neat TFA (3x1 mL). The TFA solution of peptide was concentrated 
under reduced pressure to a light yellow colored liquid (~0.5-1 mL). Crude peptide 
was precipitated by adding cold diethyl ether (-20
o
C). Followed by incubation with 
four equivalents TCEP, the crude peptide was purified by reverse phase HPLC on a 
Waters 600E HPLC system with photodiode array detector (3x250 mm C-18 column 
for analytical and PrepLC 25 mm module C-18 column for semi-preparative HPLC) 
using aqueous-acetonitrile gradients containing 0.1% TFA (v/v).  Molecular weight of 
the peptide was confirmed by matrix-assisted laser desorption/ ionization time of 
flight (MALDI-TOF MS) mass spectrometry. [M]
+ 
Calculated = 1020.99; found = 
1043.3 [(M+Na)
+
]. 
Cluster Incorporation into Peptide. Triiron dodecacarbonyl (5 mg, 0.01 mmole) in 
methanol (1.5 mL) and 0.16 mM aqueous solution of peptide (1 mL) were combined 
and refluxed for 1.5 hours resulting in a color change from green to pale red. The 
reaction mixture was concentrated under reduced pressure and was extracted with 3 
mL water. The complex was purified by reverse phase HPLC using aqueous-
acetonitrile gradients.  
Substitution of carbon monoxide ligands with trimethylphosphine.  
Trimethylphosphine (4 L, 0.038 mmol) was added to a 0.02 mM acetonitrile solution 
of peptide-[-S2Fe2(CO)6] complex (1mL)  under N2 in the dark and stirred at room 
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temperature for 1.5 hours resulting in change in color to red. The FTIR of the crude 
reaction mixture showed (CO) bands at 1980, 1940, 1900 cm-1. 
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Figure 2-1. Analytical HPLC traces for unmodified peptides and dithiol-peptide 
diiron-hexacarbonyl complex. Analytical HPLC traces from (A) WASKLPSG, (B) 
peptide with dithiol side chain modification (WAS(Dt)LPSG and (C) peptide modified 
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with both a dithiol side chain and the Fe2(CO)6 cluster. HPLC gradient 1% 
acetonitrile/min; flow rate 0.25 mL/min.  The higher amplitude signal in each case is 
absorbance at 220 nm (peptide bond) and the lower at 280 nm (tryptophan). 
 
Figure 2-2. Comparative 
1
H NMR spectra of the unmodified peptides and the 
dithiol-peptide diiron-hexacarbonyl complex. 
1
H NMR spectra from (A) WASKLPSG, 
(B) peptide with dithiol side chain modification (WAS(Dt)LPSG and (C) both a dithiol 
side chain and the Fe2(CO)6 cluster.  NMR spectra were obtained in D2O. 
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Figure 2-3. Optical and FTIR spectra of the dithiol-peptide-diiron complexes. 
Characterization of Fe2(CO)6 complex coordinated to dithiol modified peptide via (A) 
UV-vis and (B) FTIR spectroscopies and (C) FTIR spectrum of peptide-
Fe2(CO)4(PMe3)2.  UV-vis spectrum was obtained in a 1:1 mixture of water/ acetonitrile.  
For FTIR experiments, sample was applied to a single CaF2 window as a methanolic 
solution and dried under a vacuum to form a thin film.  Experiments were then performed 
with the film. 
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Figure 2-4. ESI-mass spectra of the dithiol-peptide diiron hexacarbonyl complex. 
ESI-MS spectra of peptide-[(μ-S)2[Fe(CO)3]2] complex in (A) negative mode and (B) 
positive mode. 
 
Scheme 2-1. [FeFe]-hydrogenase active site and first generation model compound 
utilizing a propane dithiol ligand. 
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Scheme 2-2. Synthetic strategy for modification of a unique lysine with a dithiol 
functional unit and incorporation of an Fe2(CO)6 unit.  The sphere represents the resin 
bead utilized for solid phase peptide synthesis. Reaction conditions: (a) 2% NH2NH2, 
DMF, Yield 100%; (b) HATU, DIEA, DMF, Yield 50%; (c) 2% NH2NH2, DMF, yield 
100%; (d) (i) cleavage: 95% TFA, 2.5% water, 2.5% TIPS (ii) HPLC purification; (e) 
Fe3(CO)12, aq. methanol, reflux, yield 80% 
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Table 2-1. Chemical shifts of the amino-acid residues in 
1
H NMR 
 
spectra of parent 
peptide, dithiol peptide and Fe2(CO)6-peptide complex 
 Ac W A S K(dt) L P S G 
-NH2 
1.83 
(s) 
7.47 (d, 1H), 
7.36 (d, 1H), 
7.14 (s, 1H), 
7.11 (t, 1H), 
7.02 (t, 1H), 
4.42 (t, 1H), 
3.11 (m, 2H) 
4.06 
(q,1H), 
1.08 (d, 
3H) 
4.31 or 
4.16 (m, 
1H), 
3.6-3.2 
(m, 2H) 
4.46 (m, 1H), 
2.81 (t, 2H; 
εH), 1.75-1.25 
(m, 6H) 
4.2-4.13 (m, 
1H), 1.75-
1.25 (m, 3H), 
0.8-0.76 (m, 
6H) 
4.32-4.28 (m, 
1H), 3.74-3.66 
(m, 1H), 3.52 
(m, 1H), 2.17 
(m, 1H), 1.94-
1.85 (m, 3H) 
4.31 or 
4.16 (m, 
1H), 3.6-
3.2 (m, 
2H) 
3.82 (s, 
2H) 
-SH 
1.82 
(s) 
7.48 (d, 1H), 
7.36 (d, 1H), 
7.14 (s, 1H), 
7.11 (t, 1H), 
7.02 (t, 1H), 
4.43 (t, 1H), 
3.14-3.02 
(m, 2H) 
4.06 (q, 
1H), 
1.08 (d, 
3H) 
4.3 or 
4.19 (m, 
1H), 
3.75-
3.66 (m, 
2H) 
4.49 (m, 1H), 
2.55-2.4 (t, 
2H; εH), 1.71-
1.18 (m, 6H), 
3.15-3 (m, 
4H), 2.55-2.4 
(1H, m) 1.71-
1.18 (m, 2H) 
4.2-4.13 (m, 
1H), 1.71-
1.18 (m, 3H), 
0.82-0.76 (m, 
6H) 
4.3-4.2 (m, 1H), 
3.75-3.66 (m, 
1H), 3.52 (m, 
1H), 2.19-2.15 
(m, 1H), 1.94-
1.85 (m, 3H), 
4.3 or 
4.19 (m, 
1H), 3.6-
3.2 (m, 
2H) 
3.78 (s, 
2H) 
-S2Fe2(CO)
6 
1.83 
(s) 
7.48 (d, 1H), 
7.35 (d, 1H), 
7.14 (s, 1H), 
7.11 (t, 1H), 
7.02 (t, 1H), 
4.6-4.44 
(αH), 3.2-
2.99 (βH) 
4.1 
(αH), 
1.10 (d, 
βH) 
4.3 or 
4.22 
(αH), 
3.75-
3.65 
(βH) 
4.6-4.44 (αH), 
3.2-2.99 (εH), 
1.7-1.1 (β, γ, 
δH), 3.2-2.99 
(dithiol side 
chain) 
4.16 (αH), 
1.1-1.7 (β, 
γH), 0.78-
0.84 (δH) 
4.28-4.32 (αH), 
3.8-3.5 (δH),  
2.2-2.14 (βH), 
1.93-1.88 (β, 
γH) 
4.3 or 
4.22 (αH), 
3.75-3.65 
(βH) 
3.65 or 
3.56 (s) 
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Abstract 
Two synthetic strategies for incorporating diiron analogues of [FeFe]-hydrogenases into 
short peptides via phosphine functional groups are described. First, utilizing a unique 
amine side chain of lysine as an anchor, phosphine carboxylic acids were coupled to 
resin-bound peptides via formation of an amide linkage to create phosphine derivatives of 
lysine. Second, we developed a general procedure for the synthesis of artificial phosphine 
containing amino acids that can be directly incorporated into peptides via solution phase 
peptide synthesis. Three amino acids with different phosphine substitution (-PPh2, -P
i
Pr2, 
-PEt2) were synthesized and incorporated into small peptides. Five distinct mono-
phosphine substituted diiron model complexes were prepared by reaction of the 
phosphine-peptides with diiron hexacarbonyl precursors, either (μ-pdt)Fe2(CO)6 or 
(μ-bdt)Fe2(CO)6 (pdt = propane-1,2-dithiolate, bdt = benzene-1,2-dithiolate). The 
formation of the complexes was confirmed by UV/Vis, FTIR and 
31
P NMR spectroscopy. 
Furthermore, electrocatalytic reduction of protons from acetic acid in acetonitrile and 
water-acetonitrile mixtures (up to 40% water) showed that addition of water significantly 
improved the catalytic efficiency of these complexes by lowering the overpotential and 
enhancing the catalytic current. 
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Introduction 
Hydrogenases, the biological catalyst for the reversible reduction of proton to molecular 
hydrogen, employ earth-abundant base metals, either iron or nickel and iron, to carry out 
this transformation under mild conditions.[1-4] The utility of this reaction for developing 
technologies to produce sustainable solar fuels has engendered widespread interest in 
[FeFe]-hydrogenases, the most efficient biological system for producing hydrogen. X-ray 
crystallographic studies revealed that the structure of the active site of [FeFe]-
hydrogenase, known as the H-cluster, consists of a [2Fe] subsite at which substrate 
binding and catalytic reaction occurs, and a covalently connected [4Fe4S] cubane which 
serves as a conduit for the transfer of electrons to/from the protein surface.[5, 6] The H-
cluster is connected to the protein through a single cysteinyl thiolate which also connects 
the [4Fe4S] cubane and [2Fe] subsite. The [2Fe] subunit features CO and CN
-
 as terminal 
diatomic ligands and a biologically unusual non-proteinaceous dithiolate that bridges the 
two iron centers. 
From a synthetic perspective, the [2Fe] subunit is reminiscent of the well known 
organoiron complex [{μ-S(CH2)3S}{Fe(CO)3}2] which serves as a convenient starting 
point for building a multitude of sophisticated biomimetic diiron analogues.[7] Although 
many of these bio-inspired organometallic models show moderate electrocatalytic proton 
reduction activity, none of them catalyzes hydrogen production with the same exquisite 
combination of high turnover frequency and low activation energy as the enzymes.[8, 9] 
Moreover, the hydrophobic nature of these diiron dithiolate clusters renders most of them 
soluble only in organic solvents. They are therefore unsuitable for applications in fuel 
cells based on aqueous solvents and their activity in such a setting cannot be evaluated. 
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In recent years, as the importance of the protein environment for the catalytic 
activity of hydrogenases and other metalloenzymes has become increasingly clear, more 
attention has been focused on incorporating the diiron cluster into supramolecular 
constructs to investigate the impact of secondary coordination sphere interactions on 
chemical properties.[10-16] While diiron models generally feature the two iron centers in 
an ''eclipsed'' conformation, in the natural system, the outer coordination sphere 
interactions constrain the coordination geometry of the catalytic site to attain a more 
catalytically active ''rotated'' form that leaves one iron center (distal iron, Fed) with an 
open coordination site.[17, 18] Recently, Berggren et al. have reported reconstitution of a 
fully functional [FeFe]-hydrogenase from a model diiron complex with limited catalytic 
activity and the apo-enzyme. This clearly demonstrates the key role played by the protein 
matrix in modulating the coordination geometry of the [2Fe] subunit to facilitate 
efficient, bidirectional catalysis.[19] 
De novo designed proteins and peptides that can bind natural and artificial 
metallocofactors are proving to be a powerful technique for understanding the function of 
metalloenzymes, and realizing the roles of metallocenters within protein scaffolds.[20-
22] The construction of small artificial peptides binding diiron models serves to bridge 
the ground between natural metalloenzymes and organometallic analogues and presents 
an appealing opportunity to introduce secondary coordination sphere interactions into 
model systems. Synthetic methods have been developed to incorporate thiolate bridged 
diiron hexacarbonyl clusters into suitably designed peptides via both natural cysteine and 
artificial dithiol groups.[23-25] However, these hexacarbonyl [FeFe]-hydrogenase 
models are less electron rich and thus, poorer catalysts than pentacarbonyl complexes in 
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which one terminal ligand is replaced by a stronger σ-donor like a phosphine. 
Furthermore, these peptide-based models offer little opportunity for improving their 
catalytic efficiency through ligand substitution because awkward solvent mixtures are 
required to simultaneously solubilize peptide and substituting ligand resulting in 
relatively low yields. 
Phosphines have been widely employed in models as a surrogate of the CN
-
 
ligand found in the natural system due to their strong electron donating ability.[26, 27] 
Thus, construction of phosphine-functionalized peptides represents a tantalizing route to 
build peptide-based diiron models with better electrocatalytic properties. Moreover, 
phosphino-peptides offer the possibility of synthesizing a wide range of ligands through 
variation of the peptide sequence as well as the substituents on the phosphines. In this 
report, we describe two general methods for introducing a phosphine functionality into 
small peptides. The first approach is to modify the side chain amine of a lysine in a resin-
bound peptide generating a phosphine containing peptide. The second method directly 
incorporates an appropriately protected artificial phosphine amino acid via solution phase 
peptide synthesis. To demonstrate the efficiency of the second synthetic approach, three 
different amino acids were prepared using the method developed by Gilbertson and 
co-workers: N-Boc-3-(diethylphosphorothioyl)alanine (Boc-Epa-OH), 
N-Boc-3-(diisopropylphosphorothioyl)alanine (Boc-Ipa-OH), and 
N-Boc-3-(diphenylphosphorothioyl)alanine (Boc-Ppa-OH).[28, 29] Four distinct diiron-
peptide complexes were synthesized using these phosphine amino acids, and the 
influence of the peptide ligands on the hydrophilicity, redox properties and 
electrocatalytic activities of coordinated diiron carbonyl complexes were explored in 
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acetonitrile and acetonitrile/water mixtures. Notably, the complexes display favorable 
energetics towards electrocatalytic proton reduction from acetic acid in the presence of 
water. 
Results and Discussion 
Synthesis of metallopeptides.  
Two different synthetic strategies were utilized to construct phosphine functionalized 
artificial peptides for can binding dithiolate bridged diiron-polycarbonyl clusters through 
coordination of the phosphine. The first method is analogous to that used for thiol 
substitution previously.[25] Using a unique amine side chain of lysine as an anchor, a 
resin-bound peptide was modified via formation of an amide with a phosphine 
functionalized carboxylic acid to create an artificial derivative of lysine bearing a 
phosphine unit. Second, several phosphine-containing amino acids, amenable to both 
solid-phase and solution-phase peptide synthesis, were synthesized and directly 
incorporated into small peptides. Phosphines are known to substitute a CO ligand from 
the diironhexacarbonyl complexes [(μ-S2)Fe2(CO)6] in the presence of a decarbonylating 
agent such as trimethylamine-N-oxide (Me3NO) to produce mono-substituted diiron 
complexes.[30-32] We show below that the phosphine-containing peptides undergo the 
same reaction under similar conditions to yield analogous diiron complexes in peptide 
scaffolds. 
On-resin modification of lysine. Scheme 3-1 shows the general method for modifying 
the resin-bound peptide to introduce a phosphine functionality and the subsequent 
incorporation of a diiron cluster. The peptide sequence utilized (WASKLPSG) is a simple 
variant of the N-terminal sequence of nickel-superoxide dismutase (SODA) from 
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Streptomyces coelicolor.[33] Previously, this sequence was employed to create an 
artificial 1,3-dithiol peptide which could bind a diiron-hexacarbonyl cluster.[25] Herein, 
we exploit a similar strategy to construct water a soluble, phosphine-substituted diiron 
cluster attached to a peptide. First, the desired eight residue peptide was synthesized via 
standard solid-phase peptide synthesis using the Fmoc/t-Bu strategy. Lysine with an 
orthogonally protected amine group was used for selective modification with 
diphenylphosphinopropionic acid to generate the iron binding site. Subsequent cleavage 
of the phosphine-peptide WASK(-PPh2)LPSG (1a) from the resin and reaction with the 
diiron hexacarbonyl precursor [(μ-pdt)Fe2(CO)6; pdt = propane-1,3-dithiolate] produced 
the desired metallopeptide (μ-pdt)[Fe-(CO)3][Fe(CO)2{WASK(PPh2)LPSG}] (1). 
However, moderate sensitivity of the phosphines to aerial oxidation reduced the overall 
yield of the process. To prevent the loss of phosphine-peptide during synthesis and 
purification, a new approach in which the free phosphine was replaced by a 
sulfur-protected phosphine synthon {3-(diphenylphosphorothioyl) propanoic acid} was 
used for peptide modification (Scheme 3-1). After cleavage of the peptide from the resin, 
the phosphine sulfide was reduced by Raney nickel to produce the free phosphine-peptide 
[WASK(-PPh2)LPSG] which was immediately used, without further purification, for the 
reaction with (μ-pdt)Fe2(CO)6. Nonetheless, use of sulfur protected phosphine did not 
lead to significant improvement in the overall yield of the process due to the inefficiency 
of the desulfurization step. 
The product metallopeptide was purified via HPLC and a range of spectroscopic 
techniques were used to confirm the presence of the desired cluster. The UV-vis spectrum 
of the complex in water consists of three prominent features: an intense charge transfer 
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band at 349 nm and a weak d-d transition at 470-480 nm both of which are associated 
with the [Fe2S2] core, and a strong π-π* transition in the range 250-280 nm originating 
from the diphenylphosphine and tryptophan residues. The IR spectrum of the complex 
contains three characteristic bands at 2042, 1980, and 1924 cm
-1
 corresponding to the 
C-O stretching modes, similar to those observed for analogous monosubstituted 
organometallic diiron models.[32, 34] Furthermore, the 
31
P NMR spectrum of the 
complex shows a single resonance at 55.4 ppm, confirming formation of a unique 
complex with a Fe-P bond. Finally, ESI-MS of the metallopeptide also indicates the 
presence of Fe2(CO)5 cluster, because in addition to the molecular ion peak, signals 
attributable to the sequential loss of CO ligands were observed. 
Artificial amino acids. The necessity of including an orthogonally protected amino acid 
in the peptide sequence and carefully designed selective protection/deprotection steps 
limits the range of phosphines that can be employed using the synthetic scheme described 
above. Therefore, a second synthetic route in which an artificial phosphine amino acid is 
directly incorporated during solid-phase peptide synthesis was developed. This second 
method has the added benefit that the side chain of the phosphine bearing amino acid is 
necessarily shorter and more stable since the amide functionality is no longer necessary. 
Since less rotamers are available, a more compact metal binding site with lesser solvent 
accessibility can be envisioned. To demonstrate the utility of this strategy, three different 
phosphine amino acids were synthesized and embedded into the tripeptide sequence, Val-
Xpa-Leu in which Xpa represents the phosphine amino acid. 
The phosphine amino acids were synthesized by the method developed by 
Gilbertson et al. starting from enantiomerically pure N-Boc-protected 3-iodo-alanine 
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methyl ester [Boc-Ala(I)-OMe].[29, 35, 36] Metalation of the iodo-amino acid with 
activated zinc, followed by metalation with copper, produced a reactive zinc/copper-iodo 
intermediate. Reaction of this intermediate with a chlorodialkylphosphine or 
chlorodiarylphosphine provided the phosphino derivative which was then protected as 
phosphine sulfide by reaction with elemental sulfur. Ester hydrolysis produced the N-Boc 
and sulfide protected phosphine amino acid in good yield. For the purposes of this study, 
three amino acids with different phosphine substituents were synthesized: N-Boc-3-
(diethylphosphorothioyl)alanine (Boc-Epa-OH), N-Boc-3-(diisopropylphosphorothioyl)-
alanine (Boc-Ipa-OH), and N-Boc-3-(diphenylphosphorothioyl)alanine (Boc-Ppa-OH).  
Three distinct tripeptides, Val-Ppa-Leu, Val-Ipa-Leu, and Val-Epa-Leu, were 
synthesized by solution-phase peptide synthesis (Scheme 3-2). The valine and leucine 
were chosen for their hydrophobic side chains to allow large-scale chromatographic 
purification of the tripeptides on a normal-phase silica column. The N- and C-termini of 
the peptides were protected as acetyl and methyl ester, respectively. Treatment of purified 
tripeptide with Raney nickel converted the phosphine sulfide to free phosphine.[28] 
Reduction of the phosphine sulfide to phosphine was monitored by 
31
P NMR and/or 
MALDI-TOF mass spectrometry. Notably, 
31
P NMR revealed that desulfurization by 
Raney nickel also caused racemization at the α-carbon of the phosphine amino acid 
resulting in diasteromeric peptides. Phosphine peptides were metalated by reaction with 
(μ-pdt)Fe2(CO)6 or (μ-bdt)Fe2(CO)6 (bdt = benzene-1,2-dithiolate) in CH3CN/CH2Cl2 in 
the presence of Me3NO to produce phosphine-substituted diiron-peptide complexes as red 
solids in good yields. Four distinct complexes were prepared. Three complexes contain 
1,3-propanedithiolate (pdt) as the dithiol ligand bridging the irons with variation of the 
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substituents on the phosphine as the only difference between the complexes: [(Val-Epa-
Leu)-{(μ-pdt)Fe2(CO)5}] (2), [(Val-Ipa-Leu)-{(μ-pdt)Fe2(CO)5}] (3), and [(Val-Ppa-
Leu)-{(μ-pdt)Fe2(CO)5}] (4). A fourth complex, [(Val-Ppa-Leu)-{(μ-bdt)Fe2(CO)5}] (5), 
was synthesized using Val-Ppa-Leu as the ligand and benzene-1,2-dithiolate (bdt) 
bridged diiron hexacarbonyl [(μ-bdt)Fe2(CO)6] as the metallo-precursor. 
Spectroscopic Characterization.  
Despite numerous attempts, crystals of X-ray quality were not obtained for the diiron-
peptide complexes. Thus, the compounds were characterized via a combination of 
spectroscopic and electrochemical methods. The spectroscopic data recorded for 
complexes 1-5  are summarized in Table 3-1. As shown in Figure 3-1, the UV-vis spectra 
of the complexes in acetonitrile consist of a characteristic Fe-S charge transfer band (CT) 
in the 340‒370 nm region and a weak shoulder at ca.470 nm. Changing the substituents 
on the phosphine from phenyl to isopropyl or ethyl but utilizing the same bridging ligand 
had little influence on the UV-vis spectra of the complexes (2 , 3, and 4) apart from the 
slight shift in the wavelength of the metal centered charge transfer band. On the other 
hand, comparing the UV-vis spectra of 4 and 5 revealed that replacing pdt by bdt, 
predictably, resulted in significant changes in the wavelength and intensity of the charge 
transfer transition. While the intensities of this charge transfer band are similar for 2, 3, 
and 4, the extinction coefficient for 5 is considerably higher (Table 3-1).  
The FTIR spectra of the complexes in acetonitrile show characteristic three-band 
patterns in the C-O stretching region originating from the monosubstituted 
(μ-S2)Fe2(CO)5 assembly. The stretching frequencies of the carbonyls are a proxy for the 
electron density on the iron centers. As shown in Table 3-1, replacing aromatic groups on 
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the phosphine with more electron donating alkyl groups (isopropyl or ethyl) resulted in a 
slight shift of the CO stretching frequencies by 5‒6 cm-1 to lower wavenumbers. The 
poorer donor ability of bdt compared to pdt is reflected in the stretching frequencies of 4 
and 5. The ν(CO) bands of the latter are shifted by an average of 9 cm-1 to higher 
frequencies relative to 4. 
Electrochemical studies 
Electrochemical studies in acetonitrile. The electrochemical properties of the 
complexes were investigated by cyclic voltammetry in acetonitrile under argon. The 
complexes show electrochemical responses similar to those reported for analogous 
monosubstituted diiron compounds.[8] Cyclic voltammograms of the pdt complexes, 2, 3 
and 4, display an irreversible wave corresponding to Fe
I
Fe
I
 / Fe
I
Fe
0 
reduction and an 
irreversible wave corresponding to Fe
I
Fe
I
 / Fe
I
Fe
II
 oxidation (Figure 3-2 and Table 3-2). 
In contrast, for complex 5, the Fe
I
Fe
I
 / Fe
I
Fe
II
 oxidation is irreversible, but the Fe
I
Fe
I
 / 
Fe
I
Fe
0 
couple is partially-reversible (  
    
     = 0.47). The cyclic voltammogram of 5 also 
exhibits a second oxidative feature at approximately -1.29 V. This feature did not appear 
when the reductive scan was stopped prior to the Fe
I
Fe
I
 / Fe
I
Fe
0
 reduction suggesting an 
EC process in which the Fe
I
Fe
0
 species undergoes a chemical change that allows it to be 
re-oxidized at a new potential. The peak potentials (Ep), both the reductive and oxidative, 
correlate well with the donating abilities of the phosphines and the thiolates. Their trends 
are the same as these established from the ν(CO) of the complexes. Among the pdt 
bridged complexes, the diphenylphosphino complex 4 is reduced at a less reducing 
potential (-1.82 V) and oxidized at a more oxidizing potential (+0.31 V) than the 
dialkylphosphino complexes 2 and 3. Notably, changing the bridging thiolate from pdt to 
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bdt has a more pronounced influence on the electronic properties of the diiron core as 
demonstrated by the 200 mV and 160 mV shift of the Fe
I
Fe
I
 / Fe
I
Fe
0 
and
 
Fe
I
Fe
II
 / Fe
I
Fe
I
 
couples, respectively, in 5 compared to 4. The electrochemical differences are more 
pronounced when cyclic voltammograms in the presence of acetic acid (vide infra), 
added as a source of protons to study electrocatalytic proton reduction, are compared. 
The ability of the monosubstituted [(μ-SR1S)Fe2(CO)5L] (L = phosphine peptide) 
complexes to electrocatalyze proton reduction from a weak acid was investigated in 
acetonitrile. For the complexes with a pdt bridge, 2, 3, and 4, sequential addition of 
AcOH resulted in increased reductive current corresponding to production of hydrogen.  
Notably, this catalytic current is not observed at the Fe
I
Fe
I
 / Fe
I
Fe
0
 reduction potential of 
the (ca. -1.8 to -1.9 V dependent on complex). Instead, catalytic current is observed at a 
lower potential in the range -2.1 to -2.2 V. This observation is consistent with 
electrochemical studies previously reported for less electron rich analogues.[37-39] 
Similarly, upon addition of AcOH, the bdt complex 5 also displays catalytic current at ca. 
-2.08 V, a potential well beyond its reduction peak at -1.62 V. However, complex 5 is 
more a efficient electrocatalyst than the other complexes as demonstrated by the greater 
catalytic current it produces under similar experimental conditions. Finally, while 5 
exhibits a shift of the potential at which half of catalytic current is observed to more 
reducing values with increasing acid concentration, no clear trend is observed for 2, 3, 
and 4. 
Electrochemistry in acetonitrile/water mixtures. The improved water solubility of the 
diiron-peptide complexes relative to analogous phosphine complexes reported in the 
literature allowed electrochemical investigation in mixed acetonitrile-water solvents. 
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Cyclic voltammograms of complexes 3, 4, and 5 were obtained in 3:1 and 3:2 
CH3CN/H2O (Figure 3-4). The redox potentials determined from these experiments are 
summarized in Table 3-2. Since the diethylphosphino complex (2) and the 
diisopropylphosphino complex (3) were already shown to have similar electronic 
properties, only the electrochemistry of 3 was studied in mixed solvents. With an 
increasing amount of water, the reductive wave associated with each of the Fe
I
Fe
I
/Fe
I
Fe
0
 
couples of 3-5 is shifted to less reducing potentials. The shifts observed for the 
Fe
I
Fe
I
/Fe
I
Fe
0
 couple on changing the solvent from neat CH3CN to 3:2 CH3CN/H2O are 
160, 100 and 150 mV for 3, 4, and 5, respectively. Similar shifts were observed when 
electrochemical measurements of analogous diiron complexes with hydrophilic 
phosphine ligands, included to improve water solubility, were performed in mixed 
acetonitrile/water solvents.[40, 41] However, the Fe
II
Fe
I
/Fe
I
Fe
I
 oxidation of complexes 3-
5 was less affected by the addition of water as indicated by nearly unaltered oxidation 
potentials. These results suggest that the presence of water can selectively tune the 
potential required for the reduction of the diiron core without impacting all 
electrochemical properties. 
The electrocatalytic activity of complexes 3-5 using AcOH as proton source was 
investigated in CH3CN/H2O mixtures (Figures 3-5 and 3-6). For complexes 3 and 4 there 
are notable changes in the intensities and positions of the catalytic waves when mixed 
aqueous solvents are used. Unlike the electrocatalysis in acetonitrile, in CH3CN/H2O 
mixtures, cyclic voltammograms of complexes 3 and 4 display catalytic electrochemical 
responses with onset at the Fe
I
Fe
I
/Fe
I
Fe
0
 reduction potential. This suggests that the 
basicity of the reduced complexes (3
-
 and 4
-
) and the acidity of AcOH is modulated by 
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water such that 3
-
 and 4
-
 can catalyze proton reduction at considerably less reducing 
potentials than in neat acetonitrile. Furthermore, in the presence of 40% water, increasing 
the concentration of AcOH from 10 mM to 50 mM resulted in 19-fold or 21-fold 
enhancement of peak current for complex 3 or 4, respectively. In contrast, only 9-fold or 
7-fold current increase was observed for the same complexes in neat acetonitrile. On the 
other hand, although the onset of catalysis by 5
-
 also shifts to less reducing potentials 
with the addition of water, it is still significantly more negative than the 5/5
-
 reduction. 
Notably, all of complexes 3-5 exhibit a negative shift for the catalytic wave with 
increasing concentration of AcOH. To quantify these trends, the catalytic peak current 
was determined as function of the number of equivalents of acetic acid (Figure 3-7). 
Addition of water resulted in noticeable improvement in the catalytic activities of 3 and 4 
as demonstrated by the steeper slope of the current response in the presence of water. On 
the other hand, the catalytic current observed for complex 5 is largely unaffected by the 
addition of water. These results suggest that although the electrocatalytic activity of some 
diiron models can be significantly increased by adding water, the trend does not hold 
even for all sets of closely related complexes. 
Conclusion 
In summary, we have demonstrated the synthesis of peptide models of 
[FeFe]-hydrogenase utilizing phosphine-peptides. Two general synthetic schemes are 
shown that have been successfully employed to introduce phosphine functional groups 
into peptides and to covalently anchor a (μ-SRS){Fe(CO)3}{Fe(CO)2(PR2R')} cluster 
through the phosphine. This approach offers major advantages over other methods 
reported for building peptide-based diiron complexes: (1) the phosphine amino acids are 
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directly incorporated into designated peptide sequences, (2) Electron rich stable diiron 
complexes are prepared in only one step with peptide as reagent resulting in better yields 
than if two peptide modifying steps are employed, and (3) the synthesis of a diverse array 
of complexes can be achieved through variation of the artificial amino acid. Importantly, 
utilization of peptide ligands significantly increased the polarity of the complexes 
allowing electrochemical studies in partially aqueous solvents. The presence of water has 
a significant influence on the electrochemical properties of the complexes as 
demonstrated by the shift of the reduction potential of the Fe
I
Fe
I
/Fe
I
Fe
0
 couple towards 
less reducing potential and increased catalytic current. Thus the synthetic approach 
described here provides convenient access to monosubstituted diiron-peptide model 
complexes and opens the door for the design of more sophisticated peptides with tailored 
outer coordination sphere interactions. 
Materials and methods 
All reactions were carried out under an atmosphere of dry nitrogen using standard 
Schlenk and vacuum line techniques unless otherwise mentioned. All anhydrous solvents 
were purchased from Sigma-Aldrich and deuterated solvents from Cambridge Isotope 
Laboratories. Fmoc protected amino acids and peptide coupling reagents were obtained 
from Protein Technologies. Compounds 3-(diphenylphosphino)-propionic acid,[42] N-
Boc-3-iodo-alanine methyl ester,[43] N-Boc-3-(diphenylphosphinothioyl)-alanine (Boc-
Ppa-OH),[29, 44] (μ-pdt)Fe2(CO)6,[45] and (μ-bdt)Fe2(CO)6 [46] were synthesized 
according to the literature procedures. The other N-Boc protected phosphine-sulfide 
amino acids (Boc-Epa-OH and Boc-Ipa-OH) were analogously synthesized by slight 
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modification of the literature method.[44] All other starting materials were commercially 
available and used as obtained. 
1
H, 
13
C and 
31
P NMR spectra were recorded at room temperature on a Varian 
Liquid-State NMR spectrometer (400 or 500 MHz for 
1
H). NMR chemical shifts are 
quoted in ppm; spectra were referenced to tetramethylsilane for 
1
H and 
13
C NMR. The 
31
P NMR spectra were referenced to external phosphoric acid at 0 ppm. Splitting patterns 
are designated as follows: s, singlet; d, doublet; t, triplet; m, multiplet; br, broad singlet; 
dd, doublet of doublet; td, triplet of doublet. FTIR spectra were recorded on a Bruker 
Vertex 70 spectrophotometer using a stainless steel sealed liquid spectrophotometer cell 
with CaF2 windows. UV-vis measurements were performed on a Hewlett-Packard 8453 
spectrophotometer using quartz cuvettes with a 1 cm pathlength. MALDI-MS (matrix 
assisted laser desorption/ionization mass spectrometry) characterization of peptides was 
performed on a Voyager DE STR instrument using α-cyano-4-hydroxycinnamic acid as 
matrix. ESI-MS of the metallopeptides with molecular weights above 1200 was 
performed using a Thermo Quantum Discovery Max triple-quadrupole mass 
spectrometer. Measurements were conducted in positive (+) and negative (–) ionization 
modes using a methanol/water (50:50 by volume) mobile phase at a flow rate of 10 mL 
min
–1
. Mass spectra of metallopeptides with lower molecular weight was recorded on a 
JEOL LCmate instrument using atmospheric-pressure chemical ionization (APCI) 
technique in positive mode. HPLC purification of peptides was performed on a Waters 
600E HPLC system with a photodiode array detector. For analytical HPLC, 3×50 mm C-
18 column was used, and PrepLC 25 mm module C-18 column was used for semi-
preparative HPLC. 
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3-(diphenylphosphinothioyl)propionic acid. 3-(diphenylphosphino)propionic acid 
(2.5 g, 9.7 mmol) and sulfur (0.316 g, 9.8 mmol) were suspended in toluene (17.5 mL) 
and refluxed under nitrogen for two hours. The reaction mixture was cooled to room 
temperature and the toluene was removed under reduced pressure to yield pure 3-
(diphenylphosphorothioyl)propionic acid as slightly yellowish solid(2.8 g, 99%). 
1
H 
NMR (400 MHz, CDCl3): δ = 7.83 (m, 4H), 7.5 (m, 6H), 2.73 (m, 4H); 
31
P {
1
H} NMR 
(161.9  MHz, CDCl3): δ = 41.86. 
N-Boc-3-(diethylphosphinothioyl)-alanine methyl ester (Boc-Epa-OMe). The N-Boc 
phosphine sulfide methyl ester was synthesized from N-Boc-3-iodo-alanine methyl ester. 
The general synthetic procedure is described in reference [44]. Yield 63%.
1
H NMR (400 
MHz, CDCl3): δ = 5.68 (d, 1H), 4.55-4.64 (m, 1H), 3.76 (s, 3H), 2.52-2.64 (m, 2H), 2.02 
(m, 4H), 1.42 (s, 9H), 1.14-1.24 (m, 6H); 
31
P {
1
H} NMR (161.9  MHz, CDCl3): δ = 
52.80. Rf = 0.3 (35% EtOAc/hexane). 
N-Boc-3-(diisopropylphosphinothioyl)-alanine methyl ester (Boc-Ipa-OMe). Same 
procedure as above. Yield 69%. 
1
H NMR (400 MHz, CDCl3): δ = 5.86 (d, 1H), 4.61-4.52 
(m, 1H), 3.75 (s, 3H), 2.38-2.46 (m, 2H), 2.13 (m, 2H), 1.43 (s, 9H), 1.15-1.24 (m, 12H); 
31
P {
1
H} NMR (161.9 MHz, CDCl3): δ = 64.74. Rf = 0.45 (40% EtOAc/hexane). 
N-Boc-3-(diethylphosphinothioyl)-alanine (Boc-Epa-OH). Hydrolysis of the N-Boc 
phosphine sulfide methyl ester by LiOH followed by acidification produced the N-Boc 
phosphine sulfide amino acid.[44] Yield 82%. 
1
H NMR (400 MHz, CDCl3): δ = 9.54 (br, 
1H), 5.87 (d, 1H), 4.58-4.64 (m, 1H), 2.51 (m, 1H), 2.39 (m, 1H), 1.84-1.99 (m, 4H), 
1.43 (s, 9H), 1.13-1.22 (m, 6H); 
13
C{
1
H} NMR (100 MHz, CDCl3): δ = 174.6 (s), 
155.6 (s), 80.8 (s), 50 (s), 29.9 (d, JC-P = 45 Hz), 24.7 (d, JC-P = 51 Hz), 24.3 (d, 
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JC-P = 51 Hz), 6.26 (d, JC-P = 5 Hz);  
31
P{
1
H} NMR (161.9  MHz, CDCl3): δ = 51.55. 
Rf = 0.13 (1:1 EtOAc/hexane) 
N-Boc-3-(diisopropylphosphinothioyl)-alanine (Boc-Ipa-OH). Same procedure as 
above. Yield 69%. 
1
H NMR (400 MHz, CDCl3): δ = 9.21 (br, 1H), 5.95 (d, 1H), 4.56-
4.62 (m, 1H), 2.42 (m, 1H), 2.32 (m, 1H), 2.09-2.21 (m, 2H), 1.42 (s, 9H), 1.15-1.27 (m, 
12H); 
13
C{
1
H} NMR (100 MHz, CDCl3): δ = 171.1 (s), 155.4 (s), 80.6 (s), 50.4 (s), 28.7 
(d, JC-P = 49 Hz), 28.3 (d, JC-P = 49 Hz), 25.5 (d, JC-P = 48 Hz), 16.1 (m), 15.8 (m); 
31
P{
1
H} NMR (161.9  MHz, CDCl3): δ = 65.14. Rf = 0.2 (1:1 EtOAc/hexane). 
Solid phase peptide synthesis. The eight amino acid containing peptide (WASKLPSG) 
was synthesized on a Protein Technologies PS3 automated peptide synthesizer using the 
standard Fmoc/tBu protection strategy and HBTU as coupling reagent on Fmoc-Gly 
wang resin (Aapptec 0.54 mmol/g, 100–200 mesh) at 0.1 mmol scale. Following 
synthesis, the peptide was acetylated at the N-terminus by treating the resin bound 
peptide with 1:1 (v/v) acetic anhydride: N-methylmorpholine in DMF for 30 min. 
On-resin modification of peptide. Resin bound peptide (0.05 mmol) was treated with 
2% hydrazine (v/v) in DMF (10 mL) for 1 h under nitrogen at room temperature. The 
resin beads were then thoroughly washed with DMF. The resin beads were then treated 
with the solution of 3-(diphenylphosphino)propionic acid or 
3-(diphenylphosphinothioyl)propionic acid (0.15 mmol), HATU (54 mg, 0.14 mmol), and 
DIEA (30 μL, 0.16 mmol) in 8 mL DMF for 45 min. The coupling was repeated to ensure 
complete reaction. The resin was then washed with DMF (4×2 mL) and dichloromethane 
(5×2 mL) followed by cleavage of peptide using 95:2.5:2.5 TFA/water/TIPS (v/v) for 
two hours (TFA = trifluoroacetic acid, TIPS = triisopropylsilane). The TFA solution of 
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the peptide was concentrated under reduced pressure. The peptide was purified by reverse 
phase HPLC using aqueous acetonitrile gradients containing 0.1% TFA (v/v). 
Peptide WASK{-COC2H4PPh2}LPSG, 1a. 
31
P{
1
H} NMR (161.9 MHz, CD3CN): δ = 
-14.4; Rt = 60 min (HPLC gradient 1% acetonitrile/min); MALDI-TOF MS: m/z = 
1149.8 (M+Na)
+
. 
Peptide WASK{-COC2H4P(S)Ph2}LPSG. 
31
P{
1
H} NMR (161.9 MHz, CD3CN): δ = 
43.08; Rt = 54 min (HPLC gradient 1% acetonitrile/min); MALDI-TOF MS: m/z = 
1181.6 (M+Na)
+
. 
Solution phase peptide synthesis. N-Boc protected phosphino amino acid (1 equiv), 
leucine methyl ester hydrochloride (1 equiv), and PyBOP (1.5 equiv) were dissolved in 
CH2Cl2 under nitrogen and cooled to 0°C. DIEA (3 equiv) was added and the reaction 
mix was allowed to warm up to room temperature. After stirring at room temperature for 
40 min, the reaction mixture was washed with 1M HCl, saturated NaHCO3, and brine. 
The CH2Cl2 solution was dried over MgSO4, filtered, concentrated under reduced 
pressure and purified over silica using hexane/ethyl acetate as eluent. The N-Boc methyl 
ester protected dipeptide was treated with 1:1 TFA/CH2Cl2 until complete removal of 
Boc as indicated by TLC. The reaction mixture was then concentrated under reduced 
pressure, dissolved in toluene and concentrated. The last step was continued until white 
solid was obtained. Then the solid was dissolved in CH2Cl2 and concentrated followed by 
drying under vacuum for 12 h. The TFA salt of the dipeptide, N-acetyl valine (1 equiv.), 
and PyBOP (1.5 equiv.) was dissolved in CH2Cl2, cooled to 0°C and DIEA (3 equiv.) was 
added. After stirring at room temperature for 40 min, the reaction mixture was washed 
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with 1M HCl, saturated NaHCO3 and brine. The CH2Cl2 layer was dried, concentrated 
and purified over silica using 2% methanol/ethyl acetate as eluent. 
Ac-Val-Epa-Leu-OMe, 2a. 
1
H NMR (400 MHz, CDCl3): δ = 7.98 (d, 1H), 7.82 (d, 1H), 
6.06 (m, 1H), 4.89 (m, 1H), 4.44 (m, 1H), 4.12-4.22 (m, 1H), 3.69 (s, 3H), 2.1-2.5 (m, 
3H), 2.06 (s, 3H), 1.7-1.94 (m, 6H), 1.37 (m, 1H), 1.11-1.21 (m, 6H), 0.89 -0.95 (m, 
12H); 
31
P{
1
H} NMR (161.9  MHz, CDCl3): δ = 52.00 (major isomer 92%), 51.98 (minor 
diastereomer 8%); Rf = 0.2 (EtOAc); MALDI-TOF MS: m/z = 500.31 (M+Na)
+
. The two 
diastereomeric tripeptides could not be separated because of their nearly identical 
polarity. 
Ac-Val-Ipa-Leu-OMe, 3a. 
1
H NMR (400 MHz, CDCl3): δ = 7.94 (d, 1H), 7.85 (d, 1H), 
6.04 (m, 1H), 4.88 (m, 1H), 4.45 (m, 1H), 4.28 (m, 1H), 3.72 (s, 3H), 2.42-2.48 (m, 1H), 
2.29-2.35 (m, 2H), 2.22-2.26 (m, 1H), 2.11-2.17(m, 1H) 2.09 (s, 3H), 1.78 (m, 1H), 1.63-
1.71 (m, 2H) 1.19-1.31 (m, 12H), 0.92-1 (m, 12H); 
31
P{
1
H} NMR (161.9  MHz, CDCl3): 
δ = 64.98. Rf = 0.22 (EtOAc). MALDI-TOF MS: m/z = 528.36 (M+Na)
+
. 
Ac-Val-Ppa-Leu-OMe, 4a. 
1
H NMR (400 MHz, CD2Cl2): δ = 7.83 (m, 4H), 7.75 (d, 
1H), 7.49 (m, 6H), 7.10 (d, 1H), 5.98 (d, 1H), 4.69-4.79 (m, 1H), 4.21 (m, 1H), 4.07 (m, 
1H), 3.64 (s, 3H), 2.09 (m, 1H), 2.06 (s, 3H), 1.97 (m, 1H), 1.52-1.54 (m, 3H), 0.81-0.90 
(m, 12 H); 
31
P{
1
H} NMR (161.9  MHz, CD2Cl2): δ = 40.35. Rf = 0.1 (2:1 
EtOAc/hexane). MALDI-TOF MS: m/z = 595.8 (M+Na)
+
. 
Preparation of 1a by desulfurization of WASK{-COC2H4P(S)Ph2}LPSG. Raney 
nickel slurry (800 mg) was transferred to a Schlenk flask and washed with degassed 
methanol until the washings were clear. Then the Raney nickel was washed with 
degassed CH3CN (3×5 mL). The peptide (29 μmol) in 4:1 CH3CN/water (v/v, 10 mL) 
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was added to the Raney nickel and stirred at room temperature for 2 h. Completion of 
desulfurization was confirmed by MALDI-TOF MS. The Raney nickel was allowed to 
settle and the reaction mixture was filtered into a Schlenk flask under an argon 
atmosphere. The Raney nickel was rinsed with 5×5 mL CH3CN and filtered into the 
Schlenk flask. The CH3CN solution was concentrated under reduced pressure and 
lyophilized overnight to obtain phosphine-peptide (1a) as white powder that was 
immediately used for the cluster incorporation. 
Synthesis of 1 from 1a. The phosphine-peptide 1a (3 μmol) was dissolved in CH3CN (5 
mL). In a separate flask (μ-pdt)Fe2(CO)6
 
(4 mg) and trimethylamine-N-oxide (2 mg) were 
dissolved in CH3CN (1 mL) and stirred in the dark for 10 min. This solution was 
transferred to the peptide solution via cannula. After stirring for two hours in the dark, the 
solvent was removed under reduced pressure, and the product metallopeptide (1) was 
purified via reverse phase HPLC. Yield 15%. 
31
P{
1
H} NMR (161.9 MHz, 10% 
D2O/CD3CN): δ = 55.43. IR (KBr, cm
-1): ν(CO) = 2044, 1981, 1958, 1925. ESI-MS: 
(EI
+
) m/z = 1458.5 (M+H-CO)
+
; (EI
-
) m/z = 1456.4 (M-H-CO)
-
, 1373.6 (M-H-4CO)
-
. Rt 
= 76 min (HPLC gradient 1% acetonitrile/min). 
Desulfurization of tripeptides (2a, 3a, 4a) by Raney nickel. To a slurry of Raney 
nickel (washed with MeOH and CH3CN) was added a solution of tripeptide (0.25 mmol) 
in CH3CN (15 mL). The reaction mixture was stirred at 45-55°C under argon until 
complete reduction of the phosphine sulfide as indicated by either 
31
P NMR or MALDI. 
The Raney nickel was allowed to settle, and the supernatant was filtered under argon. The 
filtrate was concentrated under reduced pressure and lyophilized overnight. The 
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tripeptide with free phosphine was immediately used for the reaction with diiron 
hexacarbonyl precursor. 
Reduction of 2a. Reaction condition: 2 h at 25°C, then 1 h at 44°C. MALDI-TOF MS: 
m/z = 446.37 (M+H)
+
. 
Reduction of 3a. Reaction condition: 4 h at 48°C.
 31
P{
1
H} NMR (161.9 MHz, CDCl3): 
δ = -4.06. 
Reduction of 3a. Reaction condition: 4 h at 55°C.
 31
P{
1
H} NMR (161.9 MHz, CDCl3): 
δ = -23.34. 
General procedure for cluster incorporation into tripeptide. A solution of 
(μ-SR1S)Fe2(CO)6 (0.3 mmol) in CH3CN (3 mL) was added dropwise to a CH2Cl2 (2 mL) 
solution of Me3NO.2H2O (0.3 mmol) at room temperature. After stirring the reaction 
mixture in the dark for 10 min, a CH2Cl2 (10 mL) solution of the phosphine-peptide (0.2 
mmol) was added dropwise. After 3 h, the solvent was removed under reduced pressure, 
and the residue was purified by silica gel chromatography with 2% MeOH/CH2Cl2 to 
produce the peptide-diiron complex as red powder. 
(Val-Epa-Leu)-{(μ-pdt)Fe2(CO)5}, 2. Yield 77%. 
1
H NMR (400 MHz, CD2Cl2): δ = 
6.78 (d, 1H), 6.63 (d, 1H), 5.98 (d, 1H), 4.93 (m, 1H), 4.47 (m, 1H), 4.18 (m, 1H), 3.69 
(s, 3H), 2.56 (m, 1H), 2.27 (m, 3H), 2.10 (m, 1H), 1.99 (s, 3H), 1.72-1.88 (m, 6H) 1.56-
1.60 (m, 5H), 1.23-1.26 (m, 6H), 0.90-0.94 (m, 12H); 
31
P NMR (161.9 MHz, CD2Cl2): δ 
= 54.78 (major isomer 78%), 54.95 (minor diastereomer 22%); IR (CH2Cl2, cm
-1): ν(CO) 
= 2040, 1981, 1966, 1921; Rf = 0.5 (EtOAc); MS (APCI
+
): m/z = 804.1117 (calculated 
804.1139). 
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(Val-Ipa-Leu)-{(μ-pdt)Fe2(CO)5}, 3. Yield 80%. 
1
H NMR (400 MHz, CD2Cl2): δ = 6.85 
(d, 1H), 6.63 (d, 1H), 5.95 (d, 1H), 4.98 (m, 1H), 4.47 (m, 1H), 4.03-4.18 (m, 1H), 3.67 
(s, 3H), 2.23 (m, 1H), 2.24 (m, 4H), 2.00 (m, 5H), 1.55-1.68 (m, 7H), 1.26-1.35 (m, 
12H), 0.89-0.98 (m, 12H); 
31
P NMR (161.9 MHz, CD2Cl2): δ = 70.15 (major isomer 
60%), 69.75 (minor diastereomer 40%); IR (CH2Cl2, cm
-1): ν(CO) = 2043, 1979, 1960, 
1919; Rf = 0.6 (EtOAc); MS (APCI
+
): m/z = 832.1449 (calculated 832.1452). 
(Val-Ppa-Leu)-{(μ-pdt)Fe2(CO)5}, 4. Yield 87%. 
1
H NMR (400 MHz, CD2Cl2): δ = 
7.62-7.76 (m, 4H), 7.41-7.51 (m, 6H), 6.56 (d, 1H), 5.77 (d, 1H), 5.52 (d, 1H), 4.74 (m, 
1H), 4.36 (m, 1H), 3.75 (m, 1H), 3.69 (s, 3H), 2.83-3.30 (m, 3H), 1.93 (s, 3H), 1.85 (m, 
3H), 1.50-1.58 (m, 6H), 0.85-0.88 (m, 6H), 0.73-0.80 (m, 6H); 
31
P NMR (161.9 MHz, 
CD2Cl2): δ = 55.30 (major isomer 70%), 55.91 (minor diastereomer, 30%); IR (CH2Cl2, 
cm
-1): ν(CO) = 2046, 1984, 1961, 1928; Rf = 0.3 (2% MeOH/CH2Cl2); MS (APCI
+
): m/z 
= 900.1159 (calculated 900.1139). 
(Val-Ppa-Leu)-{(μ-bdt)Fe2(CO)5}, 5. Yield 84%. 
1
H NMR (400 MHz, CD2Cl2): δ = 
7.65 (m, 2H), 7.47-7.53 (m, 4H), 7.32-7.4 (m, 2H), 7.24-7.27 (4H), 6.94 (d, 1H), 6.54 (d, 
1H), 6.48 (td, 1H), 6.39 (m, 1H), 4.84 (m, 1H), 4.41 (m, 1H), 3.73 (s, 3H), 3.7 (m, 1H), 
2.73 (m, 2H), 1.94 (s, 3H), 1.49-1.60 (m, 4H), 0.86-0.90 (m, 6H), 0.72-0.77 (m, 6H); 
31
P 
NMR (161.9 MHz, CD2Cl2): δ = 51.25; IR (CH2Cl2, cm
-1): ν(CO) = 2053, 1994, 1937; Rf 
= 0.37 (2% MeOH/CH2Cl2); MS (APCI
+
): m/z = 934.0973 (calculated 934.0983). 
Electrochemistry. Electrochemical measurements were made using a CHI 1200A 
electrochemical analyzer under an atmosphere of argon. A conventional three-electrode 
cell was used for recording cyclic voltammograms. The working electrode was a 3 mm 
diameter glassy carbon disk polished with 1 mm and 0.3 mm deagglomerated alpha 
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alumina, successively, and sonicated for 15 min in ultrapure water prior to use. The 
Ag/Ag
+
 reference electrode was prepared by immersing a silver wire anodized with AgCl 
in an CH3CN solution of 0.1 M [NBu4][PF6]. A platinum wire was used as counter 
electrode. For the electrochemical studies in pure CH3CN, a 0.1 M solution of 
[NBu4][PF6] was used as supporting electrolyte. Mixtures of 0.1 M [NBu4][PF6]  in 
CH3CN and 0.1 M KCl in water were used for the mixed solvent experiments. Deaeration 
of the solutions was performed by bubbling argon through the solution for 15 min after 
which an atmosphere of argon was maintained during the course of electrochemical 
measurements. All potentials are reported relative to the ferrocene couple (Fc
+
/Fc) as 
reference. Concentrations of the complexes were determined spectrophotometrically 
based on the extinction coefficients of the Fe-S charge transfer bands in the range 342-
365 nm. 
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Figure 3-1. Optical spectra of the phosphine-peptide substituted diiron complexes. 
UV-vis spectra of 2 (black), 3 (green), 4 (blue), and 5 (red) in acetonitrile. Spectra were 
obtained from solutions of approximately 0.1 mM complex. 
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Figure 3-2. Cyclic voltammograms of the phosphine-substituted diiron-peptide 
complexes in acetonitrile. Cyclic voltammograms of (a) 2 (0.88 mM), (b) 3 (0.69 mM), 
(c) 4 (1.39 mM), and (d) 5 (1 mM) in acetonitrile with 0.1 M [NBu4][PF6] at a scan rate 
0.2 Vs
-1
. Arrows mark the starting potential and scan direction. 
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Figure 3-3. Electrocatalytic proton reduction from AcOH in acetonitrile. Cyclic 
voltammograms of (a) 2 (0.88 mM), (b) 3 (0.69 mM), (c) 4 (1.39 mM), and (d) 5 in 
acetonitrile with various concentrations of acetic acid. The acid concentrations used are 5, 
10, 20, 30, 40, and 50 mM. Reductive current increases with increasing acid 
concentration. Other experimental conditions are as described in Figure 3-2. 
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Figure 3-4. Cyclic voltammograms of the phosphine-peptide substituted diiron 
complexes in acetonitrile/water mixtures. Cyclic voltammograms of (a) 3, (b) 4, and 
(c) 5 in 3:2 acetonitrile-water (top) and 3:1 acetonitrile-water (bottom) at a potential scan 
rate of 0.2 Vs
-1
. Cyclic voltammograms in neat acetonitrile are shown in Figure 3-2. In 
acetonitrile, 0.1 M [NBu4][PF6] is used as supporting electrolyte. Similarly, 0.1 M KCl is 
used as supporting electrolyte in water. Solvent mixtures include both electrolytes at the 
concentration formed by mixing. Concentrations of the complexes: (i) 3:1 CH3CN/H2O: 3 
(0.63 mM), 4 (1.06 mM), and 5 (0.86 mM); (ii) 3:2 CH3CN/H2O: 3 (0.64 mM), 4 (1.25 
mM), and 5 (0.72 mM). 
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Figure 3-5. Electrocatalytic proton reduction from AcOH in 3:1 acetonitrile/water. 
Cyclic voltammograms of (a) 3 (0.63 mM), (b) 4 (1.06 mM), and (c) 5 (0.86 mM) in 3:1 
acetonitrile-water with various concentrations of acetic acid. The acid concentrations 
used are 5, 10, 20, 30, 40, and 50 mM. Other experimental conditions are as described in 
Figure 3-4. 
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Figure 3-6. Electrocatalytic proton reduction from AcOH in 3:2 acetonitrile/water. 
Cyclic voltammograms of (a) 3 (0.64 mM), (b) 4 (1.25 mM), and (c) 5 (0.72 mM) in 3:2 
acetonitrile-water with various concentrations of acetic acid. The acid concentrations 
used are 5, 10, 20, 30, 40, and 50 mM. Other experimental conditions are as described in 
Figure 3-4. 
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Figure 3-7. Plots of catalytic peak current vs. [AcOH] for mixed acetonitrile/water 
(3:1 and 3:2) solvents. Dependence of the catalytic peak current (icat) on equivalents of 
acetic acid added for (a) 3, (b) 4, and (c) 5 in acetonitrile (♦), 3:1 acetonitrile-water (■), 
and 3:2 acetonitrile-water (▲). The values of icat were calculated using Figure 3-3, 3-5 
and 3-6. 
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Scheme 3-1. Synthetic scheme for on-resin modification of the lysine residue of an eight 
amino acid peptide to incorporate a phosphine functional group and subsequent reaction 
with diiron-hexacarbonyl to produce the [(μ-pdt){Fe(CO)3{peptide-Fe(CO)2}] complex 
(1). The solid circle represents the resin bead. Reaction conditions: (a) 2% N2H4, DMF; 
(b) Ph2PC2H4COOH, HATU, DIEA, DMF; (c) Ph2P(S)C2H4COOH, HATU, DIEA, 
DMF; (d) 95% TFA, 2.5% water, 2.5% TIPS; (e) (i) 95% TFA, 2.5% water, 2.5% TIPS, 
(ii) Raney nickel, aq. CH3CN; (f) (μ-pdt)Fe2(CO)6, Me3NO, aq. CH3CN. 
 
Scheme 3-2. Synthetic scheme for diiron-tripeptide complexes utilizing artificial N-Boc 
phosphine sulfide amino acids. Reaction conditions: (a) (i) H-Leu-OMe.HCl, PyBOP, 
DIEA, CH2Cl2, (ii) Ac-Val-OH, PyBOP, DIEA, CH2Cl2; (b) Raney nickel, CH3CN, heat 
(* racemization occurred during reduction); (c) (μ-SR1S)Fe2(CO)6, Me3NO, CH3CN. 
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Table 3-1. UV-vis absorbance for the Fe-S charge transfer band and IR stretching 
frequencies in the ν(CO) region data for complexes 1-5 
Complex λmax, nm (ε, M
-1
cm
-1
) ν (CO), cm-1 
1
a
 350  2044 (s), 1981 (s), 1958 (sh.), 1925 (w) 
2 342 (9300) 2040 (s), 1981 (vs), 1966 (sh.), 1921 (w) 
3 351 (13250) 2043 (s), 1979 (vs), 1960 (sh.), 1919 (w) 
4 354 (12050) 2046 (s), 1984 (s), 1961 (sh.), 1928 (w) 
5 365 (25700) 2053 (s), 1994 (s), 1937 (w) 
a
 Extinction coefficient was not determined 
 
Table 3-2. Electrochemical data for 2-5 in acetonitrile and acetonitrile/water mixed 
solvents 
Complex 
Epc (Fe
I
Fe
I
/Fe
I
Fe
0
), V Epa (Fe
II
Fe
I
/Fe
I
Fe
I
), V 
CH3CN 
3:1 
CH3CN/H2O 
3:2 
CH3CN/H2O 
CH3CN 
3:1 
CH3CN/H2O 
3:2 
CH3CN/H2O 
2 -1.93 ND
a 
ND +0.22 ND ND 
3 -1.90 -1.78 -1.74 +0.26 +0.22 +0.22 
4 -1.82 -1.77 -1.72 +0.31 +0.29 +0.32 
5 -1.62 -1.51 -1.47 +0.47 +0.48 +0.46 
a
 ND = not determined. 
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Abstract 
[FeFe]-hydrogenases feature a unique active site in which the primary catalytic unit is 
directly coordinated via a bridging cysteine thiolate to a secondary, redox active 
[4Fe4S] unit. The goal of this study was to evaluate the impact of a bidentate, redox 
non-innocent ligand on the electrocatalytic properties of the (-S(CH2)3S)Fe2(CO)4L2 
family of [FeFe]-hydrogenase models as a proxy for the iron-sulfur cluster. Reaction 
of the redox non-innocent ligand 2,2'-bipyridyl (bpy) with (-S(CH2)3S)Fe2(CO)6 
leads to substitution of two carbonyls to form the asymmetric complex (-
S(CH2)3S)Fe2(CO)4(
2
-bpy) (1) which was structurally characterized by single crystal 
X-ray diffraction. This complex can be protonated by HBF4.OEt2 to form a bridging 
hydride. Furthermore, electrochemical investigation shows that, at slow scan rates, the 
complex undergoes a two electron reduction at -2.06 V vs. Fc
+
/Fc that likely involves 
reduction of both the bpy ligand and the metal. Electrocatalytic reduction of protons 
is observed in the presence of three distinct acids of varying strengths: HBF4.OEt2, 
AcOH, and p-TsOH. The catalytic mechanism depends on the strength of the acid. 
  
75 
Introduction 
Hydrogenases are the enzymes that catalyze the oxidation of hydrogen to protons and 
electrons as well as the reverse, reduction of protons to hydrogen.
1-4
 This reaction is 
important to carbon neutral fuel production, and much research is focused on 
developing robust, renewable catalysts. Since hydrogenases rely only on earth 
abundant first row transition metals at their active sites, they have served as a source 
of inspiration for much work in this area.
5-7
 As shown in Figure 4-1, structural studies 
have shown that the active site of [FeFe]-hydrogenases, often referred to as the H-
cluster, consists of a diiron catalytic subsite bridged via a single cysteinyl thiolate to a 
redox active [4Fe4S] cluster.
8-13
 The diiron subsite is a [2Fe2S] unit in which the 
irons are linked via a bridging organic dithiolate ligand. The remainder of the 
coordination sphere of each iron is occupied by the biologically uncommon π-
acceptor ligands CO and CN
-
. 
Organometallic complexes of the type [(-SR)2Fe2(CO)6] and their derivatives 
in which one or more carbonyl ligands are substituted by -donor ligands such as 
phosphines or N-heterocyclic carbenes have proven to be both structural and 
functional models of [FeFe]-hydrogenases.
14-16
 However, several significant 
differences from the enzymes have limited the catalytic abilities of these complexes. 
First, although the enzymes utilize the Fe(II)Fe(I) redox state of the H-cluster for 
proton reduction, electrocatalysis via model compounds almost invariably relies on 
the Fe(I)Fe(0) state.
7
 The result is that model complexes require considerable 
overpotential to initiate proton reduction catalysis. Second, while the enzyme features 
an inverted geometry around one of the metal centers allowing ligand binding at an 
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exposed terminal position, the model complexes are most stable in the relatively inert 
eclipsed conformation.
17
 Third, theoretical work has indicated that electron density is 
delocalized throughout all six irons of the H-cluster and the redox active [4Fe4S] 
cubane is crucial in the catalytic cycle of the enzyme,
18, 19
 but few models have 
incorporated either an iron-sulfur cluster or a redox-active ligand.
20-23
 
Theoretical studies have suggested that asymmetrically substituted complexes 
with strong donor ligands should favor a rotated geometry and thus facilitate proton 
reduction catalysis.
24
 To this end, chelating ligands such as diphosphines, 
phenanthroline, or carbenes have proven useful in controlling and modulating the 
properties of [FeFe]-hydrogenase model compounds. 
25-32
 For example, formation of 
short-lived terminal hydrides upon protonation has been detected for complexes with 
chelating ligands of the form (-SRS)Fe2(CO)4(LL) (LL=chelating ligand).
33, 34
 This 
indicates that these compounds can attain a rotated geometry and accommodate an 
external ligand, albeit fleetingly. Although seldom used in hydrogenase models, redox 
active ligands have proven useful in modulating catalytic properties at a metallocenter 
as a function of the redox state of the ligand in other chemical contexts.
35, 36
  
To explore the effects of a chelating, redox non-innocent ligand, we have 
synthesized (-S(CH2)3S)Fe2(CO)4(
2
-bpy), in which bpy is the weakly π-accepting 
2,2'-bipyridyl ligand. In this paper, we describe the electronic properties of this 
complex as well as its electrochemical behavior under both oxidizing and reducing 
conditions. Importantly, the first reductive event is a two electron process that likely 
involves both metal and ligand reduction. Comparison to other model complexes 
suggests avenues for producing better electrocatalysts for proton reduction.   
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Results and Discussion 
Synthesis and Characterization of [(-pdt)Fe2(CO)4(
2
-bpy)], 1. 2,2-bipyridyl (bpy) 
was chosen as a ligand for substitution of carbonyls because it is both redox non-innocent 
and weakly π-accepting. The complex, [(-pdt)Fe2(CO)4(
2
-bpy)] (1), was synthesized 
from the hexacarbonyl precursor in 60% yield via substitution of two CO ligands by 2,2-
bipyridyl in refluxing toluene (pdt = 1,3-propanedithiol). Purification of the resulting 
solution via silica chromatography resulted in isolation of the product as moderately air-
stable, dark green crystals. The molecular structure of 1 was determined by X-ray 
diffraction analysis of a single crystal obtained by slow diffusion of hexane into a 
dichloromethane solution of 1. The crystal structure of 1 is shown in Figure 4-2, and 
selected bond lengths and bond angles are listed in Table 4-1. The bond angles indicate 
that, as reported previously for analogous diiron(I) pdt complexes, the coordination 
geometry around both iron centers is distorted square pyramidal.
7, 37, 38
 However, the 
structure is asymmetric with binding of 2-(2,2-bpy) to only one of the irons in a basal-
basal conformation. The two Fe units, Fe(CO)3 and Fe(CO)(2,2-bpy), are eclipsed and 
are connected by an FeFe bond and a 1,3-propanedithiolate bridge. The FeFe bond 
(2.5623(4) Å) is longer than the corresponding bond of the parent hexacarbonyl complex 
(2.5103(11) Å)
39
 but similar to the corresponding bond in reduced DdH hydrogenase 
(2.55 Å).
40
 On the other hand, the FeFe bond is shorter than that determined in related 
compounds containing basal-basal diphosphine or bis-carbene, such as 
[(-pdt)Fe2(CO)4(
2
-LL)] (LL = 1,2-bis(dimethylphosphino)ethane, 2.6038(5) Å;
27
 
LL = 1,1-bis(diphenylphosphino)methane, 2.5879(7) Å;
41
 LL = (PPh2)2N(
i
Pr), 2.6236(4) 
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Å; LL = (PPh2)2N(allyl), 2.6042(4) Å);
42
 LL = IMe-CH2-IMe , 2.5774(6) Å 
(IMe = 1-methylimidazol-2-ylidene); and LL = IMe-C2H4-IMe, 2.6253(4) Å).
34
 The 
coordination of 2,2-bpy induces a slight asymmetry of the Fe2S2 skeleton which is 
reflected by shorter Fe-S bonds to the Fe(CO)(2,2-bpy) moiety. Furthermore, the weak 
π-accepting ability of 2,2-bpy leads to a shortening of the adjacent Fe-COax [Fe(1)-C(11) 
1.755(2) Å] bond compared to the Fe-COax [Fe(2)-C(13) 1.813(2) Å] and Fe-COba 
[Fe(2)-C(12) 1.778(2) Å, Fe(2)-C(14) 1.779(2) Å] bonds on the Fe(CO)3 moiety (ax and 
ba denote axial and basal positions, respectively). 
1 was characterized by UV-vis, FTIR and NMR spectroscopies. As shown in 
Figure 4-3, IR spectra of 1 in dichloromethane or acetonitrile consist of three 
characteristic bands at 2007, 1937 and 1896 cm
-1
, similar to those observed for the 
analogous 1,10-phenanthroline substituted complex.
26
 Relative to the hexacarbonyl 
precursor, the CO bands are ca. 70 cm
-1
 lower in energy. This shift is greater than that 
of bis-phosphine analogues
25, 27, 33, 43
 and only slightly less than bis-(N-heterocyclic 
carbene) analogues.
34
 This suggests that the weak accepting ability of the 2,2-bpy 
ligand results in electron rich diiron core with the basicity of the diiron center 
comparable to that of bis-(N-heterocyclic carbene) analogues. We note also that five 
strong bands at 2002, 1993, 1935, 1920, and 1882 cm
-1
 are observed in the carbonyl 
region when the spectrum is obtained from a KBr pellet of 1. The difference suggests 
that 1 may be fluxional in solution or pellet preparation may have resulted in 
modification of crystal packing. 
The positions of the resonances of  the 2,2-bpy ligand in the 1H and 13C NMR 
spectra can be compared to those of the free ligand to describe qualitatively the 
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electronic impact of bonding interactions between the Fe and the 2,2-bpy. The 1H 
NMR spectrum of 1 in CD2Cl2 includes four resonances (two doublets and two 
triplets) in the aromatic region, indicating symmetrical coordination of 2,2 -bpy 
(Figure 4-4). As listed in Table 4-2, it is interesting to note that, relative to the free 
ligand, the chemical shifts for the 2,2-bpy H(5), H(4), and H(3) protons are all shifted 
upfield. On the other hand, H(6) is shifted downfield. The 
13
C NMR spectrum shows 
a similar pattern in the chemical shifts of the ring carbons with the exception of C(5) 
which is shifted slightly downfield. Effectively, -backdonation from the metal to the 
empty * (LUMO) of the ligand causes all of the 2,2-bpy carbons, except C(6) and 
C(5), to become more electron rich upon coordination to the iron center. From the 
NMR resonances, we conclude this back-donation is particularly prominent at 
position 3 of the ring [(1H) = -0.4 and (13C) = -2.91]. As expected since the 
C(6)-2p orbital does not contribute to the LUMO, C(6) and H(6) resonances are 
shifted slightly downfield.
44
  
The presence of a 2,2-bpy or other diimine ligands on a low spin iron complex 
usually leads to three absorption bands in the UV-vis spectrum: an intense ligand-
centered -* band in the high energy UV region, weak metal-centered d-d transitions 
in the visible region, and metal-to-ligand-charge-transfer (MLCT) bands.
45
 As shown 
in Figure 4-5, the UV-vis spectrum of 1 in acetonitrile consists of a series of 
absorptions at 298, 342, 391, 519, 613, and 685 nm. The highest energy band is likely 
attributable to the bpy * transition. The weaker, lower energy bands are thought to 
arise from Fe
I
-CO charge-transfer and Fe
I
(d)-bpy(*) interactions.46 
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Protonation of 1. The reaction of 1 in acetonitrile at room temperature (298 K) with 
excess HBF4.OEt2 resulted in a change of the color of the solution from deep green to 
light brown. The course of the reaction was monitored by IR spectroscopy. As shown in 
Figure 4-3, upon addition of acid three new bands in the CO region at 2098, 2044, and 
1970 cm
-1
 appeared with a concomitant decrease of the bands associated with 1. The 
reaction was complete, i.e. the spectrum associated with starting material disappeared, 
within six minutes. The carbonyl stretching frequencies shifted by an average of 92 cm
-1
 
to higher wavenumbers; this shift is consistent with protonation of the Fe-Fe bond of 1 to 
form a bridging hydride species.
26, 27, 34
 Corroborating evidence was obtained through 
NMR experiments. Addition of three equivalents of HBF4.OEt2 to a solution of 1 in 
CD2Cl2 at room temperature resulted in formation of a singlet at -9.01 ppm in the 
1
H 
NMR spectrum (Figure 4-6). This suggests formation of a bridging hydride species, 
[1H]
+
, under these conditions. Although, the protonated species was stable up to one hour 
in solution, attempts to isolate the product [1H][BF4] for structural analysis were 
unsuccessful. Comparison of the UV-vis spectra of 1 and [1H]
+
 (Figure 4-5) shows 
bleaching of the MLCT bands in the visible region upon protonation of 1. This can be 
explained by a decrease of electron density on the iron centers upon binding the proton. 
Oxidation of 1 to 1
+
.
 
The electrochemical properties of 1 were investigated by cyclic 
voltammetry to evaluate the effect of the redox non-innocent 2,2-bpy ligand on the 
diiron cluster. As shown in Figure 4-7A, cyclic voltammograms of 1 in CH2Cl2 under 
oxidizing conditions reveal a partially reversible (ip
c
/ip
a
= 0.62 at 0.1 V s
-1
) oxidation at 
E1/2= -0.25 V (all potentials are reported relative to Fc
+
/Fc measured under the same 
experimental conditions). By analogy to other electrochemical studies, this is likely the 
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Fe
II
Fe
I
/Fe
I
Fe
I
 couple. It is interesting to note that at faster scan rates, 0.8 V s
-1
, the 
process becomes more reversible (ip
c
/ip
a
= 0.9) suggesting that an EC process is occurring 
with a slower chemical step that does not have time to occur on shorter timescales. Loss 
of a CO ligand, although not common for complexes with bidentate chelating ligands, has 
been shown to occur under oxidizing conditions for a number of diiron carbonyl 
complexes.
47, 48
 Thus, we hypothesized that loss of CO was the chemical step, and 
experiments were also undertaken in the presence of CO. As shown in Figure 4-7B, under 
an atmosphere of CO, complete reversibility of the redox couple was maintained even at 
scan rates as low as 0.05 V s
-1 
( ip
c
/ip
a
= 0.88, 0.9, and 0.94 at 0.05, 0.2, and 0.8 V s
-1 
respectively). Thus it is likely that oxidation under an inert atmosphere leads to loss of 
CO. Although loss of CO is known for many iron carbonyl compounds, it was not 
observed for either [(-pdt)Fe2(CO)4(dppe)] or [(-pdt)Fe2(CO)4(IMe-CH2-IMe)], 
analogous complexes including bidentate chelating ligands.
30, 31
 In the case of the dppe 
derivative, oxidation led to binding of an additional CO which was detected by a new 
oxidation peak in the voltammogram.
31
 On the other hand, cyclic voltammograms of 
[(-pdt)Fe2(CO)4(IMe-CH2-IMe)]  were identical under N2 and CO suggesting no reaction 
occurs between [(-pdt)Fe2(CO)4(IMe-CH2-IMe)]
+
 and CO.
31
 Thus the electrochemical 
behavior of 1 under oxidative conditions is significantly different from both the dppe and 
IMe-CH2-IMe analogues. 1
+
 is likely less stable than the other two cationic compounds and 
loses CO very readily. 
Reaction of 1
+
 with P(OMe)3. Both experimental and theoretical studies have shown 
that diiron complexes analogous to 1 with a chelating ligand [(-SRS)Fe2(CO)4(
2
-
LL)] undergo a change in geometry upon oxidation in which one of the iron centers 
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adopts an inverted pyramidal structure, creating an open coordination site for external 
ligand binding.
24, 49
 Thus the oxidized compound is often more reactive towards 
formation of adducts or substitution reactions than the neutral parent compound. To 
explore the reactivity of 1
+
, we have undertaken electrochemical experiments in the 
presence of P(OMe)3. Experiments were carried out under CO to minimize the 
undesired loss of CO. 
As shown in Figure 4-8, the oxidation of 1 in CH2Cl2 at room temperature in 
the presence of P(OMe)3 was partially reversible with a new reduction occurring at -
1.06 V. This suggests a coupled EC process in which, after the initial oxidation, the 
phosphite is coordinated by 1
+
. Substitution of a carbonyl by P(OMe)3 typically leads 
to a negative shift of reduction potential of 0.310-0.375 V.
30
 The negative shift of 0.8 
V in the reduction potential  of 1
+
 is consistent with increased electron density around 
the metal attributable to the coordination of two phosphite ligands to the diiron center. 
Using cyclic voltammetry at faster scan rates ( = 0.8 V s-1), two different reductive 
events were observed at Ep = -0.76 and -1.06 V. This suggests that the reaction 
between 1
+
 and P(OMe)3 may produce two species. The reduction at -0.76 V may be 
attributable to a complex containing a single P(OMe)3 ligand and whereas that at -
1.06 V likely possesses two P(OMe)3 ligands. In further support of this hypothesis, 
we note that even at faster scan rates, addition of excess P(OMe)3, which should 
thermodynamically favor formation of a more substituted product, led to an increase 
in the reductive peak current at Ep = -1.06 V (Figure 6, bottom panel). Taken together, 
these results suggest the species at Ep = -0.76 V forms first and that at -1.06 V is 
formed later or in the presence of more ligand. Chemical synthesis of the phosphite 
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substituted cationic complex by addition of P(OMe)3 to a solution of 1
+
 (produced by 
addition of 1 equivalent of FcBF4 at -42C) was unsuccessful due to the extreme 
sensitivity of the oxidized product to air and temperature. 
The cationic complex [1-P(OMe)3]
+
 likely formed in these experiments could 
be either an adduct [(-pdt)Fe2(CO)4(
2
-bpy)(P(OMe)3)]
+
 or a P(OMe)3/CO 
substitution product [(-pdt)Fe2(CO)3(
2
-bpy)(P(OMe)3)]
+
. Formation of CO 
substituted complex (Ep = -0.76 V) seems more likely since the experiments in 
CH2Cl2 demonstrated that 1
+
 is prone to loss of CO. Similarly, we anticipate that the 
complex with a reduction at -1.06 V is likely the disubstituted cation, 
[(pdt)Fe2(CO)2(
2
-bpy)(P(OMe)3)2]
+
. Similar results have been reported for the dppe 
complex [(-pdt)Fe2(CO)4(
2
-dppe)]
+
.
30
 The P(OMe)3 substituted cationic bis-carbene 
complex [Fe2(CO)3(P(OMe)3)(
2
-IMe-CH2-IMe)(-pdt)]
+
 has been reported to undergo 
disproportionation to form a disubstituted dication and the neutral unsubstituted 
complex.
31
 However, there is no evidence that [1+P(OMe)3]
+
 disproportionates. If the 
dication were to form, it is expected that it would have a much less negative reduction 
potential. The relative ease of losing CO from oxidized forms of 1 may explain why 
they do not undergo disproportionation. 
Reduction of 1. Cyclic voltammograms of 1 in acetonitrile under an inert atmosphere 
show a reduction at Ep
red
 = -2.06 V which was completely irreversible at scan rates 
lower than 1 V s
-1
 (Figure 4-9). At faster scan rates (1-10 V s
-1
), the reduction became 
quasi-reversible (ip
c
/ip
a
= 1.84 (Ar) and 4.67 (CO) at 4 V s
-1
; ip
c
/ip
a
= 2.42 (Ar) and 5.85 
(CO) at 2 V s
-1
) under both Ar and CO. The reduction is likely an EC process, but this 
demonstrates that loss of CO is not the chemical step. Additionally, the chemical step 
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following reduction must be reasonably slow. Controlled-potential coulometry 
demonstrated that the reduction at -2.06 V is a two electron process (Figure 4-10). 
Moreover, at scan rates faster than 1 V s
-1
, the reductive peak begins to split into two 
reductive features, separated by 0.25 V, indicating that the process is not concerted. 
This behavior has been observed previously for several diiron complexes with N-
heterocyclic carbene ligands.
50-52
  Since substituted iron carbonyl complexes in this 
family are not usually observed to form an Fe
0
Fe
0
 state, we hypothesize that only one 
of the reductions occurs at a metal center forming an Fe
I
Fe
0
 species.
30, 31, 50, 51
 The 
other likely corresponds to the bpy
0
/bpy
1-
 couple. This assignment is consistent with 
the reduction potential of the bpy ligand alone, -2.63 V in CH3CN, assuming that 
coordination of the ligand by removing electron density will shift its reduction 
potential to more positive values.
53
 The presence of two small oxidation peaks at Ep = 
-1.53, and -1.19 V suggests that the reduction may be followed by a chemical 
reaction(s) resulting in multiple products that are reoxidized at different potentials.  
Electrocatalytic proton reduction activity of 1. The electrocatalytic proton 
reduction activity of 1 was investigated in CH3CN in the presence of three distinct 
proton sources: a strong acid (HBF4.OEt2), a weak acid (AcOH) and an acid of 
intermediate strength (p-TsOH).  
As shown in Figure 4-11, sequential addition of AcOH from 1.4 mM to 42 mM 
(1-30 equiv), shows a 12-fold enhancement of peak current at -2.06 V with little 
impact on the rest of the voltammogram. This is characteristic of electrocatalytic H2 
evolution.
54-56
 The catalytic efficiency (C.E.) of 1 in AcOH was calculated using the 
method defined by Felton and coworkers,
15
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(icat = catalytic current, id = current for reduction of catalyst in absence of acid, CHA = 
concentration of acid, Ccat = concentration of catalyst).  The value of C.E. of 1 varies 
in the range 0.44 to 0.25, decreasing with increasing acid concentration. The 
overpotential for the process, defined as the difference between the standard potential 
for reduction of the acid and the half-wave potential for catalytic proton reduction, 
was 0.68 V.
56, 57
 The shift of the catalysis to less reducing potentials as acid 
concentration increases is consistent with a proton coupled electrochemical process. 
On the basis of these experimental results and previous reports on similar complexes, 
it is reasonable to propose an EECC mechanism such as that depicted in Figure 4-12 
to account for the electrocatalysis by 1 in AcOH.
52, 55, 58, 59
 First, 1 undergoes a 
two-electron reduction with one metal-centered reduction and one ligand-based 
reduction producing the electron rich dianion 1
2-
. Then the dianion accepts two 
protons. The catalyst is regenerated following reductive elemination of hydrogen. 
In the presence of HBF4, cyclic voltammograms of 1 exhibit two new 
reduction peaks at -1.33 and -1.69 V in addition to the peak at -2.06 V observed in 
weak acid (Figure 4-13A).  All three peaks grow at a similar rate with increasing acid 
concentration indicating electrocatalytic proton reduction occurs. The electrocatalytic 
behavior of 1 in p-TsOH is similar to that observed in HBF4 with three different 
catalytic processes as shown in Figure 4-13B. However, the first two reduction events 
at less negative potential are poorly separated and appear as a broad peak at ca. -1.4 
to -1.7 V. The current for the second reduction increases at a faster rate than the first 
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reductive current with increasing concentration of p-TsOH, when the acid is not 
present in large excess. This experimental observation suggests that the strength of 
the acid plays an important role in controlling the mechanism of electrocatalytic 
proton reduction (direct reduction of HBF4 and p-TsOH on the glassy carbon 
electrode in absence of 1 are shown in Figure 4-14).  
The FeFe bond of a sufficiently basic model diiron compound can be 
protonated by HBF4 to form bridging hydride species which are reduced at potentials 
from 0.75 to 1.08 V more positive than the parent compound.
15
 The 2,2-bpy ligand of 
1 should make it basic enough to be protonated by HBF4 at the Fe
I
Fe
I
 level leading to 
formation of the bridging hydride species, 1H+. The electrocatalysis at -1.33 V, 0.74 
V more positive than the catalysis in HOAc, is expected to arise from this species via 
an ECEC mechanism as shown in pathway A of Figure 4-15. First, 1H+ is reduced to 
1H, followed by protonation to produce 12H+. Then it accepts another electron to 
form the neutral complex 12H which gets further protonated followed by evolution 
of hydrogen and regeneration of 1H+. However, this pathway cannot account for the 
catalytic reduction of protons observed at -1.7 V. Instead, based on similar 
electrochemistry observed for [(-pdt)Fe2(CO)4(
2
-dppe)(-H)]+,60 we propose that 
the active electrocatalytic species for the second process is 1H and the mechanism 
for the catalysis is probably CEEC, as shown in Figure 4-15 (pathway B). The 
catalytic current arises from the reduction of 12H to 12H- which occurs at -1.7 V. 
Protonation of 12H- followed by release of hydrogen regenerates the active species 
1H. Electrocatalysis observed in presence of p-TsOH also supports such a CEEC 
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mechanism. The catalytic current for the second process at -1.7 V increases faster 
than the first process for p-TsOH when concentration of acid is low (1-4 equivalent). 
It suggests that protonation and reduction of 12H compete with each other, and the 
reduction is dominant when p-TsOH rather than HBF4 is used. HBF4, being a stronger 
acid, tends to favor pathway A by protonating 12H. Moreover, when excess p-TsOH 
(> 4 equivalent) is present, the acidity of the solution is sufficiently high that pathway 
A becomes more prominent than pathway B.  
Conclusions 
Our studies have focused on the impact of incorporating a redox non-innocent, 
bidentate chelating ligand on the electronic and catalytic properties of dithiolate-
bridged diiron models. In comparison to the parent hexacarbonyl complex, 
substitution of two of the CO ligands by 2,2-bpy leads to a negative shift of the 
Fe
I
Fe
I
/Fe
I
Fe
0
 reduction potential by 0.4 V and an average shift of the νCO of 70 cm
-1
 
to lower energy (to 2007, 1937, and 1896 cm
-1
). Both of these properties can be 
explained by the weaker π-accepting propensity of the 2,2'-bpy ligand. In essence, 
increased electron density at the iron makes it more difficult to reduce the metal 
complex, resulting in a shift of the reduction potential. Furthermore, the extra electron 
density is, in large part, accommodated by increased density in the orbitals with 
largely CO * character, decreasing the energies of the CO vibrations. In fact, for 
complexes in this family, there is usually a correlation between the average value of 
(CO) and the reduction potential of the complex. In the case of 1, however, this 
strong correlation does not seem to hold. Although the CO vibrational frequencies of 
1 are similar to those of bidentate ligand substituted complexes such as bis-phosphine 
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or N-heterocyclic carbene containing complexes (for example, 1996, 1920 and 
1872 cm
-1
 for [(-pdt)Fe2(CO)4(
2
-(IMe-CH2-IMe))]), the reduction potentials are not 
aligned. The reduction potential of 1 is closer to what would be expected for a 
monosubstituted complex such as [[(-pdt)Fe2(CO)5(PMe3)] (-1.94 V) than either the 
analogous 1,2-bis(diphenylphosphino)ethane complex (Ep
red
 = -2.33 V) or the IMe-
CH2-IMe substituted complex (  
   = -2.42 V).
9a, 9c, 10, 17, 29
 In essence, the reduction 
potential of 1 is 300-400 mV higher than might be expected based on its FTIR 
frequencies and comparisons to related compounds. The physical mechanisms by 
which the FTIR frequencies of 1 are shifted more dramatically than the reduction 
potential are unclear. It could be a result of either the -acidity or redox non-
innocence of the ligand. With that in mind, it is interesting to note that 1 undergoes 
both ligand and metal centered reductions at similar potentials. The physical 
mechanism not withstanding, the result is an exciting one because it suggests that 1 
should be relatively basic and nonetheless reduced at relatively mild potentials. These 
are exactly the properties desired in a good proton reduction electrocatalyst, and 
indeed 1 is able to reduce protons supplied by the relatively weak acid HOAc as well 
as stronger acids. This stands in contrast to [Fe2(CO)4(bma)(-pdt)] {bma=2,3-bis 
(diphenylphosphino) maleic anhydride}, a related complex incorporating a chelating, 
redox active ligand that has no detectable proton reduction activity. In short, by 
decoupling to some extent basicity and redox potential, utilization of redox non-
innocent ligands with reduction potentials similar to those of the iron may allow us to 
develop catalysts that operate both at high efficiency and with little overpotential.  
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Experimental Section 
General procedures. All reactions were carried out at room temperature under an 
atmosphere of nitrogen using standard Schlenk and vacuum-line techniques unless 
otherwise noted. Anhydrous dichloromethane, toluene and acetonitrile were obtained 
from Sigma-Aldrich and deuterated solvents from Cambridge Isotope Laboratories. 
(-S(CH2)3S)Fe2(CO)6 was synthesized according to literature method;
13
 all other 
starting materials were obtained commercially and used without further purification.  
Synthesis of (-pdt)Fe2(CO)4(
2
-bpy), (1). (-pdt)Fe2(CO)6 (410 mg, 1.06 mmol) 
and 2,2-bipyridyl (337 mg, 2.15 mmol) were dissolved in toluene (20 mL) and the 
solution was heated to reflux under nitrogen until the evolution of carbon monoxide 
stopped (12 hours). The reaction mixture was concentrated under reduced pressure, 
and the residue was purified via column chromatography on silica gel using 
dichloromethane/hexane as eluent. The dark green band was collected and dried under 
vaccum. The dark green solid was thoroughly washed with hexane to remove any 
unreacted (-pdt)Fe2(CO)6 Single crystals for X-ray diffraction were grown via slow 
diffusion of hexane into a CH2Cl2 solution of the compound at -20C. Yield: 290 mg 
(60%). IR (KBr pellet, cm
-1
): 2002 (s), 1993 (sh), 1935 (s), 1920 (s), 1882 (vs). IR 
(CH2Cl2, cm
-1
): 2007 (vs), 1937 (s), 1896 (m). 
1
H NMR (400 MHz, CD2Cl2):  = 8.73 
(d, 2H, bpy, C(6)-H), 8.03 (d, 2H, bpy, C(3)-H), 7.74 (tr, 2H, bpy, C(4)-H), 7.23 (tr, 2H, 
bpy, C(5)-H), 2.05 (m, 3H, pdt), 1.88 (tr, 2H, pdt), 1.31 (m, 1H, pdt). 
13
C {
1
H} NMR 
(100 MHz, CD2Cl2):  = 216.9 (CO), 213.6 (CO), 155.9 (bpy, C(2)), 151 (bpy, C(6)), 
133.8 (bpy, C(3)), 122.7 (bpy, C(4)), 121.3 (bpy, C(5)), 29.6 (pdt), 23.9 (pdt). Anal. 
Calcd for C17H14N2Fe2O4S2: C, 42.00; H, 2.90; N, 5.76. Found: C, 41.90; H, 3.15; N, 
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5.65. 
Protonation of 1. To a solution of 1 (12 mg, 0.024 mmol) in anhydrous acetonitrile 
(6 mL), HBF4.OEt2 (7 L, 0.051 mmol, 2.13 equivalent) was added at room 
temperature under argon. The FTIR spectrum of the solution was monitored as a 
function of time. IR (CH3CN, cm
-1
), t = 0 min (before addition of acid): 2006 (vs), 
1935 (s), 1895 (m); t = 2 min (after addition of acid): 2094 (m), 2079 (sh), 2036 (m), 
2015 (sh), 2006 (s), 1966 (m), 1935 (m), 1895 (m); t = 8 min: 2094 (vs), 2044 (s), 
1975 (sh). 
To a solution of 1 (5.2 mg, 0.011 mmol) in CD2Cl2 (0.75 mL) in an NMR tube, 
HBF4.OEt2 (5 L, 0.036 mmol, 3.27 equivalent) was added at room temperature. The 
solution changed color from green to reddish brown. The 
1
H NMR spectrum of the 
clear solution was recorded. 
1
H NMR (400 MHz, CD2Cl2):  = 8.87.4 (m, 8H, bpy), 
-9.04 (s, 1H, FeHFe), {1,3-propanedithiolate peaks were masked by the diethyl 
ether signals}. 
X-Ray Crystallography. The crystal was mounted on the end of a thin glass fiber 
using Apiezon type N grease and optically centered. Cell parameter measurements 
and single-crystal diffraction data collection were performed at low temperature (123 
K) with a Bruker Smart APEX diffractometer using graphite monochromated Mo K 
radiation ( = 0.71073 Å) in the  scanning mode. The structure was solved by 
direct methods and refined by full-matrix least-squares on F
2
. The following is the list 
of the programs used: data collection, Bruker Instrument Service v2010.9.0.0; cell 
refinement and data reduction, SAINT V7.68A; structure solution and refinement, 
SHELXS-97; molecular graphics, XShell v6.3.1; preparation of material for 
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publication, Bruker APEX2 v2010.9-1.
30
 Details of crystal data and parameters for 
data collection and refinement are listed in Table 3. 
Electrochemistry. Electrochemical measurements were conducted using a PG-STAT 
128N Autolab electrochemical analyzer. All cyclic voltammograms were recorded in 
a conventional three-electrode-cell under inert atmosphere at room temperature. The 
working electrode was a 3 mm diameter glassy carbon disk polished with 1 m and 
0.3 m deagglomerated alpha alumina, successively, and sonicated for 15 min in 
ultrapure water prior to use. The supporting electrolyte was [
n
Bu4N][PF6] (0.1 M in 
acetonitrile or dichloromethane, as mentioned). The Ag/Ag
+
 reference electrode was 
prepared by immersing a silver wire anodized with AgCl in an CH3CN or CH2Cl2 
solution of 0.1 M [
n
Bu4N][PF6]. A platinum wire was used as counter electrode. For 
studies under argon and carbon monoxide, deaeration of the solutions was performed 
by bubbling argon or carbon monoxide through the solution (15 min) and then 
maintaining an atmosphere of Ar or CO over the solution during the course of 
electrochemical measurements. All other electrochemical experiments were carried 
out under nitrogen in a glovebox. All potentials are reported relative to the Fc/Fc
+
 
couple as reference (Fc = ferrocene). The concentration of iron complex in solution 
was determined spectrophotometrically based on 613 = 3500 M
-1
 cm
-1
. 
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Figure 4-1. Structure of the active site of [FeFe]-hydrogenase. [FeFe]-hydrogenase 
active site (H-cluster). 
 
Figure 4-2. X-ray crystal structure of 1. Molecular structure of (-pdt)Fe2(CO)4(
2
-
bpy) with thermal ellipsoids drawn at 50% probability level. Hydrogen atoms have been 
omitted for clarity. 
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Figure 4-3. FTIR spectra of 1 in the presence of HBF4.OEt2. FTIR spectra as a 
function of time for 1 upon addition of 3 equivalents HBF4 in acetonitrile solution. 
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Figure 4-4.
 1
H and 
13
C NMR spectra of 1. (A) 
1
H NMR spectrum and (B) 
13
C NMR 
spectrum of 1 in CD2Cl2. 
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Figure 4-5. Optical spectra of 1 in the presence of HBF4.OEt2. UV-vis spectra of 1 
(solid line) and [1H][BF4] (dotted line) in acetonitrile at room temperature. Spectra were 
obtained from solutions of approximately 0.1 mM compound. 
 
Figure 4-6. 
1
H NMR spectrum of 1 in the presence of HBF4.OEt2. 
1
H NMR of 1 (10 
mM) in CD2Cl2 in presence of 3 equivalents of HBF4.OEt2. 
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Figure 4-7. Cyclic voltammograms of 1 under argon and CO atmosphere. Cyclic 
voltammograms of 1 (1.1 mM) in dichloromethane, (A) under nitrogen at scan rates of 
0.8 V s
-1 
(solid line) and 0.1 V s
-1
 (dotted line), (B) under CO at scan rates of 0.8 V s
-1
 
(solid line), 0.2 V s
-1
 (dashed line), and 0.05 V s
-1
 (dotted line). 
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Figure 4-8. Cyclic voltammograms of 1 in the presence of P(OMe)3. Cyclic 
voltammograms of 1 (1.1 mM) in dichloromethane in the presence of 1-2 equivalent of 
P(OMe)3 under an atmosphere of CO. Solid lines are without addition of phosphine. 
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Dashed lines include 1 equivalent of P(OMe)3 and dotted lines include 2 equivalents of 
P(OMe)3. 
 
Figure 4-9. Cyclic voltammograms of 1 at different potential-scan rates. Cyclic 
voltammograms of 1 in acetonitrile under (A) argon (0.75 mM of 1) and (B) CO (0.68 
mM of 1). Potential scan rates shown are 0.2, 0.4, 0.6, 0.8, 1, 2, 4, 6, 8, 10 Vs
-1
. 
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Figure 4-10. Bulk electrolysis of 1. Cyclic voltammograms of 1 in an acetonitrile 
solution before bulk electrolysis (dotted line), after passage of 1 F mol
-1
 charge (dashed 
line), and after passage of 2.4 F mol
-1
 charge (solid line). 
 
Figure 4-11. Electrocatalytic proton reduction from AcOH by 1. Cyclic 
voltammograms of 1 (1.4 mM) with various concentrations of acetic acid in acetonitrile. 
Acid concentrations are 0, 1.4, 2.8, 5.6, 8.4, 11.2, 16.8, 22.4, 28, 33.6, 42 mM. 
100 
 
Figure 4-12. Proposed mechanism for electrocatalytic proton reduction from AcOH. 
Proposed EECC mechanism for H2 production from acetic acid by 1. 
 
Figure 4-13. Electrocatalytic proton reduction from HBF4 and p-TsOH by 1. Cyclic 
voltammograms of (A) 1 (1.36 mM) with HBF4 in acetonitrile (acid concentrations are 
1.4, 2.7, 4.1, 5.4, 6.8, 8.2, 11 mM) and (B) 1 (0.90 mM) with p-TsOH in acetonitrile (acid 
concentrations are 1.1, 2.2, 3.3, 4.3, 5.4, 6.5, 8.6 mM).  
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Figure 4-14. Direct reduction of HBF4 and p-TsOH at the electrode. Cyclic 
voltammograms of (A) HBF4 and (B) p-TsOH in acetonitrile solution (0.1 M n-Bu4NPF6) 
in absence of 1 with a glassy carbon electrode at scan rate of 0.2 Vs
-1
. 
 
Figure 4-15. Proposed mechanism for electrocatalytic proton reduction from HBF4 
and p-TsOH by 1. Proposed mechanism for electrocatalytic proton reduction by 1 in 
presence of strong acids. 
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Table 4-1. Selected bond lengths (Å) and bond angles () for 1. 
Bond lengths 
Fe(1)-S(1) 2.2081(5) Fe(1)-N(2) 1.9901(15) 
Fe(1)-S(2) 2.2151(5) Fe(2)-C(12) 1.778(2) 
Fe(2)-S(1) 2.2703(5) Fe(2)-C(13) 1.813(2) 
Fe(2)-S(2) 2.2766(5) Fe(2)-C(14) 1.779(2) 
Fe(1)-Fe(2) 2.5623(4) N(1)-C(5) 1.360(2) 
Fe(1)-C(11) 1.755(2) N(2)-C(6) 1.461(2) 
Fe(1)-N(1) 1.9819(15) C(5)-C(6) 1.363(3) 
Bond angles 
S(1)-Fe(1)-S(2) 85.958(19) S(2)-Fe(2)-Fe(1) 54.097(14) 
S(1)-Fe(1)-Fe(2) 56.250(14) Fe(1)-S(1)-Fe(2) 69.784(16) 
S(2)-Fe(1)-Fe(2) 56.354(15) Fe(1)-S(2)-Fe(2) 69.549(17) 
S(1)-Fe(2)-S(2) 83.087(18) N(1)-Fe(1)-N(2) 80.81(6) 
S(1)-Fe(2)-Fe(1) 53.966(15) C(12)-Fe(2)-C(14) 91.84(8) 
 
Table 4-2. 
1
H
 
and 
13
C chemical shifts of 2,2-bipyridyl. 
Position 
 
 (1H)  (13C) 
2,2-bpy Complex 1 2,2-bpy Complex 1 
2 - - 156.04 155.91 
3 8.43 8.03 136.73 133.82 
4 7.82 7.74 123.64 122.67 
5 7.31 7.23 120.71 121.27 
6 8.65 8.73 149.06 150.99 
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Table 4-3. Crystallographic experimental data for 1. 
Parameter 1 
Empirical formula C17H14Fe2N2O4S2 
Formula weight 486.12 
Temperature (K) 123(2) 
Wavelength (Å) 0.71073 
Z 8 
Crystal system Monoclinic 
Space group C 1 2/c 1 
a (Å) 31.260(3) 
b (Å) 7.5532(7) 
c (Å) 17.5720(17) 
 () 90 
 () 118.7770(10) 
 () 90 
Volume (Å
3
) 3636.6(6) 
 (mm-1) 1.852 
Density (g cm
-3
) 1.776 
Goodness-of-fit 1.034 
R1, wR2 [I > 2(I)] 0.0214, 0.0528 
R1, wR2 (all data) 0.0237, 0.0542 
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Abstract 
To evaluate the impact of redox non-innocent ligands on a well-known class of [FeFe]-
hydrogenase models, three new asymmetrically disubstituted diiron complexes of the 
general formula (μ-SRS){Fe(CO)3}{Fe(CO)(N-N)} [SRS = propane-1,3-dithiolate (pdt) 
or benzene-1,2-dithiolate (bdt), and N-N = 2,2'-bipyridine (bpy) or 2,2'-bipyrimidine 
(bpym)] have been synthesized from their parent hexacarbonyls by ligand substitution, 
and characterized. The new complexes (μ-pdt)Fe2(CO)4(κ
2
-bpym) (2), 
(μ-bdt)Fe2(CO)4(κ
2
-bpy) (3), and (μ-bdt)Fe2(CO)4(κ
2
-bpym) (4) were fully characterized 
by spectroscopic and electrochemical techniques, and the results are compared to those of 
a similar complex (μ-pdt)Fe2(CO)4(κ
2
-bpy) (1).  The structure of (2) was determined by 
single crystal X-ray diffraction showing that the ligand lies in the basal plane. IR spectra 
and electrochemical analyses indicate that electron density at the iron centers decreases in 
the order 1>2>3>4. Furthermore, 2 undergoes a ligand-centered reduction at the same 
potential as the hexacarbonyl precursor. However, unlike the bpy derivatives 1 and 3, the 
bpym complexes 2 and 4 do not catalyze electrochemical proton reduction from acetic 
acid.  
111 
Introduction 
[FeFe]-hydrogenases are exceptionally efficient natural biocatalysts for producing 
hydrogen. They catalyze proton reduction with high turnover frequencies, 6000-9000 s
-1
, 
under ambient conditions.
1-4
 Recently, these metalloenzymes have attracted widespread 
attention due to their tremendous potential in energy-related applications involving 
utilization of molecular hydrogen as a carbon-neutral fuel. Hydrogen is a promising 
future energy carrier and implementation of a hydrogen based economy requires efficient 
catalysts for interconversion of protons and hydrogen. In current applications, this 
reaction is catalyzed by expensive noble metals such as platinum and palladium.
5, 6
 Since 
hydrogenases primarily rely on first row transition metals, iron and/or nickel, to catalyze 
this reaction, their active sites serve as ideal templates for developing inexpensive 
catalysts.
7, 8
 As shown in Scheme 5-1, the X-ray crystal structure shows that the active 
site of [FeFe]-hydrogenases, commonly referred to as the H-cluster, is a unique six-iron 
cluster that is comprised of two subunits: a redox-active [4Fe4S] cubane that serves as a 
conduit for shuttling electrons, and a butterfly [Fe2S2] subsite where the catalytic reaction 
takes place.
9, 10
 The two iron centers in the [Fe2S2] unit are linked by a bridging dithiolate 
(-SCH2NHCH2S-) and are ligated to the diatomic ligands carbon monoxide (CO) and 
cyanide (CN
-
) that are otherwise biologically uncommon. One of the iron atoms of the 
[Fe2S2] cluster, defined as the proximal iron (Fep), is connected to the cuboidal [4Fe4S] 
cluster via a cysteinyl thiolate, and the other iron center (distal iron, Fed) contains an open 
coordination site for substrate binding. Other interesting features of the enzyme include a 
proton-channel, gas-channel, and several [4Fe4S] cubanes for electron transport to and 
from the active site. 
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The [Fe2S2] cluster bears remarkable resemblance to a well known organometallic 
compound (μ-S2C3H6)Fe2(CO)6 that has been exploited by synthetic chemists to build a 
multitude of biomimetic diiron complexes and provided a better understanding of the 
structure-function relationship of the enzyme.
11-13
 While the hexacarbonyl models have 
been demonstrated to be poor electrocatalyst for proton reduction, replacing CO ligands 
with better σ-donor ligands has led to better structural and functional models that are 
more efficient electrocatalysts. However, in contrast to the natural system that utilizes the 
Fe
II
Fe
I
 redox state for proton reduction catalysis, most diiron model complexes rely on 
the Fe
I
Fe
0
 redox state, leading to a requirement for high overpotentials for 
electrocatalytic proton reduction.
14
 Furthermore, theoretical studies have indicated that 
electron density is delocalized throughout all six irons of the H-cluster,
15, 16
 but redox-
active cofactors are rarely incorporated in diiron models.
17-21
 
Non-innocent ligands have attracted considerable interest because changing the 
oxidation state of the ligand can modulate the electronic properties of the metal center 
and thus facilitate catalytic redox transformations.
22
 For diiron model systems, redox 
active ligands can serve as a proxy for the [4Fe4S] cluster. In particular, when a reducible 
organic ligand is appended to the diiron unit, reduction of the complex can occur either 
on the ligand or the Fe center or the electron(s) can be delocalized over the entire metal-
ligand framework. Such interaction between metal and ligand may lower the large 
overpotential required for proton reduction catalysis. Heterocyclic α-diimine ligands such 
as 2,2'-bipyridine (bpy) and 2,2'-bipyrimidine (bpym) have found extensive application in 
inorganic and organometallic chemistry owing to their chelating ability, π-accepting 
character and redox-activity.
23-26
 Both ligands can be readily reduced by two one-electron 
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processes to first produce the radical anion and then the dianion.
27
 Since replacement of 
CH by N lowers the energy of the molecular orbitals of the ligands, 2,2'-bipyrimidine is 
easier to reduce than 2,2'-bipyridine. The ligand 2,2'-bipyrimidine also acts as a better π-
acceptor, stabilizing reduced metal center(s) by delocalizing the extra electron density 
into the empty π* orbitals. Moreover, recent computational studies have suggested that 
electronic asymmetry provided by chelating ligands in diiron complexes is important for 
attaining robust, functional models which makes the aforementioned ligands good 
candidates for building catalysts.
28
 
Here, we report synthesis and characterization of three new diiron complexes each 
with a non-innocent α-diimine ligand: (μ-pdt)Fe2(CO)4(κ
2
-bpym) (2), 
(μ-bdt)Fe2(CO)4(κ
2
-bpy) (3), and (μ-bdt)Fe2(CO)4(κ
2
-bpym) (4) (pdt = propane-1,3-
dithiolate, bdt = benzene-1,2-dithiolate). We have investigated the effect of the nitrogen 
ligands and bridging dithiolates on the electronic and catalytic properties of the 
complexes by spectroscopic techniques and cyclic voltammetry, and the results are 
compared to the related diiron analogue (μ-pdt)Fe2(CO)4(κ
2
-bpy) (1).
21
 
Results and Discussion 
Synthesis. Two bidentate nitrogen donor ligands, 2,2'-bipyridine (bpy) and 2,2'-
bipyrimidine (bpym), were chosen because both of them are weak π-acceptors, and can 
participate in redox reactions. All complexes were synthesized from the corresponding 
diiron-hexacarbonyl-dithiolate complexes (Scheme 5-2). The synthesis of 3 was similar 
to that already reported for 1.
21
 Refluxing the hexacarbonyl precursor, (μ-bdt)Fe2(CO)6,  
in toluene resulted in the formation of the 2,2'-bipyridyl substituted derivative 3, which 
was isolated in moderate yield (38%). However, this synthetic route failed to produce the 
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2,2'-bipyrimidine substituted derivatives leading instead to decomposition of the starting 
diiron complex. Reaction of 2,2'-bipyrimidine and the diiron hexacarbonyl precursor 
(μ-pdt)Fe2(CO)6 or (μ-bdt)Fe2(CO)6 in acetonitrile in the presence of two equivalents of 
Me3NO resulted, over 2 hours, in the formation of  a dark green solution. Following 
purification complexes 2 and 4 were isolated in moderate yields (40‒45%) after 
purification. Although (μ-bdt)Fe2(CO)6 has been reported to undergo reactions with 
strong donor ligands to produce mononuclear Fe
II
 complexes of the form (bdt)Fe(CO)(L-
L) or (bdt)Fe(CO)2L2 (L-L = chelating ligand, L = monodentate ligand), no such complex 
was isolated in the reaction with bpy and bpym.
29-31
 The molecular structure of 2 was 
determined by X-ray diffraction analysis of a single crystal obtained from 
hexane/dichloromethane mixture. The crystal structure of 2 is shown in Figure 5-1, and 
important metric parameters are summarized in Table 5-1. The structure shows that the 
bpym ligand coordinates one iron center in a basal-basal mode, consistent with the small 
bite angle of the ligand (N-Fe-N = 80.26°).
32
 The bond angles indicate that the both iron 
centers have distorted square pyramidal first coordination sphere, and each of the two 
irons centers is in an eclipsed confirmation. As observed also for the bpy system of 
complex 1, the inter-ring C-C bond (C11-C12) in the bpym ligand of 2 is slightly shorter 
(1.474 Å) than the same bond in free ligand (1.511 Å).
21, 33
 The LUMO of the ligand is a 
π* orbital with an in-phase overlap between the p-orbitals of the two carbon atoms 
linking the two rings.
34
 Therefore, increased electron density on the LUMO due to π-
backdonation from the metal to the ligand results in greater double bond character of the 
C-C bond.
21, 33, 35
 While the Fe-Fe bond of 2 (2.5558 Å) is longer than the parent 
hexacarbonyl precursor (2.5103 Å),
36
 it is slightly shorter than that reported for similar 
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diiron complexes with donor bidentate ligands such as bis-phosphine or di-carbene.
37-40
 
This suggests that bpym, owing to its low lying π* orbitals and the concomitant π-
acceptor ability, lowers the electron density on the diiron center. 
Spectroscopic Characterization. Complexes 1-4 were characterized spectroscopically by 
FTIR, UV-vis and NMR, and the results are summarized in Tables 5-2 and 5-3. As shown 
in Figure 5-2, the IR spectra of all of the complexes in dichloromethane consist of three 
characteristic bands in the C-O stretching region, similar to analogous diiron complexes 
with chelating donor ligands.
40-42
 The average of the IR stretching frequencies of the CO 
ligands is usually considered a reliable indicator of the electron densities about the metal 
centers. Thus, the shifts of the C-O bands on changing ligands provide an estimate of the 
donating ability of the ligands. In general, comparison of the IR spectra of 1‒4 reveal that 
replacing bpy with bpym results in significant strengthening of the C-O bonds as 
demonstrated by an shift of the average of the C-O stretching bands by 9 cm
-1
 towards 
higher energy for complexes 2 and 4. One hypothesis is that the stronger π-acceptor 
strength of bpym relative to bpy withdraws more electron density from the iron core at 
the expense of backbonding into carbonyls. In essence backbonding into bpym substitutes 
for backbonding into the CO ligands. This leads to stronger C-O bonds in 2 and 4 relative 
to 1 and 3. The average value of the CO bands for 2 is similar to that of the bis-phosphine 
analogue, (μ-pdt)Fe2(CO)4(κ
2
-dppe) (dppe = Ph2PCH2CH2PPh2),
43
 indicating that 
electron density on the diiron center of the bpym complex is similar to that of the dppe 
analogue. On the other hand, changing the bridging ligand from pdt to bdt led to a blue-
shift of the C-O stretching bands by an average of 13 cm
-1 
as a result of the lower electron 
densities on the Fe centers caused by electron delocalization over the aromatic ring of 
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bdt. According to the IR stretching frequencies of the complexes, the electron density of 
the diiron core increases in the order 4 < 3 < 2 < 1. 
Three types of electronic transitions must be considered in describing the UV-vis 
spectra of low-spin iron complexes containing α-diimine ligands: ligand centered π‒π* 
bands in the high energy UV region, metal to ligand charge transfer (MLCT) bands, and 
weak metal-centered d-d transitions.
27, 44
 As shown in Figure 5-3, the UV-vis spectra of 
the complexes with the bpy ligand (1 and 3) consist of an intense band at ca. 295 nm that 
can be attributed to a bpy π‒π* transition. In the case of the complexes with the bpym 
ligand (2 and 4), this ligand centered transition requires higher energy and consequently 
appears at shorter wavelengths region (<250 nm). The spectra of all four complexes 
feature an intense band in the region 340‒350 nm (ε > 103 M-1cm-1) that is likely 
associated with the Fe-S core (Table 5-2). Since the energies of MLCT transition bands 
are dependent on the energy of the LUMO of the diimine ligand, they are likely to occur 
at a lower energy for 2 and 4 than 1 and 3, respectively.
27
 The charge transfer bands at 
391 and 603 nm in the spectrum of 1 are red-shifted to 449 and 634 nm, respectively, in 
the spectrum of 2. Similarly, red-shifts of the charge transfer bands are also observed 
when comparing the spectra of 3 and 4 in the regions 390‒430 nm and 550‒650 nm 
(Figure 5-3 and Table 5-2).  The metal-centered d-d transitions with relatively low molar 
absorptivity are likely masked by the intense charge transfer bands. 
The 
1
H NMR spectra of 1 and 2 show the expected signals for the propane-1,3-
dithiolate bridge in the region 1.2‒2.2 ppm, slightly upfield compared to the parent 
hexacarbonyl complex. In contrast, the 
1
H NMR signals for the aromatic protons of 
benzene-1,2-dithiolate in complexes 3 and 4 appear at 7.08-7.09 and 6.59 ppm, chemical 
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shifts nearly identical to the corresponding hexacarbonyl starting material.
45
 More 
interestingly, the chemical shifts of the resonances of the α-diimine ligands (bpy and 
bpym) in 1‒4 relative to the non-coordinated free ligand provide a qualitative description 
of the nature of the bonding between the Fe and the ligand. As listed in Table 5-3, the 
NMR spectra of the bpy derivatives, 1 and 3, consist of four resonances in the aromatic 
region, consistent with symmetrical coordination of bpy. It is noticeable that, relative to 
the free ligand, the resonances attributable to the protons at positions 3, 4 and 5 of the 
bpy, shifted upfield in both complexes. However, the resonance of the proton on the 
carbon adjacent to the coordinated nitrogen, H(6), is shifted downfield for 1 and upfield 
for 3. Similarly, while upfield shifts are observed for the resonances of H(4) and H(5) of 
the bpym ligand in 2 and 4, the resonance of the proton [H(6)] next to the coordinated 
nitrogen undergoes a small downfield shift in 2 and upfield shift in 4. The underlying 
reason for this difference is not yet clear. Overall, the NMR data suggest that π-back 
donation from the electron rich Fe
I
 center to the empty π* of the α-diimine ligand leads to 
an increase in π-electron density over the ligand. 
Electrochemistry. To evaluate the influence of the two α-diimine ligands and the two S-S 
linkers on the redox properties of the diiron clusters, cyclic voltammograms of the 
complexes were measured in acetonitrile. Voltammograms of 1‒4 are shown in Figure 
5-4, and the redox potentials tabulated in Table 5-4. We have previously reported that 1 
undergoes a two-electron reduction at -2.06 V with one metal-centered reduction and the 
other likely a ligand-centered reduction.
21
 As shown in Figure 5-4, cyclic 
voltammograms of 2 show two irreversible reductive waves at Ep = -1.76 and -2.25 V as 
well as a small oxidative wave at Ep = -1.55 V during the return scan. Interestingly, when 
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the reductive scan is stopped prior to the second reduction, the first reductive event 
(Ep = -1.76 V) becomes reversible with E1/2 = -1.72 V (  
   
   = 1.1), and the oxidative 
wave at -1.55 V disappears. Comparison of the reduction peak currents suggests that if 
we assume that the first reduction is a one-electron process, then the second reduction 
involves transfer of two-electrons (  
     = 27 μA and   
     = 54 μA;   
        
     = 2). 
Ordinarily, displacement of two CO ligands from the hexacarbonyl complex 
(μ-pdt)Fe2(CO)6 with better donor ligands and/or weak π-accepting ligands lead to 
increased electron density on the Fe centers making the complex more difficult to reduce. 
However, this reasoning clearly does not hold for 2 which is reduced at potentials almost 
identical to those of the all-CO parent compound (Table 5-4). This despite the significant 
shift of average ν(CO) upon replacement of two CO ligands by bpym (76 cm-1) indicating 
increased electron density in the iron core. According to previous studies, the free ligand, 
2,2'-bipyrimidine, undergoes a primary reversible one-electron reduction (bpym/bpym
1-
) 
at -2.12 V and a subsequent irreversible one-electron reduction (bpym
1-
/bpym
 2-
) at -2.83 
V.
27
 Assuming that the diiron center withdraws electron density from the ligand making 
its reduction easier, these results suggest that the first reduction of 2 is likely centered on 
the bpym ligand. The second reduction at -2.24 V, two-electron process, likely 
corresponds to one metal-centered reduction forming a Fe
I
Fe
0
 species and one ligand 
centered reduction corresponding to the bpym
1-
/bpym
2-
 couple. It is worth noting that, 
relative to the hexacarbonyl analogue, the negative shift of the reduction potential of the 
metal based reduction is 500 mV for 2, largest among all of the diiron complexes 
discussed here. However, the physical mechanism responsible for the large shift of the 
metal based reduction is still unclear. The presence of the small oxidation wave at -1.55 
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V on the return scan suggests an EC process in which the three electron reduced species, 
Fe
0
Fe
I
(bpym
2-
),  undergoes a fast chemical reaction generating a product with a new 
reduction potential, detected as the oxidative peak at -1.55 V. 
Cyclic voltammograms of complex 3 in acetonitrile features an irreversible 
reduction at Ep = -1.71 V indicating that, relative to the parent hexacarbonyl complex, 
(μ-bdt)Fe2(CO)6, coordination of the bpy ligand results in a 440 mV negative shift of the 
reduction potential. This shift is higher than the 320 mV observed for the pdt complex, 1. 
On the other hand, substitution of (μ-bdt)Fe2(CO)6 with bpym results in only of 310 mV 
shift of the first reduction as observed for complex 4. This is in keeping with the better π-
accepting ability of the bpym ligand relative to bpy and also consistent with the FTIR 
results. Previous electrochemical investigations have shown that the diiron-hexacarbonyl 
complexes with aromatic dithiolates are reduced to dianions in a reversible two-electron 
process.
31, 46
 Therefore, based on the previous reports on electrochemical properties of the 
parent hexacarbonyl analogue, (μ-bdt)Fe2(CO)6, it is reasonable to suggest that the 
reductions of 3 and 4 are two-electron processes forming the dianions [3]
2-
 and [4]
2-
,  
respectively.
46, 47
 It is interesting to note that in voltammograms from 3 and 4, unlike 
those from the pdt analogues, distinct reduction waves for ligand-centered reductions 
were not observed. However, the electrochemical reversibility observed for the two 
electron reduction of the hexacarbonyl analogue is completely lost upon introduction of 
the α-diimine ligands suggesting lower stability of the reduced complexes in the presence 
of the donor ligands. The poor electron donating ability of the bdt bridge results in 
significantly less negative reduction potentials for 3 and 4 than the pdt analogues, and 
thus makes them potentially attractive candidates for proton reduction catalysts. 
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Complexes 1‒4 all undergo irreversible oxidation in the range -0.14 to -0.27 V. 
Based on previous electrochemical studies on similar diiron complexes, this oxidation 
peak can be assigned to Fe
II
Fe
I
/Fe
I
Fe
I
 couple of the complexes.
14
 Furthermore, ratios of 
the oxidative peak currents [  
                  ] to the peak currents for the reduction of 
the complexes (  
   for metal-centered and/or ligand-centered reductions in the range 
-1.5 to -2.3 V) were calculated for 1‒4 which clearly indicate that the observed oxidations 
are one-electron processes (Table 5-4). The complexes with the bpym ligand, 2 and 4, are 
more difficult to oxidize by 70‒100 mV than the corresponding bpy complexes, 1 and 3, 
respectively. This is consistent with the relative donating abilities of the ligands. 
Electrochemical proton reduction. The abilities of the complexes 1‒4 to electrocatalyze 
hydrogen production from acetic acid (0‒40 mM) in acetonitrile was investigated by 
cyclic voltammetry. Although IR and NMR studies show that none of the complexes 
undergo reaction with acetic acid at low acid concentrations (0‒10 mM) in the resting 
redox state, we expected that reduction of the complexes would make them sufficiently 
basic to bind protons and catalyze the reduction. Since the reduction potential for each 
complex is more negative than the standard reduction potential of acetic acid in 
acetonitrile (-1.36 V), such electrocatalysis is thermodynamically possible.
48
 
Furthermore, we have reported that 1 can act as an homogeneous electrocatalyst for 
proton reduction from acetic acid with considerably less overpotential than similar diiron 
analogues.
21
 As shown in Figure 5-5A, sequential addition of acetic acid (from 5 mM to 
20 mM) to an acetonitrile solution of complex 2 did not increase the current of the two 
primary reductive waves at -1.72 and -2.24 V, indicating catalysis does not take place. In 
particular, upon addition of acetic acid, the first reduction peak shifted by 90 mV to more 
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positive potential without affecting the peak current, and the reduction became 
completely irreversible even when the scan was stopped prior to the second reduction. 
These results hint towards an EC process occurring at the first reduction event in the 
presence of acid. First a ligand centered reduction produces 2
-
; then a protonation of the 
bpym ligand of 2
-
 occurs to give 2H which is apparently not active towards any proton 
reduction catalysis. This result implies a lack of efficient electronic communication 
between the ligand and the iron center because the ligand-centered reduction does not 
increase the basicity of the diiron core sufficiently to facilitate metal based protonation. 
Thus, no catalysis was observed. While the 2H intermediate appears to undergo further 
two-electron reduction at more negative potentials (beyond -2.2 V), the three electron 
reduced species is probably unstable towards excess acid. Observed decomposition of 2 
in the presence of excess acetic acid (above 20 mM) using IR supports the hypothesis. 
However, even in the concentration range 5 mM‒20 mM, in which the complex is 
moderately stable, no significant electrocatalytic activity is observed. 
The bdt-bridged analogues, 3 and 4, are reduced at milder potentials than the 
analogous pdt complexes. As shown in Figure 5-6B, in the case of complex 3, addition of 
acetic acid did not increase the peak current of the primary reductive wave at -1.71 V. 
Instead a new catalytic wave appeared at Ep = -2.05 V, the potential of which was shifted 
to more negative values upon incremental increase of acetic acid concentration. It is 
worth noting that the onset of catalytic peak current for 3 is only at a slightly more 
positive potential than that of 1 although the primary reduction of 3 occurs at 
considerably more positive potential (350 mV). For a more detailed comparison, the 
catalytic peak currents for both complexes (1 and 3) were plotted against concentrations 
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of AcOH (Figure 5-7A). This analysis reveals an exponential dependence of catalytic 
current on acid concentration, suggesting a first order reaction with respect to the acid. 
Assuming first order dependence on catalyst concentration, bimolecular catalytic rate 
constants of 0.8×10
2
 and 3×10
2
 M
-1
s
-1
 can be estimated for 1 and 3, respectively, from the 
slope of the linear plot of catalytic peak current (icat) vs. [AcOH]
1/2
 (Figure 5-7B).
49
  The 
overpotential for the process, which is defined as the difference between the standard 
reduction potential of the acid and the half-wave potential for the catalytic wave, is ca. 
620 mV for 3 which is similar to that observed  for 1 (680 mV).
48
 Importantly direct 
reduction of acetic acid on the glassy carbon electrode is negligible in this potential range 
(-1.9 to -2.2 V). On the other hand, as shown in Figure 5-5B, the electrochemical 
response of complex 4 towards acetic acid is similar to that of 2. While the addition of 
acetic acid did not affect the primary reduction wave of 4 at -1.58 V, a new reduction 
wave appears at ca. -2 V which grows only slightly with increasing acid concentration. In 
fact, a plateau in catalytic current was observed quickly at the relatively low acid 
concentration of 4 mM. Although the complexes with the bpym ligand have more 
positive reduction potentials than the bpy analogues and might be expected to be more 
potent catalysts, they exhibit essentially no electrocatalytic activity towards proton 
reduction from acetic acids. 
Conclusions 
In summary, we have synthesized four different [(μ-SRS){Fe(CO)3}{Fe(CO)(N‒N)}] 
(N‒N = bidentate α-diimine ligand) complexes with two dithiolate-bridges and two 
chelating N-donor ligands. To our knowledge, complexes 3 and 4 are the first examples 
of benzene-1,2-dithiolate bridged asymmetric diiron complexes with chelating ligands. 
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The primary purpose of our study was to evaluate the influence of the redox non-
innocent, chelating α-diimine ligands 2,2'-bipyridine and 2,2'-bipyrimidine on the 
electrochemical properties of the diiron models of [FeFe]-hydrogenases. Since bpym has 
lower energy empty π* orbitals compared to bpy, it is easier to reduce and it acts as a 
better π-acceptor ligand. This distinction in electronic properties of the two ligands is 
reflected in the IR and electrochemical results which clearly indicate that replacing bpy 
with bpym led to higher ν(CO) frequencies and more positive reduction potentials for the 
complexes. In particular, complex 2 undergoes one-electron, ligand-centered reduction at 
the same potential as the hexacarbonyl precursor despite the substitution of two CO 
ligands with the better electron donating bpym ligand. However, this reduction of the 
ligand in 2 does not increase the electron density of the diiron site sufficiently for proton 
reduction catalysis. Complex 4 was also inactive towards electrocatalytic proton 
reduction. This suggests that although coordination of bpym increases the electron 
density on the diiron center to the same extent as of bis-phosphine ligands, the electronic 
properties of bpym are unsuitable for catalysis.  
The second goal of this study was to investigate the impact of replacement of the 
aliphatic pdt ligand with benzene-1,2-dithiolate on diiron model complexes with 
chelating donor ligands. Since bdt is a significantly weaker donor than the 
alkyldithiolates, it can potentially compensate for the negative shift of reduction potential 
caused by strong donor ligands on the iron center while maintaining the basicity of the 
diiron core. Although the bdt bridged complex 3 is reduced at more positive potentials 
than the pdt complex, the potential at which proton reduction catalysis occurs and the rate 
of catalysis are similar for the two complexes. In short, the results demonstrate that the 
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electronic properties of the diiron models can be tuned by using different dithiolate-
bridges and α-diimine ligands, but the impact of those variations on improving catalytic 
activity of the complexes is minimal. 
Experimental Section 
All reactions were performed under an inert atmosphere (nitrogen or argon) using a 
double manifold Schlenk vacuum line. The complexes (μ-pdt)Fe2(CO)6
36
 and 
(μ-bdt)Fe2(CO)6
45
 were prepared according to literature methods. All anhydrous solvents 
and chemicals were of the highest available grades from Aldrich and were used as 
received. NMR spectra were recorded at room temperature on a Varian Liquid-State 
NMR spectrometer (400 or 500 MHz for 
1
H). NMR chemical shifts are quoted in ppm; 
spectra are referenced to tetramethylsilane. FTIR spectra were recorded on a Bruker 
Vertex 70 spectrophotometer using a stainless steel sealed liquid spectrophotometer cell 
with CaF2 windows. UV-vis measurements were performed on a Hewlett-Packard 8453 
spectrophotometer using quartz cuvettes with a 1 cm pathlength.  
Synthesis of (μ-pdt)Fe2(CO)4(κ
2
-bpym), (2). The metalloprecursor (μ-pdt)Fe2(CO)6 
(451 mg, 1.16 mmol) and trimethylamine-N-oxide (260 mg, 2.34 mmol) were dissolved 
in acetonitrile (10 mL) and stirred in the dark at room temperature for 15 min. Then the 
solution was anaerobically transferred to a suspension of 2,2'-bipyrimidine (370 mg, 2.33 
mmol) in acetonitrile (5 mL) and heated to reflux in the dark for two hours. The reaction 
mixture was concentrated under reduced pressure, and the dark residue was purified via  
silica gel chromatography using 1:1 hexane/ethyl acetate with 1% triethylamine as eluent 
to give the desired product as a dark green solid. Yield: 230 mg, 41%. 
1
H NMR (400 
MHz, CDCl3): δ = 9.04 (dd, 2H), 8.89 (dd, 2H), 7.30 (t, 2H), 2.20‒2.17 (dt, 2H), 2.08 (m, 
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1H), 1.65 (td, 2H), 1.27 (m, 1H). IR (CH2Cl2, cm
-1
): 2014, 1946, 1907. Rf = 0.32 (1:4 
hexane/ethyl acetate, 1% NEt3). 
Synthesis of (μ-bdt)Fe2(CO)4(κ
2
-bpy), (3). A solution of (μ-bdt)Fe2(CO)6 (174 mg 
0.41 mmol) and 2,2'-bipyridine (130 mg, 0.83 mmol) in toluene (12 mL) was refluxed 
under argon until evolution of carbon monoxide ceased (2 h). The reaction mixture was 
concentrated under reduced pressure, and the dark residue was purified by column 
chromatography on silica  gel. A dark bluish green solution eluted with 1:1 
hexane/dichloromethane. After collection of this fraction and removal of the solvent, the 
desired complex was collected as a dark reddish brown solid. Yield: 80 mg, 38%. 
1
H 
NMR (400 MHz, CD2Cl2): δ = 8.36 (s, 2H), 8.08 (s, 2H), 7.79 (s, 2H), 7.22 (s, 2H), 7.09 
(s, 2H), 6.59 (s, 2H). IR (CH2Cl2, cm
-1
): 2016, 1949, 1916. 
Synthesis of (μ-bdt)Fe2(CO)4(κ
2
-bpym), (4). A solution of (μ-bdt)Fe2(CO)6
 
(160 mg, 
0.38 mmol) and trimethylamine-N-oxide (85 mg, 0.76 mmol) in acetonitrile (10 mL) was 
stirred in the dark under nitrogen for 15 min. Then 2,2'-bipyrimidine (90 mg, 0.57 mmol) 
was added anaerobically to the reaction mixture and stirred for 2 h. The dark green 
reaction mixture was concentrated under reduced pressure and thoroughly washed with 
hexane until the washings were colorless. The residues was redissolved in 
dichloromethane (25 mL) and filtered through celite followed by silica. Finally, upon 
evaporation of the solvent, the desired complex was obtained as a green powder. Yield: 
90 mg, 45%. 
1
H NMR (400 MHz, CD2Cl2): δ = 8.89 (br, 2H), 8.62 (s, 2H), 7.29 (br, 2H), 
7.08 (s, 2H), 6.59 (s, 2H). IR (CH2Cl2, cm
-1): 2022, 1958‒1927 (broad). 
X-ray crystallography. Cell parameter measurements and single-crystal diffraction data 
collection were performed at low temperature (123 K) with a Bruker Smart APEX 
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diffractometer. Graphite monochromated Mo Kα radiation (λ = 0.71073 Å) in the ω–φ 
scanning mode was used for the measurements. The structure was solved by direct 
methods and refined by fullmatrix least-squares on F
2
. The following is the list of the 
programs used: data collection, Bruker Instrument Service v2010.9.0.0; cell refinement 
and data reduction, SAINT V7.68A; structure solution and refinement, SHELXS-97; 
molecular graphics, XShell v6.3.1; preparation of material for publication, Bruker 
APEX2 v2010.9-1.30. Details of crystal data and parameters for data collection and 
refinement are listed in Table 5-5. 
Electrochemistry. Electrochemical experiments were performed using either a CHI 
1200A or a PG-STAT 128N Autolab electrochemical analyzer. A conventional three-
electrode cell was used for recording cyclic voltammograms. The working electrode was 
a 3 mm diameter glassy carbon disk polished with 1 mm and 0.3 mm deagglomerated 
alpha alumina, successively, and sonicated for 15 min in ultrapure water prior to use. The 
supporting electrolyte was [NBu4][PF6] (0.1 M in acetonitrile). The reference was a 
Ag/Ag
+
 electrode prepared by immersing a silver wire anodized with AgCl in an 
acetonitrile solution of 0.1 M [NBu4][PF6]. A platinum wire was used as counter 
electrode. The cyclic voltammograms were recorded either inside a glovebox or on the 
benchtop under an argon atmosphere. All potentials are reported relative to the ferrocene 
couple (Fc
+
/Fc) as reference. Concentrations of the complexes were determined 
spectrophotometrically based on the following extinction coefficients: ε(603 nm) = 3500 
M
-1
 cm
-1
 (complex 1), ε(634 nm) = 1950 M-1cm-1 (complex 2), ε(520 nm) = 2400 M-1cm-1 
(complex 3), and ε(636 nm) = 1950 M-1cm-1 (complex 4). 
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Table 5-1. Selected bond lengths (Å) and bond angles (°) for 2 
Bond lengths    
Fe1-Fe2 2.5558 Fe2-S2 2.2094 
Fe1-C2 1.8005 Fe2-C1 1.7611 
Fe1-C3 1.7808 Fe2-N1 1.9932 
Fe1-C4 1.7875 Fe2-N3 1.9924 
Fe1-S1 2.2823 C11-C12 1.4737 
Fe1-S2 2.2780 N1-C11 1.352 
Fe2-S1 2.2079 N3-C12 1.357 
Bond angles    
C2-Fe1-C3 93.0805 Fe1-S2-Fe2 69.4178 
Fe1-S1-Fe2 69.3654 N1-Fe2-N3 80.2595 
 
Table 5-2. UV-vis absorptions and CO vibrational stretching frequencies for complexes 
1-4 and relevant related diiron complexes 
Complex ν(CO), cm-1 
Average 
ν(CO), cm-1 
λ, nm (ε, M-1cm-1) 
(μ-pdt)Fe2(CO)6 2072, 2033, 1993 2032 325, 452 (shoulder) 
(μ-bdt)Fe2(CO)6 
45
 2080, 2044, 2004  2043 - 
1
21
 2007, 1937, 1896 1947 
298, 342, 391 (shoulder, 5200), 
519 (2700), 603 (3500), 685 
(shoulder, 2500) 
2 2014, 1946, 1907 1956 
339 (5500), 449 (3700), 634 
(1950) 
3 2016, 1949, 1916 1960 
292, 350 (2800), 390 
(shoulder), 520 (2400), 625 
(broad shoulder, 1900) 
4 2022, 1958‒1927 (broad) 1969 
347 (4100), 429 (3100), 636 
(1950) 
(μ-pdt)Fe2(CO)4(dppe)
43
 2019, 1949, 1904 1957 - 
(μ-pdt)Fe2(CO)4(IMe-CH2-IMe)
39
 1996, 1920, 1872 1929 - 
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Table 5-3. 
1
H NMR chemical shifts of 2,2'-bipyridine and 2,2'-bipyrimidine 
Position 2,2'-bpy 1 3 2,2'-bpym 2 4 
3 8.43 8.03 8.08 - - - 
4 7.82 7.74 7.79 8.98 8.89 8.62 
5 7.31 7.23 7.22 7.43 7.30 7.29 
6 8.65 8.73 8.36 8.98 9.04 8.89 
 
Table 5-4. Electrochemical data for the ligands, diiron hexacarbonyl precursors, and 
complexes 1‒4 in acetonitrile 
Compound Eox, V 
a
 Ered, V 
a (  
      
  )
 b
 Note 
2,2'-bpy - -2.63 (r), -3.13 (i)
 
NA
c
 Ref. 
50, 51 
2,2'-bpym - -2.12 (r), -2.83 (i) NA
c
 Ref. 
27
 
(μ-pdt)Fe2(CO)6 +0.74 (i) -1.74 (r), -2.35 (i) ND
d
 Ref. 
52
 
(μ-bdt)Fe2(CO)6 - -1.27 (r) NA
d
 Ref. 
47
 
1 -0.21(i) -2.06 (i) 2.1 Ref. 
21
 
2 -0.14 (i) -1.72 (r), -2.24 (i) 1.0, 2.1 This work 
3 -0.27 (i) -1.71 (i) 1.8 This work 
4 -0.17 (i), 0.73 (p) -1.58 (i) 1.9 This work 
a
 (i), (r) and (p) denote irreversible, reversible and partially reversible redox processes, 
respectively; 
b
 ratio of the peak currents for the reduction in the range -1.58 to -2.23 V 
and the oxidation in the range -0.14 to -0.27 V; 
c
 NA = not applicable; 
d
 ND = not 
determined. 
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Table 5-5. Crystallographic experimental data for 2 
Parameter 2 
Empirical formula C15H12Fe2N4O4S2, (CH2Cl2)1/2 
Formula weight 534.11 
Temperature 123 (2) 
Wavelength 0.71073 
a (Å) 27.052 
b (Å) 10.961 
c (Å) 13.676 
α (°) 90 
β (°) 90 
γ (°) 90 
Volume (Å
3
) 4054.8 
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Scheme 5-1. Active site of [FeFe]-hydrogenase (H-cluster) 
 
Scheme 5-2. Synthetic routes to complexes 1‒4 from hexacarbonyl precursors and 
bidentate N-donor ligands. 
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Figure 5-1. X-ray crystal structure of 2. Molecular structure of 2: (left) thermal 
ellipsoid representation (50 % probability level); (right) rotated stick view indicating the 
eclipsed conformation of the two iron centers. Hydrogen atoms have been omitted for 
clarity. 
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Figure 5-2. Comparative FTIR spectra for the diiron complexes 1‒4 with 2,2'-bpy 
and 2,2'-bpym ligands. IR spectra of (A) 1 (black trace), (B) 2 (blue trace), (C) 3 (green 
trace), and (D) 4 (red trace) in dichloromethane.  
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Figure 5-3. Comparative optical spectra for diiron complexes 1‒4. UV-vis spectra of 
1 (black trace), 2 (blue trace), 3 (green trace), and 4 (red trace) in acetonitrile at room 
temperature. Spectra were collected from solutions of approximately 0.1 mM complex. 
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Figure 5-4. Cyclic voltammograms of diiron complexes 1‒4. Cyclic voltammograms 
of (A) 1 (1.2 mM), (B) 2 (1.3 mM), (C) 3 (0.88 mM), and (D)  4 (1.6 mM) measured in 
0.1 M [NBu4][PF6]/ acetonitrile at potential scan rate 0.2 Vs
-1
. Arrows indicate the 
starting potential and scan direction. 
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Figure 5-5. Cyclic voltammograms of 2 and 4 in the presence of AcOH. Cyclic 
voltammograms of 2 (A; 1.3 mM) and 4 (B; 1.6 mM) with various concentrations of 
acetic acid. Acid concentrations used are 2, 4, 6, 8, 10 mM for complex 4 and 5, 10, 15, 
20 mM for complex 2. Other experimental conditions are as described in Figure 5-4. 
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Figure 5-6. Electrocatalytic proton reduction from AcOH by 1 and 3. Cyclic 
voltammograms of 1 (A; 1.4 mM) and 3 (B; 0.88 mM) with various concentrations of 
acetic acid. Acid concentrations used are 2, 4, 6, 10, 15, 20, 30, 40 mM for complex 3 
and 1.4, 2.8, 5.6, 8.4, 11.2, 16.8, 22.4, 28, 33.6, 42 mM for complex 1. Other 
experimental conditions are as described in Figure 5-4. 
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Figure 5-7. Plots of catalytic peak currents as functions of [AcOH] and [AcOH]
1/2
. 
(A) Dependence of icat on concentration of acetic acid added to a solution of 1 (1.4 mM, 
▲) and 3 (0.88 mM, ■), and (B) plot of icat  as a function of [AcOH]
1/2
 for 1 (▲, 
k = 0.78×10
2 
M
-1
s
-1
) and 3 (■, k = 3×102 M-1s-1). 
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Abstract 
Two pentacoordinate mononuclear iron carbonyls, (bdt)Fe(CO)P2 (bdt = benzene-1,2-
dithiolate; P2 = 1,1'-diphenylphosphinoferrocene (1), 
methyl-2-{bis(diphenylphosphinomethyl)amino}acetate (2)) were prepared as 
biomimetic models for the distal iron (Fed) of the active site of [FeFe]-hydrogenase. X-
ray crystal structures of the complexes reveal that, despite similar ν(CO) stretching bands, 
they have different geometries. The iron center of 1 is in a distorted trigonal bipyramidal 
arrangement and that of 2 is in a distorted square pyramidal geometry. Electrochemical 
investigation shows that both complexes can catalyze electrochemical proton reduction 
from acetic acid at mild overpotential, 0.17 and 0.38 V for 1 and 2, respectively. 
Although coordinatively unsaturated, the complexes display only weak, reversible 
binding affinity towards CO (1 bar). However, ligand centered protonation by a strong 
acid, HBF4-OEt2, triggered quantitative CO uptake by 1 to form a dicarbonyl analogue 
[1(H)-CO]
+
, which was reversibly converted back to 1 upon deprotonation by NEt3. DFT 
calculations suggest that the iron center in both 1 and 2 is largely of Fe
I
 character due to 
non-innocence of bdt ligand. Ligand based protonation interrupts the extensive electron 
delocalization over the Fe and bdt, and thus, makes 1(H)
+
 susceptible to external CO 
binding. 
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Introduction 
Hydrogen produced from solar energy and water offers the tantalizing opportunity to 
produce a storable, renewable fuel on a scale comparable to global energy challenges.
1
 
However, developing efficient and renewable catalysts for this transformation has proven 
challenging. Thus hydrogenases, the biological catalysts for reversible proton reduction 
to hydrogen, have caught the attention of a broad range of researchers.
2, 3
 Since the 
elucidation of the structures of both [NiFe]- and [FeFe]-hydrogenases revealed that these 
enzymes feature organometallic active sites including the diatomic ligands CO and CN 
(Figure 1),
4-7
 inorganic chemists have sought to produce both structural and functional 
models in an effort to understand and reproduce these enzymes.
8
 However, although 
natural hydrogenases have turnover frequencies exceeding 1000 s
-1
 at potentials close to 
the thermodynamic reduction potential of the proton, synthetic models seldom come 
close to this exquisite reactivity.
9, 10
   
The active site of [FeFe]-hydrogenases, referred to as the H-cluster, is a unique 
six iron cluster consisting of a [4Fe4S] cluster bridged via a cysteinyl thiolate to a diiron 
subsite.
5, 6
 This diiron subcluster, although biologically unprecedented, is highly 
reminiscent of known organometallic complexes. As shown in Figure 6-1, it consists of a 
dithiolate ligand bridging the two iron ions as well as the strong -acceptors CO and CN- 
at each iron center. The proximal iron, Fep, so designated due to its relative proximity to 
the [4Fe4S] center, is a coordinatively saturated, octahedral site. On the other hand, 
hydrogen binding or production occurs at the distal iron, Fed, an electron deficient, five-
coordinate, pseudo-square pyramidal center featuring a terminal open coordination site.  
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Organometallic complexes of the type [(-SR2)Fe2(CO)6] and their derivatives in 
which one or more of the carbonyls have been replaced with strongly -donating ligands 
such as phosphines, have been used extensively as both structural and functional mimics 
of [FeFe]-hyrogenases.
3, 11, 12
 Although the natural enzyme features iron centers in square 
pyramidal environments that are inverted relative to one another such that a terminal 
open coordination site is available, the irons in these model complexes are in the so-
called “eclipsed” geometry in which the two pyramids have the same orientation. In this 
geometry, the bridging, as opposed to terminal, position is most reactive, facilitating 
formation of stable but unreactive bridging hydrides.
13-15
 Thus the models tend to be poor 
catalysts for proton reduction and require substantial overpotentials for the catalysis. 
Development of mononuclear iron complexes with an open coordination site can, in 
principle, overcome this difficulty and mimic the reactivity of the distal iron site of the 
enzyme if an appropriate ligand set can be found to simulate the electronic environment 
of the second missing metal. 
Although synthetic efforts immediately following the elucidation of the crystal 
structure of [FeFe]-hydrogenases produced a series of coordinatively saturated 
mononuclear iron complexes as spectroscopic models for the H-cluster,
16-18
 relatively few 
five coordinate models have been reported. Liaw and coworkers demonstrated the 
synthesis of a pentacoordinate, 16-electron Fe(II) complex[Fe(CO)2(CN)(S,NH-C6H4)]
-
 
and showed that it readily reacted to form hexacoordinate complexes or dimers.
19
 They 
did not, however, investigate the catalytic activity of this compound.  Darensbourg and 
coworkers have also produced pentacoordinate iron dicarbonyls using the strongly 
-donating, redox noninnocent ligand 2-amido-thiophenylate as models for the 
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mononuclear Fe-containing hydrogenases.
20, 21
 Only recently have Ott and coworkers 
used the related, redox non-innocent, benzene-1,2-dithiolate (bdt) ligand together with a 
chelating phosphine to create coordinatively unsaturated monocarbonyl models of the 
distal iron site of [FeFe]-hydrogenases and show that these compounds are active in 
electrocatalytic proton reduction.
22, 23
 
 In this paper, we present a new coordinatively unsaturated, five-coordinate Fe(II)-
carbonyl in a P2S2 coordination environment that employs two chelating ligands to 
stabilize an unusual trigonal bipyramidal geometry. The phosphines are provided by 1,1'-
{bis(diphenyl)phosphino}ferrocene (dppf), and the steric constraints of the ferrocene 
moiety in this ligand cause it to have one of the largest bite angles observed for a 
chelating phosphine. On the other hand, benzene-1,2-dithiolate (bdt), well known for its 
redox non-innocence associated with the conjugation of the sulfur donors to the aromatic 
ring, provides the sulfur ligands. The result is that [(κ2-dppf)Fe(CO)(κ2-bdt)] (1) 
electrocatalytically reduces protons from the weak acid acetic acid with unprecedentedly 
low overpotentials. Furthermore, the protonated complex binds exogenous CO, a reaction 
seldom seen in model compounds but well known for the enzyme. The electrocatalytic 
properties of this complex are directly compared to those of an analogous square-based 
pyramidal compound [(κ2-NP2)Fe(CO)(κ
2
-bdt)]  (2) for NP2 = methyl-2,-
{bis(diphenylphosphinomethyl)amino}acetate, and electronic explanations for the 
differing reactivities of the two complexes are considered. 
Results and Discussion 
Synthesis and spectroscopic characterization. Two pentacoordinate iron(II)-carbonyl 
complexes each with a chelating bis-phosphane and benzene-1,2-dithiol (bdt) were 
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synthesized starting from FeCl2: (κ
2
-dppf)Fe(CO)(κ2-bdt) (1) and (κ2-NP2)Fe(CO)(κ
2
-bdt) 
(2) where dppf is 1,1'-bis(diphenylphosphino)ferrocene and NP2 is methyl-2-
{bis(diphenylphosphinomethyl)amino}-acetate (Scheme 6-1). The bdt ligand was 
employed both for its strong -donor propensity and its redox non-innocence. Similarly, 
the ligand dppf was chosen because it is both chelating and redox-active. Furthermore, 
dppf, among common chelating bis-phosphane ligands, has one of the widest bite angles. 
This angle has a major influence on the structure of the resulting complex and the 
corresponding catalytic properties.
24-27
 For comparison, to evaluate the impact of dppf on 
the electronic and catalytic properties of the Fe
II
S2P2 center, 2, which features an N-
containing bis-phosphane ligand (NP2) instead of dppf, was synthesized. The ligand NP2 
is easily obtained by reaction of two equivalents of Ph2PCH2OH with glycine methyl 
ester in refluxing ethanol.
28
 As shown in Scheme 1, treatment of a methanolic solution of 
anhydrous FeCl2 with a solution of  the appropriate bis-phosphane in THF and benzene-
1,2-dithiol in the presence of a base (triethylamine) under a CO atmosphere afforded the 
desired diamagnetic complexes, 1 and 2 in 65% and 60% isolated yields, respectively. A 
single resonance is observed in the 
31
P{
1
H} NMR spectrum at 66.32 ppm for 1 and 50.21 
ppm for 2. 
In a tetrahydrofuran (THF) solution, 1 is reddish brown with visible absorbances 
at 467 nm (ε = 4433 M-1 cm-1) and 745 nm (ε = 974 M-1 cm-1) (Figure 6-2). Another very 
intense band in the UV range 250‒300 nm arising from the π-π* transition of the phenyl 
groups was also present. The 467 nm band features a prominent shoulder on the lower 
energy side, and, by comparison to the spectrum of 2 (vide infra) likely consists of two 
distinct charge transfer transitions. The 745 nm band is thought to arise from a d-d 
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transition. By comparison, despite a similar coordination environment and metal 
oxidation state, 2 is dark green in a THF solution with absorption maxima at 437 nm 
(ε = 4537 M-1 cm-1) and 579 nm (ε = 2883 M-1 cm-1). These bands are tentatively assigned 
as charge transfers involving the Fe center and the benzene-1,2-dithiolate ligand. 
IR spectra of both 1 and 2 in dichloromethane consist of a single peak in the CO-
stretching region at 1918 or 1915 cm
-1
, respectively (Figure 6-3A and 6-3B, bottom 
panel). The energy of this absorbance is comparable to that of related Fe
II
 complexes 
such as (κ2-dppp)Fe(CO)(Cl2bdt) (dppp = diphenylphosphinopropane, Cl2bdt = 3,6-
dichloro-1,2-benzenedithiolate).
22
 The remarkable similarity of the CO-stretching 
frequencies for the two complexes indicates that changing the bis-phosphane ligand has 
little detectable impact on the Fe-CO bonding interactions. 
Crystal Structures. The structures of 1 and 2 were determined by single-crystal X-ray 
diffraction and are shown in Figure 6-4. Selected bond distances and angles are given in 
Tables 6-1 and 6-2 and additional crystallographic information is available in Table 6-3. 
Crystals were grown by slow diffusion of hexane into a dichloromethane (1) or 
chloroform (2) solution of complex. The two complexes feature remarkably different 
geometries about the central iron atom. Complex 2 is a distorted square pyramid (SP) 
with an axial CO ligand while complex 1 is a distorted trigonal bipyramid (TBP) with 
CO, phosphorus and sulfur in the equatorial positions and phosphorus and sulfur in the 
apical positions. The geometries of the complexes were further characterized by 
Addison's τ value, defined as τ    β  α     for which β is the larger of the angles 
between the trans ligands on the basal plane of a SP or the angle between the two axial 
ligands for a TBP. The parameter α is defined as the smaller of the angles between the 
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trans ligands on the basal plane of a SP or the larger of the basal angles for a TBP.
29
 For 
pentacoordinate complexes, τ value is a measure of the degree of distortion from ideal SP 
(τ = 0) or ideal TBP (τ = 1) geometry. The calculated value of τ is 0.099 for 2 (based on 
β(S1-Fe1-P2) = 165.1427˚ and α(S2-Fe1-P1) = 159.2057˚) and 0.721 for 1 (based on 
β(S2-Fe1-P1) = 171.7433˚ and α(S1-Fe1-P2) = 128.4776˚) corroborating the geometry 
assignmentts of the complexes described above. As noted above, dppf has a much larger 
bite-angle (P-Fe-P = 101.17˚) than NP2 (87.49˚), and this difference is likely responsible 
for the geometric differences about the irons of 1 and 2. For complex 1, the three 
equatorial ligands show a significant distortion from symmetrical arrangement with bond 
angles of 134.58˚ (C-Fe-S), 128.48˚ (S-Fe-P), and 96.69˚ (P-Fe-C). The two axial 
ligands, thiolate and phosphane, are also slightly distorted from a linear arrangement with 
an S-Fe-P angle of 171.74˚. We note that 1 is a diamagnetic, FeII complex. Perfect TBP 
geometry does not permit a diamagnetic ground state for a d
6
 metal, but the observed 
distorted geometry is consistent with the S = 0 ground state.
30, 31
 Despite the metal 
coordination geometry differences, the Fe-C and C-O bond lengths of 1 and 2 are very 
similar to one another. This is consistent with the similar ν(CO) stretching frequencies 
observed for the two complexes. Additionally, as shown in Table 6-2, the C-C bond 
lengths of the benzene-1,2-dithiolato ligand show an alternating pattern of two shorter C-
C bonds (average 1.37 Å for 1 and 1.38 Å for 2) and four longer ones (average 1.40 Å for 
1 and 2) for both 1 and  2. Moreover, the two C-S bonds are also not identical. The 
average C-S bond lengths, 1.74 Å for 1 and 1.75 Å for 2, are slightly shorter than typical 
bond lengths for the C-S single bonds (1.76 - 1.77 Å) in benzene-1,2-dithiolate, 
suggesting that in the metallocomplexes the C-S bond orders are greater than one.
32-34
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The observed distortions of the bdt ligand represent clear evidence that it is partially 
oxidized and possesses substantial 1,2-dithiobenzosemiquinonate, π-radical character.34, 
35
 Concomitantly, the physical oxidation state of the Fe center in both complexes should 
be less than +2. The distortion of the ligand is more obvious for 1 indicating that the bdt 
ligand is more oxidized and the pentacoordinate Fe center is more reduced in this 
complex than in 2. 
Reactivity towards CO. To investigate whether the open coordination site on complexes 
1 and 2 is accessible for external ligand binding, reactions of 1 and 2 with CO were 
studied. Figure 6-3A shows the FTIR spectrum of a solution of 1 after it was saturated by 
bubbling with CO for ten minutes. In addition to the 1918 cm
-1
 signal of the parent 
complex, two new CO stretching bands are observed at 1996 and 2020 cm
-1
 indicating 
formation of an Fe(CO)2S2P2 complex, 1-CO. The presence of two new bands indicates 
that the CO ligands are in a cis orientation. The 
31
P NMR spectrum obtained under the 
same conditions also includes both the 66.32 ppm resonance of the starting material and a 
new signal at 62.59 ppm, providing additional evidence for formation of 1-CO. 
Following removal of CO from the solution by purging with nitrogen, the signals 
associated with 1-CO were no longer present. This demonstrates that binding of external 
CO to 1 is a reversible process. The analogous reaction for 2 was also observed via 
identification of new CO stretches at 1995 and 2021 cm
-1
 (Figure 6-3B). The complex 2-
CO also reverted reversibly to 2 upon removal of the CO. We note, however, that 
formation of 2-CO was less complete than formation of 1-CO. The complex 2-CO was 
not produced in quantities sufficient to be detected by 
31
P NMR. Furthermore, the ratios 
of the intensities of the CO stretching bands in the IR spectrum also suggest that the 
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majority of 2 remains unreacted. The difference in reactivities of the two complexes may 
be attributable to the geometries about the iron centers. Formation of a cis dicarbonyl 
from 2 will require a substantial distortion so that one of the extant ligands moves to a 
position trans to a carbonyl. However, such a large rearrangment is not required for the 
reaction of 1.  
A quantitative reaction between 1 and CO was observed if the strong acid 
HBF4-OEt2 was also present. The newly formed complex, [1(H)-CO]
+
, is red in solution 
and has characteristic CO stretching vibrations at 2089 and 2043 cm
-1
 (Figure 6-3C). 
Complex 1 could be reversibly regenerated from [1(H)-CO]
+
 by purging the solution 
with nitrogen and addition of triethylamine. An analogous reaction of 2 was not observed 
under the same conditions. The relative intensities of and energy gap between the two 
signals associated with CO stretching in the IR spectrum of [1(H)-CO]
+
 are reminiscent 
of the well characterized cis,cis,cis-Fe(CO)2(dppe)(SPh)2 which has analogous peaks at 
2017 and 1970 cm
-1
.
36
 Most notable is that the stretching frequencies of [1(H)-CO]
+
 are 
73 cm
-1
 higher in energy compared to this reference compound. This shift can be 
explained by the requirement for acid for this reaction. Since bdt complexes of transition 
metals can have mixed metal-ligand character frontier orbitals (vide infra), the complex is 
likely protonated at one of the sulfurs resulting in a substantially weaker ligand and 
increasing the electrophilicity of the metal center.
37-39
 The result is less back-bonding into 
the π* LUMO of the CO and a stronger C‒O bond reflected in a higher energy stretch. 
Such enhanced electrophilicity of a d
6
 metal ion on ligand protonation is not 
unprecedented.
20, 40
 Hence we postulate that the protonated dicarbonyl species is 
cis,cis,cis-[Fe(CO)2(κ
2
-dppf)(bdt-H)]
+
. 
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Electrochemistry and catalysis. The effects of the change in geometry on the redox 
behavior of the complexes were probed by cyclic voltammetry. Electrochemical analysis 
of 1 and 2 in 0.1 M [NBu4][PF6]/THF was performed under an argon atmosphere. The 
number of electrons involved in the observed redox processes was determined on the 
basis of peak separations (Δ  ). As shown in Figure 6-5, cyclic voltammograms of 1 
show a reversible reduction wave at      = -1.65 V (  
   
   = 1.01, Δ   = 0.144 V)  and 
two reversible oxidation waves at      = +0.13 V (  
   
   = 0.90, Δ   = 0.140 V ) and 
+0.44 V (  
   
   = 0.98, Δ   = 0.137 V) vs. Fc
+/0
 (Fc = ferrocene). Upon comparison of 
the peak separations to that of the Fc
+/0
 couple under the same conditions, 0.156 V, we 
conclude that all three transitions are one-electron redox processes. The reduction wave 
at -1.65 V can be attributed to the Fe
II/I
 couple corresponding to the pentacoordinate Fe 
center. The oxidation waves at +0.13 and +0.44 V can be assigned to the Fe
III/II
 couples 
for the Fe center in dppf and the pentacoordinate Fe center. The oxidation wave at +0.13 
V is likely associated with the oxidation of the Fe
II
 center in dppf since quasi-reversible 
oxidation of free dppf occurs at      = 0.183 V in 1,2-dichloroethane.
41, 42
 On the other 
hand, cyclic voltammograms of 2 reveal that it undergoes a reversible one-electron 
reduction at      = -1.86 V (  
   
   = 1.04, Δ   = 0.164 V) and an irreversible one-
electron oxidation at      = +0.32 V. By analogy to 1, the reduction and oxidation waves 
are likely to be Fe
II/I
 and Fe
III/II
 couples, respectively. Notably, reduction of the 
pentacoordinate Fe
II
 center in  2 occurs at more negative potential than 1 due to the 
change from TBP to SP geometry. More interestingly, in contrast to the two reversible 
Fe
III/II
 couples in trigonal bipyramidal 1, the Fe
III/II
 couple in square pyramidal 2 is 
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irreversible, indicating coordination of dppf leads to improved stability of oxidized 
complex in Fe
III
Fe
II
 and Fe
III
Fe
III
 states. In case of 2, oxidation of the pentacoordinate Fe
II
 
center might be associated with a geometry change or subsequent reaction with solvent 
molecules or ligand dissociation. 
The electrocatalytic proton reduction activities of 1 and 2 were investigated in 
THF in the presence of acetic acid (         = 24.42) and p-toluenesulfonic acid (p-
TsOH). As shown in Figure 6-6, sequential addition of acetic acid from 0.2 M to 1.4 M 
renders the reduction wave for the Fe
II/I
 couple irreversible and leads to an increase in 
current. This is characteristic of electrocatalytic proton reduction since direct proton 
reduction from acetic acid at the glassy carbon electrode is negligible in this potential 
range (Figure 6-7).
43,44
 The overpotentials for proton reduction by the two complexes, 
determined using the method reported by Artero and co-workers, were relatively small, 
only 0.17‒0.2 V and 0.38‒0.43 V for 1 and 2, respectively (Table 6-4).45  The half-wave 
potentials for the catalytic current, used for the overpotential calculation, were 
determined as the potential corresponding to the maximum value of (di/dE), i.e. the first 
derivative of the current data from the cyclic voltammograms. Notably, a mononuclear 
iron complex {κ2-(Ph2PCH2N(X)CH2PPh2)}Fe(CO)(κ
2
-bdt) (X = 1,1-diethoxy-ethyl) 
similar to 2 was reported to reduce protons from acetic acid in acetonitrile with 
overpotential in the range 0.23‒0.27 V.22 The kinetics of proton reduction were evaluated 
by considering the effect of catalyst concentration and acid concentration on observed 
activity (see Figures 6-8 and 6-9). Figure 6-8 shows that catalytic peak current, icat, 
depends linearly on catalyst concentration, [cat], for both 1 and 2. This demonstrates a 
first-order dependence of the catalytic current on the concentration of the catalyst at fixed 
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acid concentrations as described by eq. 1 in which n is the number of electrons involved 
in the catalytic reaction, A is the area of the electrode, D is the diffusion coefficient of the 
catalyst, k is the rate constant and x is the order of the reaction with respect to acid.
46
 
Figure 6-9 shows that the ratio of catalytic current to reductive peak current measured in 
the absence of acid,        , is also linear with respect to acid concentration for catalyst 
concentrations in the range 0.74‒1.13 mM for 1 and 0.47‒1.35 mM for 2. This indicates 
the reaction is second-order with respect to acid concentration as described by eq. 2, for a 
scan rate υ of 0.1 V s-1. At the highest acid concentration investigated (1.6 M), a value of 
        of 35 was obtained for 2 (0.6 mM), corresponding to a turnover frequency of 241 
s
-1
. A much slower rate was observed for 1 (0.74 mM) with a turnover frequency of 10 s
-1
 
at 1.8 M acetic acid. 
                          ........................................................................................... (1) 
                               υ   ........................................................................ (2) 
The electrocatalytic activities of the two complexes were also studied in the 
presence of the stronger acid, p-TsOH. Irreversible catalytic waves corresponding to the 
reduction of protons are observed at the potentials of the 1/1
-
 and 2/2
-
 couples (Figure 
6-10). The catalytic peak current is largely independent of catalyst concentration (panel B 
of Figure 6-11) for 1 over the investigated range (0.28–0.83 mM)  and increases linearly 
with increasing concentration of p-TsOH (panel A of Figure 6-11). A similar result has 
been reported for the mononuclear iron complex analogous to 2 incorporating a different 
NP2 ligand N,N-bis{(diphenylphosphino)methyl}-2,2-diethoxyethanamine.
22
 
Interestingly, for both 1 and 2, at low concentration of p-TsOH (1-2 eq. of the catalyst), a 
new reduction wave at 150 mV less negative potential is observed together with the 
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original Fe
II/I 
couple which grows with increasing acid concentration (Figure 6-12). 
However, at higher acid concentration (more than 2 eq.), the two peaks merge to produce 
a single catalytic wave. The observation that this new peak emerges for both complex 1 
and 2 excludes the possibility that it is associated with protonation at the amine group of 
the NP2 ligand in 2. Association between either the sulfurs or the aromatic ring of the bdt 
ligand and the proton/acid is, however, a distant possibility. 
Computational Studies. To complement the experimental results on the pentacoordinate 
iron complexes, density functional theory (DFT) calculations were carried out on 1 and 2. 
Calculations were performed using the B3LYP hybrid functional, and the DFT-optimized 
structures, which agree well with the corresponding crystal structures, were confirmed as 
energy minima. Table 6-5 presents a comparison of the calculated and experimental 
metric parameters,  and Figure 6-13 shows the calculated frontier molecular orbitals for 
the two complexes. Complexes 1 and 2 both have HOMOs that are delocalized over the 
Fe and much of the bdt ligand, emphasizing the importance of the redox non-innocence 
of this ligand to the electronic structure of the complex. In particular, the HOMOs are a 
bonding combination of iron d orbitals and sulfur p(π) orbital(s), and an antibonding 
combination of sulfur and the adjacent carbon atoms, implying strong electron 
delocalization over the iron and the bdt ligand (see overlap population in Table 6-6). It is 
worth noting, however, that the Fe-S interactions are not equivalent for the two 
complexes. The HOMO of 1 includes interactions only between the Fe and S1, likely a 
result of the unusual geometry. On the other hand, the HOMO of 2 includes substantial 
contributions from both sulfurs of the bdt ligand. Furthermore, the HOMOs of 1 and 2 
bear considerable resemblance to the HOMO of the free bdt
2-
 ligand or the SOMO of the 
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free ligand in the π-radical anion form (bdt‒•).47, 48 From the molecular orbital approach, 
the metal dithiolate interaction in the complexes can best be described as transfer of 
electron density from the HOMO of a bdt
2-
 ligand to empty Fe d orbitals. Alternatively, 
the bonding pattern can also be thought of as an Fe
I
 center antiferromagnetically coupled 
to a radical anion bdt
•-
 ligand, leading to diamagnetic complexes. It is particularly 
important to note that only one sulfur atom contributes to the HOMO of 1, but both sulfur 
atoms have significant contributions to the HOMO of 2. On the other hand, the orbital 
density profiles shown in Figure 6-13 and the percentage orbital contribution given in 
Table 6-6 indicate that the LUMOs are dominated primarily by contributions from the Fe 
d orbitals with the sulfur and phosphorus atoms playing a minor role, and almost no 
contribution from the rest of the ring structure. This suggests that reduction of the 
complexes results in substantial accumulation of charge at the metal center yielding a 
highly basic iron site for interaction with protons. Furthermore, the significant iron 
character of the LUMOs (51% and 43% for 1 and 2, respectively) is consistent with the 
abilities of these complexes to reversibly bind CO. 
To correlate the observed trends in the reactivity of the two complexes with CO in 
the presence of acid, DFT calculations were also undertaken for the protonated 
complexes 1(H)
+
 and 2(H)
+
, assuming compositional integrity following protonation. For 
complex 1, protonation is most likely to occur at either the Fe center or the thiolate sulfur 
with the highest contribution to the HOMO. The possibilities for 2 are more numerous 
since both the sulfurs contribute to the HOMO and it features an amine group in the NP2 
ligand that could also serve as a protonation site. Calculations for 1(H)
+
 with the proton 
localized on the Fe indicate that it is 13 kcal/mol higher in energy than a 1(H)
+
 complex 
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with a thiolate protonated. Likewise, in the case of 2, an N-protonated species is 6.4 
kcal/mol higher in energy than the S-protonated species. Therefore, the rest of the 
computational studies were carried out assuming that protonation occurs exclusively at 
the thiolate sulfur. The geometry optimized structure of 1(H)
+
 shows that protonation 
results in only minor changes about the Fe center; in particular, the τ value of 1(H)+, 0.65, 
is not significantly different from that of 1, 0.72 (Table 6-5). In contrast, upon 
protonation, 2 undergoes considerable distortion from its nearly square pyramidal 
geometry (τ = 0.09) to a hybrid of square pyramidal and trigonal bipyramidal geometries 
(τ = 0.42). Furthermore, electron density profiles of the HOMO and LUMO of  1(H)+ and 
2(H)
+
 reveal stark differences that are important for understanding their different 
reactivities towards CO. The HOMO of 1(H)
+
 is localized entirely on the ferrocene 
moiety, while the HOMO of 2(H)
+
 is delocalized over the entirety of the bdt ligand with 
minimal contribution from the Fe atom. The bonding pattern in the bdt ligand and the 
orbital contributions in the HOMO suggest that in 2(H)
+
, the bdt ligand is non-innocent 
and, consequently, the physical oxidation state of the Fe center is less than +2. On the 
other hand, computational results suggest that addition of a proton to 1 likely disrupts the 
electron delocalization between the bdt ligand and the Fe center, reinstating the 
aromaticity of the C6H4-ring of the protonated bdt ligand. Therefore, 1(H)
+
 to behaves 
more like a typical, coordinatively unsaturated Fe
II
, d
6
 complex. This difference in the 
electronic structures of 1(H)
+
 and 2(H)
+
 is likely responsible for the fact that protonation 
induced CO uptake is observed only for 1. 
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Conclusions 
In summary, we have synthesized two pentacoordinate Fe
II
(CO)S2P2 complexes using 
benzene-1,2-dithiol and two different chelating bis-phosphane ligands: NP2 and dppf. In 
contrast to the SP complex formed with NP2, the wider bite-angle of dppf provides access 
to a pentacoordinate iron carbonyl in TBP geometry, leading to significant changes in 
both the electronic and the chemical properties of the complex. This is highlighted by the 
differences in their reactivity towards CO, reduction potentials, electrocatalytic activity, 
and energies of charge-transfer bands. The TBP complex requires considerably less 
overpotential to reduce protons, but the overall rate is very slow. The strong electron 
donor ligands, thiolates and phosphanes, make the iron basic enough to electrocatalyze 
proton reduction but render the metal insufficiently electrophilic for efficient binding of 
external ligands such as H2 or CO that might be expected for a coordinatively unsaturated 
d
6
 metal center.
49
 Computational studies indicate that the bdt ligand is ''non-innocent'' in 
both complexes, and, as a result of the extensive π-overlap between the metal and the 
ligand, the physical oxidation state of the iron is less than +2. The flexibility of the π-
interaction between iron and bdt in complex 1 is demonstrated by the ligand-protonation 
induced CO uptake by 1 to produce an 18-electron hexacoordinate iron dicarbonyl. This 
model complex of [FeFe]-hydrogenase might serve as a template for developing 
reversible iron catalysts capable of binding and activating H2 as well as catalyzing 
electrochemical proton reduction. 
Experimental Section 
All reactions were carried out under an atmosphere of nitrogen using standard Schlenk 
and vacuum-line techniques unless otherwise noted. Anhydrous dichloromethane and 
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methanol were purchased from Sigma-Aldrich and deuterated solvents from Cambridge 
Isotope Laboratories. Tetrahydrofuran was dried by distilling overnight over sodium and 
benzophenone. All starting materials were obtained commercially and used without 
further purification. 
1
H, 
13
C and 
31
P NMR spectra were recorded at room temperature on 
a Varian Liquid-State NMR spectrometer (400 or 500 MHz for 
1
H). NMR chemical shifts 
are quoted in ppm; spectra were referenced to tetramethylsilane for 
1
H and 
13
C NMR. 
The 
31
P NMR spectra were referenced to external phosphoric acid at 0 ppm. FTIR spectra 
were recorded on a Bruker vertex 70 spectrophotometer using a stainless steel sealed 
liquid spectrophotometer cell with CaF2 windows. UV-vis measurements were performed 
on a Hewlett-Packard 8453 spectrophotometer using quartz cuvettes with a 1 cm 
pathlength. 
Synthesis of methyl 2-(bis(diphenylphosphinomethyl)amino)acetate, NP2. To a 
degassed solution of formaldehyde (37 wt.% in water; 1 mL, 12.3 mmol) in absolute 
ethanol (10 mL), diphenylphosphine (1.9 mL, 10.9 mmol) was added dropwise under 
argon. The reaction mixture was stirred at room temperature for 30 min followed by 
addition of a degassed solution of glycine methyl ester hydrochloride (0.7 g, 5.6 mmol) in 
40% aqueous ethanol (5 mL). The cloudy reaction mixture became clear on stirring for 2 
h. Volatile materials were removed under reduced pressure to afford a colorless oily 
residue. The crude product was purified via column chromatography on silica with 
hexane/ethyl acetate/triethylamine (66:33:1) as eluent to afford NP2 as a colorless oil. 
Yield: 2.4 g (85%). Rf = 0.85 (1:1 hexane/ethyl acetate, 1% NEt3). 
1
H NMR (400 MHz, 
CDCl3): δ = 7.38 (m, 8H), 7.26 (m, 12H), 3.81 (s, 2H), 3.7 (d, 4H), 3.61 (s, 3H). 
13
C{
1
H} 
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NMR (100 MHz, CDCl3): δ = 171.21, 137.58, 137.46, 133.09, 132.90, 128.57, 128.37, 
128.34, 128.30, 58.02, 55.65, 51.28. 
13
P{
1
H} NMR (161.8 MHz, CDCl3): δ = -27.19. 
Synthesis of (dppf)Fe(CO)(bdt), 1. To an anaerobic solution of anhydrous FeCl2 (60.3 
mg, 0.48 mmol) in anhydrous methanol (8 mL), 1,1'-bis(diphenylphosphino)ferrocene 
(280 mg, 0.5 mmol) in THF (4 mL) was added dropwise under a CO atmosphere. After 
stirring the reaction mixture for 30 min at room temperature, a degassed solution of 
benzene-1,2-dithiol (0.07 mL, 0.6 mmol) and triethylamine (0.17 mL, 1.2 mmol) in 
methanol (3 mL) was added dropwise. The reaction turned to violet and then to dark 
brown. After stirring for 1 h at room temperature, the solvent was removed under reduced 
pressure and the residue was purified via column chromatography on silica with 
hexane/dichloromethane (1:2) as eluent. The product was obtained as dark brown 
powder. Yield: 244 mg (65%). Rf = 0.4 (1:1 hexane/CH2Cl2). 
1
H NMR (400 MHz, 
CD2Cl2): δ = 8.04 (dd, J = 6.0, 3.2 Hz, 2H), 7.59 (m, 4H), 7.41-7.36 (m, 8H), 7.18-7.10 
(m, 10H), 4.89 (s, 2H), 4.48 (s, 2H) 4.24 (s, 2H), 4.12 (s, 2H). 
13
C{
1
H} NMR(100 MHz, 
CD2Cl2): δ = 134.98, 132.71, 130.39, 129.50, 129.32, 127.76, 127.41, 121.38, 76.96, 
74.92, 74.79, 72.60, 71.40. 
31
P{
1
H} NMR (161.8 MHz, CD2Cl2): δ = 66.32. IR (CH2Cl2, 
cm
-1): ν(CO)  1918. APCI mass spectrum (positive mode): 751.0198 [(M-CO+H)+]. 
Synthesis of (NP2)Fe(CO)(bdt), 2. To an anaerobic solution of anhydrous FeCl2 (75 mg, 
0.6 mmol) and NP2 ligand (264 mg, 0.56 mmol) in anhydrous methanol (11 mL) under a 
CO atmosphere, benzene-1,2-dithiol (0.07 mL, 0.6 mmol) and triethylamine (0.17 mL, 
1.2 mmol) was added. The color of the solution turned black. After stirring at room 
temperature for 2 h, the solvent was removed under reduced pressure and the residue was 
purified via column chromatography on silica with hexane/ethyl acetate (4:1) as eluent. 
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The desired compound was obtained as a green solid. Yield: 240 mg (60%). Rf = 0.3 (3:1 
hexane/ethyl acetate). 
1
H NMR (400 MHz, CD2Cl2): δ = 7.99 (dd, J = 6, 3.2 Hz 2H), 7.64 
(m, 4H), 7.50 (m, 6H), 7.15 (m, 6H), 7.09 (dd, J = 6, 3.2 Hz, 2H), 6.96 (t, J = 7.6 Hz, 
4H), 4.05-3.97 (m, 2H), 3.86-3.80 (m, 2H), 3.70 (s, 3H), 3.59 (s, 2H). 
13
C NMR (100 
MHz, CD2Cl2): δ = 133.68 (t), 132.74 (t), 130.46 (s), 129.83 (s), 129.05 (s), 128.42 (t), 
127.82 (t), 121.34 (s), 62.00 (t), 56.73 (s) 56.57 (s), 51.64 (s). 
31P NMR (161.8 MHz): δ = 
50.21. IR (CH2Cl2, cm
-1): ν(CO) 1915. APCI mass spectrum (positive mode): m/z = 
710.0799 [(M+H)
+
], 682.0787 [(M-CO+H)
+
]. 
Reaction of 1 with CO in the presence of HBF4.OEt2. A solution of 1 (3.2 mg, 4.1 
μmol) in CH2Cl2 (2 mL) was saturated with CO and HBF4.OEt2 (0.2 mL 0.074 M 
solution in CH2Cl2, 14.3 μmol, 3.6 equivalent) was added dropwise to the reaction 
mixture. After stirring for 10 min at room temperature, the color of the solution changed 
from dark brown to red. Formation of the CO adduct [1(H)-CO]
+
 was indicated by IR 
and 
31P NMR. Addition of triethylamine (0.04 mL, 28.6 μmol) to the reaction mixture 
followed by purging with N2 led to release of CO and quantitative regeneration of 1. IR 
(CH2Cl2): ν(CO) 2089, 2043. 
31
P {
1
H} NMR (161.8 MHz, CD2Cl2): δ = 4.92.  
X-ray crystallography. The crystal was mounted on the end of a thin glass fiber using 
Apiezon type N grease and optically centered. Cell parameter measurements and single-
crystal diffraction data collection were performed at low temperature (123 K) with a 
Bruker Smart APEX diffractometer. Graphite monochromated Mo Kα radiation (λ = 
0.71073 Å) in the ω–φ scanning mode was used for the measurements. The structure was 
solved by direct methods and refined by fullmatrix least-squares on F
2
. The following is 
the list of the programs used: data collection, Bruker Instrument Service v2010.9.0.0; cell 
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refinement and data reduction, SAINT V7.68A; structure solution and refinement, 
SHELXS-97; molecular graphics, XShell v6.3.1; preparation of material for publication, 
Bruker APEX2 v2010.9-1.30. Details of crystal data and parameters for data collection 
and refinement are listed in Table 6-3. 
Electrochemistry. All electrochemical experiments were carried out using a CHI 1200A 
electrochemical analyzer. A conventional three-electrode cell was used for recording 
cyclic voltammograms. The working electrode was a 3 mm diameter glassy carbon disk 
polished with 1 mm and 0.3 mm deagglomerated alpha alumina, successively, and 
sonicated for 15 min in ultrapure water prior to use. The supporting electrolyte was 
[NBu4][PF6] (0.1 M in THF). The Ag/Ag
+
 reference electrode was prepared by 
immersing a silver wire anodized with AgCl in an THF solution of 0.1 M [NBu4][PF6]. A 
platinum wire was used as counter electrode. Deaeration of the solutions was performed 
by bubbling argon through the solution for 15 min after which an atmosphere of Ar was 
maintained during the course of electrochemical measurements. All potentials are 
reported relative to the ferrocene couple (Fc
+
/Fc) as reference. Concentrations of the 
complexes were determined spectrophotometrically based on the following extinction 
coefficients: ε(467 nm) = 4433 M-1 cm-1 and ε(437 nm) = 4537 M-1cm-1 for 1 and 2, 
respectively.  
Determination of catalytic overpotential. Theoretical half-wave potentials     
  were 
calculated using eq. 3 as defined by Fourmond et al. in which     
  is the standard 
potential for the reduction of protons,        is the bulk concentration of the acid,    
  is 
the concentration of dissolved H2 (at p(H2) =  10
5
 Pa) and    is a measure of the rate of 
diffusion of the products with respect to that of the reactant (eq. 4).
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The standard reduction potential of protons in THF was calculated by Danielle and co-
workers using HClO4 as acid and Pt microelectrodes.
58
 Since HClO4 is a weak acid in 
THF (pKa = 7.7), the reported value of      (-440 mV vs Fc
+
/Fc) is not equal to         
 . 
The reported value was interpreted as              
  and the actual value of         
  in 
THF was corrected using eq. xx. The concentration of HClO4 used by Daniele and 
coworkers for the determination of       is 6 mM. Substituting           = 6 mM,    
 = 
3.3 mM,
59
   = 40 mV,    = 7.7, and     
 = -440 mV into eq. 3 gives,       
 
 = -0.018 V 
which was used to calculate theoretical half-wave potentials     
  for different 
concentrations of acetic acid. The experimental and theoretical half-wave potentials for 
reduction of AcOH in THF (0.1M [NBu4][PF6] as supporting electrolyte) on a glassy 
carbon electrode catalyzed by 1 and 2 are listed in Table 6-4. 
Computational Details. Density functional theory (DFT) calculations were carried out 
using the Becke gradient-corrected exchange functional and Lee−Yang−Parr correlation 
functional with three parameters (B3LYP) and the 6-31G* basis set.
50-56
 In light of recent 
studies indicating the improved performance of the BP86 and TPSS functionals in 
describing transition metal containing systems, the geometries and energies of 2  were 
also calculated using these functionals and the larger TZVPP basis sets.
55, 57
 These results 
are shown in Table 6-7 which indicate that the B3LYP/6-31G* level of theory is most 
reliable for the systems investigated in this study. The ''overlap population'' parameter 
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listed in Table 6-6 is a measure of the nature of the interaction between the orbitals 
involved. Thus, a positive overlap population represents a bonding interaction, a negative 
overlap population corresponds to an anti-bonding interaction, and a zero overlap 
population indicates no bonding between the fragments. 
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Figure 6-1. Structures of the active sites of [FeFe]- and [NiFe]-hydrogenase. The 
active site of (A) [FeFe]-hydrogenase (H-cluster) and (B) [NiFe]-hydrogenase. Fed and 
Fep denote the distal and proximal iron, respectively, in the H-cluster. 
 
Figure 6-2. Comparative optical spectra of 1 and 2. UV-vis spectra of 1 (solid line) 
and 2 (dashed line) in THF at room temperature. Spectra were collected from THF 
solutions of approximately 0.1 mM complex. 
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Figure 6-3. Comparative FTIR spectra of 1 and 2 under CO atmosphere. IR spectra 
in the presence and absence of CO for 1 (A) and 2 (B) in absence of acid. (C) Analogous 
spectra for 1 in the presence of 3 equiv. HBF4. Black traces show the IR spectra after 
bubbling CO through the solutions of the complexes; Grey traces show the IR spectra 
after purging the solution with nitrogen to remove CO (A and B) and after addition of 
NEt3 (C). Spectra were collected in CH2Cl2. 
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Figure 6-4. X-ray crystal structures of 1 and 2. Molecular Structures of 1 (left) and 2 
(right) with thermal ellipsoids drawn at 50% probability level; hydrogen atoms have been 
omitted for clarity; color code: iron (brown), carbon (black), sulfur (yellow), phosphorus 
(green), oxygen (red), nitrogen (blue). 
 
Figure 6-5. Cyclic voltammograms of 1 and 2. Cyclic voltammograms of 1 (solid line; 
0.48 mM) and 2 (dashed line; 1.5 mM) in 0.1 M [NBu4][PF6]/ THF at a scan rate of 0.2 
Vs
-1
.  
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Figure 6-6. Electrocatalytic proton reduction from AcOH by 1 and 2. Cyclic 
voltammograms of 1 (top; 0.56 mM) and 2 (bottom; 1.25 mM) with various 
concentrations of acetic acid. The acid concentrations used are 0.2, 0.4, 0.6, 0.8, 1, 1.2, 
1.4 M for complex 1 and 0.05, 0.1, 0.2, 0.4, 0.6, 0.8, 1 M for complex 2. Other 
experimental conditions are as described in Figure 6-5. 
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Figure 6-7. Direct reduction of AcOH at the electrode. Cyclic voltammogram of 
AcOH (1.8 M) in absence of catalysts using glassy carbon electrode. Other experimental 
conditions are as described in Figure 6-5. 
 
Figure 6-8. Plots of catalytic peak current (icat) against [catalyst]. Dependence of      
on catalyst concentration for (A) 1 and (B) 2 at constant acetic acid concentrations. Other 
experimental conditions are as described in Figure 6-5 with a scan rate of 0.1 Vs
-1
. The 
straight lines shown are the best fit lines. The concentrations of AcOH used: (A) 1 M (♦) 
and 1.5 M (■); (B) 0.2 M (♦), 0.4 M (■), 0.6 M (▲), and 0.8 M (●). 
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Figure 6-9. Plots of (icat/ip) against [AcOH]. Dependence of         on the concentration 
of acetic acid added in the experiment of 1 (A) and 2 (B). The straight lines shown are the 
best fit lines. The catalyst concentrations used: (A) 0.74 mM (■, k = 4.67), 0.8 mM (♦, k 
= 4.67), and 1.13 mM (▲, k = 3.73); (B) 0.47 mM (♦, k = 91), 0.6 mM (■, k = 96.9), 0.93 
mM (▲, k = 58.9), and 1.35 mM (●, k = 53) where k is the trimolecular rate constant. 
Other experimental conditions are as described in Figure 6-5 with a scan rate of 0.1 Vs
-1
. 
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Figure 6-10. Electrocatalytic proton reduction from p-TsOH by 1 and 2 Cyclic 
voltammograms of 1 (top; 0.83 mM) and 2 (bottom; 0.88 mM) in the presence of p-
TsOH. Acid concentrations are 2, 4, 6, 8, 10 mM for complex 1 and 1, 2, 3, 5, 10 mM for 
complex 2. Other experimental conditions are as described in Figure 6-5. 
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Figure 6-11. Plots of (icat/ip) against [p-TsOH] and icat against [1]. (A) Dependence of 
        on the concentration of p-TsOH added to the solution of 1; concentration of 
catalyst used: 0.40 mM (♦), 0.58 mM (■), and 0.83 mM (▲) (B) Dependence of      on 
concentration of 1 at fixed acid concentrations, 2 mM (♦), 4 mM (■), and 6 mM (▲). 
Other experimental conditions are as described in Figure 6-5 with a scan rate of 0.1 Vs
-1
. 
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Figure 6-12. Cyclic voltammograms of 1 and 2 in the presence of 0‒2.5 equivalents 
of [p-TsOH]. Cyclic voltammograms of 1 (top; 0.95 mM) and 2 (bottom; 1.39 mM) in 
the presence of varying p-TsOH concentrations ([p-TsOH]/[1] = 0–2.5. Other 
experimental conditions are as described in Figure 6-5. 
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HOMO (1) 
 
LUMO (1) 
 
HOMO 1(H)
+ 
 
LUMO 1(H)
+ 
 
HOMO (2) 
 
LUMO (2) 
 
HOMO 2(H)
+
 
 
LUMO 2(H)
+ 
Figure 6-13. Frontier molecular orbitals of 1, 2, 1(H)
+
 and 2(H)
+
. Electron density 
profiles of the HOMOs and LUMOs of 1, 1(H)
+
, 2, and 2(H)
+
. 
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Scheme 6-1. Synthesis of complexes 1 and 2 from FeCl2, the appropriate bis-phosphane 
ligand, benzene-1,2-dithiol, and CO. 
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Table 6-1. Selected bond lengths (Å) and bond angles (˚) for 1 and 2. 
Bond lengths 1 2 
Fe1-S1 2.1719(7) 2.2007(12) 
Fe1-S2 2.2243(7) 2.1767(12) 
Fe1-P1 2.2405(7) 2.2222(12) 
Fe1-P2 2.2241(7) 2.2249(12) 
Fe1-C41 1.732(3)  1.715(4) 
C41-O41 1.162(3) 1.154(5) 
Bond angles 1 2 
P2-Fe-P1 101.18(2) 87.49(4) 
S1-Fe1-S2 89.21(2) 89.31(4) 
C41-Fe1-S1 134.57(8) 101.30(14) 
C41-Fe1-S2 88.52(8) 106.58(14) 
C41-Fe1-P1 90.19(8) 94.11(14) 
C41-Fe1-P2 96.69(8) 93.28(14) 
S1-Fe1-P2 128.48(3) 165.14(5) 
S2-Fe1-P1 171.74(3) 159.2(5) 
O1-C41-Fe1 173.4(2) 176.7(4) 
 
Table 6-2. Bond distances (Å) within the benzene-1,2-dithiolate ligand in complexes 1 
and 2. 
Bond lengths 1 2 
C1-C6 1.398(3) 1.412(6) 
C1-C2 1.404(3) 1.386(6) 
C2-C3 1.410(3) 1.407(6) 
C3-C4 1.365(3) 1.373(6) 
C4-C5 1.401(4) 1.394(7) 
C5-C6 1.380(3) 1.385(6) 
C1-S1 1.745(2) 1.746(3) 
C2-S2 1.735(2) 1.757(4) 
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Table 6-3 Selected X-ray crystal data for 1 and 2 
Parameter 1 2 
Empirical formula C41H32Fe2OP2S2 C36H34FeNO3P2S2, CHCl3 
Formula weight 778.43 828.91 
Temperature (K) 123(2) 123.(2) 
Wavelength (Å) 0.71073 0.71073 
Z 4 4 
Crystal system Monoclinic Monoclinic 
Space group P1 21/n 1 P1 21/c 1 
a (Å) 9.7375(6) 10.9358 (18) 
b (Å) 20.8536(13) 19.445(3) 
c (Å) 16.8851(11) 17.386(3) 
 () 90 90 
 () 95.2680(10) 94.357(2) 
 () 90 90 
Volume (Å
3
) 3414.2(4) 3686.4(10) 
 (mm-1) 1.100 0.865 
Density (g cm
-3
) 1.514 1.494 
Goodness-of-fit 1.019 1.070 
R1, wR2 [I > 2(I)] 0.0296, 0.0653 0.0535, 0.1326 
R1, wR2 (all data) 0.0460, 0.0714 0.0843, 0.1552 
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Table 6-4. Experimental half-wave potentials for reduction of AcOH (pKa = 24.42) in 
THF catalyzed by 1 (0.56 mM) and 2 (1.25 mM), theoretical half-wave potentials in 
THF, and the overpotentials for 1 and 2. 
[AcOH] 
  /M 
Potential (    ) /V vs Fc
+/0 
Calculated 
(    
 ) 
1 2 
Experimental 
(    
 ) 
Overpotential 
(    
  ‒     
 ) 
Experimental 
(    
 ) 
Overpotential 
(    
  ‒     
 ) 
0.05 -1.454 - - -1.832 0.378 
0.1 -1.463 -1.633 0.17 -1.84 0.377 
0.2 -1.472 -1.647 0.175 -1.853 0.381 
0.4 -1.480 -1.653 0.173 -1.864 0.384 
0.6 -1.486 -1.662 0.176 -1.88 0.394 
0.8 -1.489 -1.68 0.191 -1.902 0.413 
1 -1.492 -1.685 0.193 -1.92 0.428 
1.2 -1.495 -1.69 0.195 - - 
1.4 -1.497 -1.703 0.203 - - 
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Table 6-5. Comparison of selected structural data for 1, 2, 1(H)
+
, and 2(H)
+
 obtained 
from single crystal X-ray analysis and DFT calculations 
Bond lengths 
(Å) and bond 
angles (°) 
X-ray structure Calculated  (B3LYP/6-31G*) 
1 2 1 2 1(H)
+
 2(H)
+
 
Fe1-S1 2.1719(7) 2.2007(12) 2.218 2.229 2.194 2.357 
Fe1-S2 2.2243(7) 2.1767(12) 2.285 2.239 2.386 2.192 
Fe1-P1 2.2405(7) 2.2222(12) 2.297 2.263 2.320 2.284 
Fe1-P2 2.2241(7) 2.2249(12) 2.256 2.256 2.321 2.288 
Fe1-C1 1.732(3) 1.715(4) 1.735 1.706 1.742 1.733 
C1-O1 1.162(3) 1.154(5) 1.162 1.165 1.158 1.157 
C1-C6 1.398(3) 1.412(6) 1.407 1.411 1.404 1.397 
C1-C2 1.404(3) 1.386(6) 1.407 1.409 1.399 1.399 
C2-C3 1.410(3) 1.407(6) 1.409 1.409 1.397 1.404 
C3-C4 1.365(3) 1.373(6) 1.388 1.391 1.394 1.393 
C4-C5 1.401(4) 1.394(7) 1.405 1.407 1.399 1.399 
C5-C6 1.380(3) 1.385(6) 1.389 1.391 1.393 1.394 
C1-S1 1.745(2) 1.746(3) 1.764 1.757 1.780 1.794 
C2-S2 1.735(2) 1.757(4) 1.757 1.758 1.794 1.781 
P2-Fe-P1 101.18(2) 87.49(4) 102.4 89.3 100.8 92.9 
S1-Fe1-S2 89.21(2) 89.31(4) 88.4 89.3 87.2 86.9 
C1-Fe1-S1 134.57(8) 101.30(14) 137.9 102.4 130.4 93.3 
C1-Fe1-S2 88.52(8) 106.58(14) 86.3 99.1 89.4 119.5 
C1-Fe1-P1 90.19(8) 94.11(14) 89.9 96.0 89.5 92.8 
C1-Fe1-P2 96.69(8) 93.28(14) 97.0 97.9 96.3 93.8 
S1-Fe1-P2 128.48(3) 165.14(5) 124.7 159.7 132.9 172.6 
S2-Fe1-P1 171.74(3) 159.2(5) 168.8 164.9 171.8 147.6 
O1-C1-Fe1 173.4(2) 176.7(4) 172.6 173.4 170.5 173.0 
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Table 6-6. Orbital contributions (%) and overlap populations of different fragments of 1, 
1(H)
+
, 2, and 2(H)
+
 to the corresponding HOMOs and LUMOs 
Atoms or molecular fragments 
HOMO (energy, eV) LUMO (energy, eV) 
1 
(-4.79) 
1(H) 
(-8.16) 
2 
(-4.81) 
2(H) 
(-8.47) 
1 
(-1.72) 
1(H) 
(-5.06) 
2 
(-1.48) 
2(H) 
(-4.96) 
Fe1 
s 0 0 0 1 1 0 0 0 
p 3 0 5 3 4 8 7 9 
dz2 10 0 11 6 11 23 21 36 
dxz 3 0 0 0 2 3 22 10 
dyz 0 0 1 1 12 9 0 2 
dx2-y2 0 0 0 1 22 19 0 0 
dxy 6 0 0 1 4 0 0 4 
Total d 19 0 12 9 51 55 43 52 
Fe2 (ferrocene) 
s 0 0 - - 0 0 - - 
p 0 0 - - 0 0 - - 
d 0 79 - - 1 1 - - 
S1 
s 0 0 0 0 0 0 0 0 
p 0 0 9 1 8 9 8 2 
d 0 0 0 0 0 0 0 0 
S2 
s 0 0 0 0 0 0 0 0 
p 41 0 26 37 6 1 7 10 
d 0 0 0 0 0 0 0 0 
CO 
s 0 0 0 0 1 2 4 4 
p 0 0 1 1 2 2 2 2 
d 0 0 0 0 0 0 0 0 
P1 
s 0 0 0 0 0 0 0 0 
p 1 0 2 1 2 2 4 5 
d 0 0 0 0 0 0 1 0 
P2 
s 0 0 0 0 1 0 0 0 
p 0 0 1 1 7 6 4 3 
d 0 0 0 0 1 0 1 0 
Phenyl ring (bdt) Total 32 0 40 39 5 5 4 5 
Cp rings of dppf (1)/ 
NP2 ligand (2) 
Total 0 20 0 0 2 1 0 0 
Phenyl rings (PPh2) Total 2 1 3 7 9 5 16 5 
Proton (H) Total - 0 - 0 - 1 - 1 
Overlap Populations 
Fe1-S1 0.00 0.00 0.02 -0.01 -0.08 -0.08 -0.07 0.02 
Fe1-S2 0.02 0.00 0.04 0.04 -0.04 0.01 -0.07 -0.08 
Fe-C 0.00 0.00 -0.01 -0.01 0.02 0.00 0.00 0.01 
Fe-P1 0.03 0.00 0.02 0.01 0.00 0.04 0.05 0.03 
Fe-P2 0.00 0.00 0.01 0.01 -0.04 0.02 0.05 0.04 
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Table 6-7. Comparison of the optimized geometries of 2 evaluated using different 
functionals and basis sets with the experimentally obtained geometry. 
Bond 
lengths (Å) 
and bond 
angles (°) 
X-ray 
BP86/ 
6-31G* 
BP86/ 
TZVPP 
TPPS/ 
6-31G* 
TPPS/ 
TZVPP 
B3LYP/ 
6-31G* 
Fe1-S1 2.201 2.211 2.211 2.208 2.206 2.227 
Fe1-S2 2.177 2.202 2.199 2.206 2.198 2.222 
Fe1-P1 2.225 2.232 2.230 2.229 2.229 2.292 
Fe1-P2 2.222 2.237 2.236 2.229 2.224 2.285 
Fe1-C1 1.715 1.709 1.711 1.716 1.716 1.723 
C1-O1 1.154 1.185 1.173 1.182 1.170 1.164 
P2-Fe-P1 87.5 91.1 90.1 89.0 88.9 91.1 
S1-Fe-S2 89.3 88.8 88.8 89.1 89.0 88.9 
C1-Fe-S1 101.3 101.5 101.5 102.3 101.8 100.0 
C1-Fe-S2 106.6 106.8 105.8 104.6 105.1 103.3 
C1-Fe-P1 94.1 94.8 96.1 95.2 95.8 96.7 
C1-Fe-P2 93.3 94.1 93.4 94.4 94.3 94.6 
S1-Fe-P2 165.1 163.7 165.1 162.2 163.9 163.3 
S2-Fe-P1 159.2 159.1 158.1 161.0 159.0 162.1 
O1-C1-Fe 176.7 175.8 175.5 175.9 175.7 175.9 
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